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S u m m a r y
Skeletal muscle is a highly organised yet adaptive tissue, capable of changing aspects 
of fibre phenotype in response to demand. While the external signals mediating these 
changes, such as patterns of motor neuron activity or hormone signalling, are well 
studied the manner by which these external stimuli are converted into specific patterns 
of gene expression is less understood. GATA-2 and NFAT-2 are two transcription 
factors implicated in this process. In this study, conserved regions of the GATA and 
NFAT transcription factor families were used to design primers for a homology-based 
PCR-cloning approach to isolate the porcine orthologues of GATA-2 and NFAT-2. The 
pig was chosen as the target species for this investigation, given the importance of 
porcine muscle both as a large animal model for muscle development and as a 
commercially important meat animal.
The long-term goal of the work was to determine what effects these transcription 
factors might have in the regulation of stage- and isofoim-specific gene expression. A 
porcine orthologue of GATA-2 was cloned, and the sequence submitted to GenBank 
(Accession N~ AY251012). Though only a tmncated cDNA clone was obtained from 
efforts to clone porcine NFAT-2, sufficient sequence data was recovered for the design 
of isoform-specific primers for quantitative real-time RT-PCR. GATA-2 and NFAT-2 
were found to have a wide tissue distribution. A novel finding was that GATA-2 was 
found to be highly expressed in uterine smooth muscle. This suggests that the 
segregation of GATA-family members between haemopoietic functions and 
mesodermal tissues may not be as distinct as was previously thought.
In addition to studying rraiig-acting factors, this study also looked at potential targets 
for factors modifying fibre phenotype, in particular the isoforms of myosin heavy chain 
(MyHC). The different MyHC isofoims expressed in a muscle fibre gieatly influence 
aspects of phenotype such as shortening velocity and ATPase activity, and are 
indicative of fibre type. One such isofomi, the embryonic MyHC (emMyHC), was one 
of the last remaining uncharacterised isoforms in the pig. The first intron and 
immediate upstream region of the porcine embryonic MyHC were isolated and 
sequenced, and it was found that the translation start site of the porcine isoform was
located on exon 2 , something which had not been previously reported in any other 
isoforms or orthologues of the gene. A GATA-2 binding site was found, 4 kb upstream 
of the transcriptional start site. Reporter constructs were generated for use in 
conjunction with the GATA-2 clone.
Through in vitro transcription-tianslation, the GATA-2 clone was found to encode a 
functional reading frame for a protein of the expected size and was deemed suitable for 
functional studies. Technical difficulties frustrated the efforts to quantify changes in 
MyHC expression in porcine primary myoblasts through quantitative real-time RT- 
PCR. However, a preliminary in vitro study in C2C 12 murine myoblasts suggested that 
emMyHC reporter activity was reduced by GATA-2 overexpression. Together with 
developmental expression patterns showing an upregulation in GATA-2 coinciding 
with the developmental downregulation of emMyHC, and the presence of a putative 
GATA-2 binding site in the 5’ UTR, this was taken as evidence of a possible role for 
GATA-2 in negatively regulating emMyHC. Some possibilities for studies to further 
explore these findings are discussed.
T a b l e  o f  C o n t e n t s
Summary 3
Table of Contents 5
List of Tables 8
List of Figures 9
Acknowledgements 12
Declaration 13
Abbreviations 14
C h a p t e r  O n e  - G e n e r a l  In t r o d u c t io n  18
1.1 Introduction 19
1.2 An Overview of Muscle Fibres 19
1.2.1 Muscle Fibres and Fibre Types 19
1.2.2 Muscle Growth and Development 25
1.2.3 Skeletal Muscle Adaptation 35
1.2.4 Practical Implications 40
1.3 Post-Natal Muscle Transcription Factors 44
1.3.1 Transcriptional Conti'ol 44
1.3.2 MRFs and Fibre Type 45
1.3.3 IGF-IR Signal Transduction 46
1.3.4 The MEF-2 Family 51
1.4 Calcineurin and NFAT 57
1.4.1 Structure and Function of Calcineurin 57
1.4.2 The NFAT Family 60
1.4.3 The GATA Family 63
1.4.4 Roles for Calcineurin/NFAT Signalling in Muscle 64
1.5 Summary 72
1.6 Project Aims 73
C h a p t e r  T w o  - G e n e r a l  M a t e r ia l s  &  M e t h o d s  74
2.1 Introduction 75
2.2 Methods 75
2.2.1 Recombinant DNA Techniques 75
2.2.2 Polymerase Chain Reaction 80
2.2.3 DNA Sequence Analysis 81
2.2.4 Southern and Northern Blot Hybridisation 83
2.2.5 Primary Cell Culture 90
2.2.6 Quantitative Real-Time RT-PCR 95
C h a p t e r  T h r e e  - C lo n in g  P o r c in e  M u s c le  GATA-2 & 100
NFAT-2
3.1 Introduction 101
3.1.1 GATA Zinc fingers 101
3.1.2 NFAT REL-Homology Region 103
3.1.3 Cloning Strategies 104
3.1.4 Aims 105
3.2 Materials and Methods 106
3.2.1 PCR-Homology Cloning 106
3.2.2 Lambda Library Screening 110
3.2.3 NFAT 5' Modification 112
3.2.4 SMART-RACE PCR 114
3.2.5 Sequencing 117
3.3 Results 120
3.3.1 PCR Cloning 120
3.3.2 Library Screening 121
3.3.3 GATA 121
3.3.4 NFAT 131
3.4 Discussion 141
C h a p t e r  F o u r  - E m b r y o n ic  M y H C  P r o m o t e r  R e g io n  144
C l o n in g
4.1 Introduction 145
4.1.1 MyHC Genomic Organisation 145
4.1.2 BAG Libraiy Screening 148
4.1.3 Aims 148
4,2. Materials and Methods 149
4.2.1 BAC Library Screening 149
4.2.2 Cloning emMyHC Reporter Constructs 150
4.2.3 LI-COR Sequencing 152
4.2.4 ABI Sequencing 154
4.2.5 Sequence Analysis 154
4.3 Results 155
4.3.1 BAC Library Screening 155
4.3.2 Promoter Region Cloning 155
4.3.3 Sequencing 157
4.4. Discussion 164
C h a p t e r  F iv e  - GATA-2 & NFAT-2 F u n c t io n a l  &  166
E x p r e ssio n  St u d ie s
5.1 Introduction 167
5.1.1 Distribution of GATA-2 167
5.1.2 Distribution of NFAT-2 168
5.1.3 GATA-2 Function in Muscle 169
5.1.4 Aims 170
5.2 Materials and Methods 171
5.2.1 Quantitative Real Time RT-PCR 171
5.2.2 Protein Analysis 172
5.2.3 Primary Cell Cultures 176
5.2.4 C2C12 Cultures 179
5.3 Results 181
5.3.1 mRNA Expression 181
5.3.2 Protein Analysis 184
5.3.3 Primary Cell Culture 186
5.3.4 C2C12 Myoblast Culture 189
5.4 Discussion 192
5.4.1 Expression Patterns 192
5.4.2 GATA-2 Function 193
C h a p t e r  Six : G e n e r a l  D is c u ssio n  196
6.1 Introduction 197
6.2 The Role of GATA-2 198
6 .2.1 Fibre type switch 199
6.2.2 Development and Regeneration 200
6.3 NFAT Distribution 201
R e f e r e n c e s  202
L ist  o f  Ta bl es
Table 1.1. The properties of different fibre types.
Table 1.2. Fibre-type specific expression of MyHC isofoims in porcine, adult
muscle.
Table 1.3. Summary of the investigation into the roles of MRF proteins in
myogenesis discovered through the generation of homozygous 
knockout mice.
Table 1.4. Nomenclature for NFAT family members.
Table 1.5. Tissue distribution of NFAT family members.
Table 1.6. Multiple, possibly overlapping functions of GATA family transcription
factors.
Table 1.7. Studies supporting the role of calcineurin signalling in the acquisition
of the slow fibre phenotype.
Table 4.1. Putative transcription factor binding sites of interest found in the 5’
UTR sequence of the porcine emMyHC.
Table 5.1. Tissue distribution of GATA-2 during development and in the adult.
Table 5.2. Tissue distribution of NFAT-2 during development and in the adult.
Table 5.3. GATA-2, NFAT-2 and (3-actin primer and probe sets designed for
TaqMan real-time PCR.
Table 5.4. Porcine primer and probe sets designed for TaqMan real-time PCR.
Table 5.5. Average C t readings for the initial characterisation of myoblast cultures
derived from primary tissue extractions.
L ist  o f  F ig u r es
Figure 1.1. Levels of organisation in skeletal muscle.
Figure 1.2. Myosin heavy chain dimer with bound myosin light chains.
Figure 1.3. Compartmentalisation in the somite.
Figure 1.4. Delamination of limb-muscle precursors and migration.
Figure 1.5. Different modes of skeletal muscle hypertrophy.
Figure 1.6. Summary of the extiinsic factors influencing MyHC expression and
fibre type.
Figure 1.7. Correlation of patterns of ATPase staining with myonuclear domains 
in the longitudinal sections of hybrid fibres taken from very old 
subjects.
Figure 1.8. Summary of IGF-1R mediated pathways in myoblast proliferation and 
differentiation.
Figure 1.9. Details of the PI3-K/Akt pathway.
Figure 1.10. The activation of MEF-2 transcription factors by calcium/calmodulin-
dependent protein kinase (CaMK).
Figure 1.11. Summary of the calcineurin/NFAT signalling pathway, as is present in
a number of cell types.
Figure 1.12. Structural features of NFAT proteins.
Figure 1.13. Model for the activation of NFAT proteins and the formation of a
transcriptional complex with calmodulin/calcineurin, emphasising the 
conformational changes involved.
Figure 1.14. A summary of the different myogenic processes mediated by 
calcineurin.
Figure 3.1. Structure of GATA zinc fingers.
Figure 3.2. Stiucture of the highly conserved NFAT binding domain.
Figure 3.3. Pileup of zinc-finger DNA binding domains from mouse, human and
chicken GATA-2.
Figure 3.4. Pileup of Rel-homology regions fi’om mouse and human NFAT-2 and 
NFAT-1 isofoims.
Figure 3.5. Summary of the cloning strategy used to modify the 5’ end of the 
truncated NFAT clone.
Figure 3.6. Sequences obtained for the products of PCR homology cloning.
Figure 3.7. Results of successive rounds of library screening.
Figure 3.8. Restriction map of the full-length GATA clone ligated into the pBK-
CMV vector.
Figure 3.9. Nucleotide sequence and deduced amino acid sequence of porcine
GATA-2 transcription factor.
Figure 3.10. Sequence comparison of the deduced amino acid sequence of the 
acquired GATA clone with those of different human GATA isoforms.
Figure 3.11. Pileup of amino-acid sequences for GATA-2 transcription factors 
across a range of species.
Figure 3.12. Restriction map of the truncated NFAT clone ligated into the pBK- 
CMV vector.
Figure 3.13. Nucleotide sequence and deduced amino acid sequence of porcine 
NFAT-2 transcription factor.
Figure 3.14. Sequence comparison of the acquired NFAT sequence with other 
human NFAT isoforms.
Figure 3,15, Pileup of amino-acid sequences for NFAT-2 transcription factors 
across a range of species. NFATmac is a porcine NFAT-2 isolated 
from macrophages.
Figure 4.1. Organisation of MyHC genes.
Figure 4.2. Previously isolated porcine emMyHC cDNA.
Figure 4.3. Southern Blots from the BAC library screening.
Figure 4.4. BanüFl restriction map of the three promoter region fragments used in
the construction of reporter constructs.
Figure 4.5. Cloning strategies used to generate the pEGFP-1/emMyHC reporter 
conshucts.
Figure 4.6. Genomic sequence 5 ’ of the porcine emMyHC coding region, 
including exons 1 and 2 .
Figure 4.7. Multiple alignments of the immediate emMyHC promoter regions of 
hamster, rat and pig, showing the high degree of homology in the 
proximal 250 bp.
Figure 5.1. Experimental set-up for transient emMyHC/GFP transfections in 
C2C12 cells.
10
Figure 5.2. SDS-PAGE analysis of the porcine GATA-2 clone.
Figure 5.3. Tissue distribution of GATA-2 and NFAT-2 expression in a six-week-
old pig.
Figure 5.4. Relative expression of GATA-2 and NFAT-2 expression in fast (LD) 
and slow (psoas) muscles.
Figure 5.5. Expression of GATA-2 and NFAT-2 in different stages of pre- and 
post-natal porcine development, in LD muscle.
Figure 5.6. Examples of desmin staining of primary cultures from porcine muscle,
showing the variability of myoblast differentiation.
Figure 5.7. Pileup comparison of the porcine GATA clone and murine GATA-2.
Figure 5.8. Verification of GATA-2 expression in the C2C12/GATA-2 cell line.
Figure 5.9. Effect of GATA-2 on emMyHC reporter constructs.
Figure 5.10. Comparison of developmental patterns of expression between the
GATA-2 clone and emMyHC.
11
A c k n o w l e d g e m e n t s
No account of the study described herein would be complete without an 
acknowledgement of the friends and colleagues whose help and encouragement along 
the way has been invaluable. I am particularly indebted to Dr Kin-Chow Chang, my 
academic supervisor while studying at the Molecular Medicine Laboratory, for advice, 
helpful criticism and for his forbearance in the final stages of producing this work. This 
study was funded by a BBSRC/CASE award, co-sponsored by Sygen/PIC. I would like 
to thank Dr Gaiy Evans, my industry supervisor, for his input into the time I spent at 
Cambridge, particularly during the Sygen/PIC student conferences. I am gi'ateful also 
to Dr Graham Plastow and Dr Alan Mileham, also at Sygen/PIC, for their part in 
supporting this study. Thanks also to Dr Yuh-Man Sun, then at the Roslin Institute, 
Edinburgh, for the opportunity to collaborate in the emMyHC promoter work.
A gieat debt of gratitude is owed my colleagues in the Molecular Medicine Laboratory, 
past and present: Nuno da Costa, Christine McGillivray, Dr Hadi Alzuherri and Irene 
Johnson; and also Nicholas Beuzen, Qian-Fan Bai and Peck-Tong Ooi, fellow travellers 
along a long road. I am grateful to to all those I have met and worked with in my time 
in the Veterinary Pathology Department, as friendly and welcoming as any PhD student 
could hope for. Special mention is also due Gary Jackson, in the Department of 
Veterinary Physiology, for advice in those times when Sequencing Goes Bad. Last, but 
by no means least, I would like to acknowledge the many friends I have made while 
studying in Glasgow, who I will sorely miss, who made my time in that fair city a 
memorable one.
12
D e c l a r a t io n
The studies described in this thesis were carried out in the Molecular Medicine 
Laboratory, in the Department of Veterinary Pathology at the University of Glasgow 
Veterinary School between September 1999 and February 2004. The author was 
directly responsible for all the work described herein, with the exception of the 
following: Sequencing using the ABI PRISM dGTP BigDye Sequencing kit described 
in Chapter Three was carried out by staff at the MB SU department at Glasgow 
University. The characterisation of the porcine emMyHC isofoim 5’ regulatory region, 
described in Chapter Four was done as part of a collaboration between the Molecular 
Medicine Laboratory and Dr Yuh-Man Sun of the Roslin Institute, Edinburgh. The 
three GFP-promoter constructs resulting from this work were kindly donated by Dr 
Yuh-Man Sun. Western blotting and In Vitro Transcription Translation described in 
Chapter Five were carried out by Dr Hadi Alzuherri, also in the Molecular Medicine 
Laboratory at the University of Glasgow Veterinary School. Pooled cDNA used in the 
investigation of GATA and NFAT expression in development and in different dietaiy 
conditions was graciously supplied by Mr Nuno da Costa, Molecular Medicine 
Laboratory. The desmin immunostaining described in Chapter Five was carried out by 
Mr Collin Nixon. The humane slaughter of the animals used in the study was carried 
out by Veterinary Faculty pathologists.
13
A b b r e v ia t io n s
“c degrees Celsius
jal microlitre(s)
pM micromolar
A260/280/600 absorbance at 260/280/600 nm
Akt see PKB
APS ammonium persulphate
bHLH basic helix-loop-helix
BMP-4 bone morphogenetic protein-4
bp base pair
CaM calmodulin
cDNA complementary deoxyribonucleic acid
Cain calcineurin inhibitor
CaMK calcium/calmodulin-dependent protein kinase
Ci curie
Cn calcineurin
CsA cyclosporin A
Ct threshold cycle
DEPC diethylpyrocarbonate
DMEM Dulbecco’s modified Eagle medium
DMSO dimethylsulphoxide
DNA deoxyribonucleic acid
DTT dithiothretiol
ECL enhanced chemiluminescence
EDTA ethylene diamine tetra acetic acid
EGFP enhanced green fluorescent protein
emMyHC embryonic myosin heavy chain
ERK extiacellular signal regulated kinase
EtBr ethidium bromide
FG fast-glycolytic
FOG friend of GATA or fast oxidative-glycolytic
FCS foetal calf serum
14
GATA
GFP
Grb2
GSK3
GSP
HATs
HDACs
HRP
HEPES
IGF
IGF-IR
IRS-1
kDa
L
LD
LiCl
LiDS
LB
MAPK
MADS domain 
M
MEF-2
MEK
MESA
ml
mg
MOPS
MPC
MRF
mTOR
MyHC
mRNA
NCAM
family o f transcription factors recognising the consensus binding
site 'WGATAR'
green fluorescent protein
growth factor receptor bound protein 2
glycogen synthase kinase 3
gene specific primer
histone acetyltransferases
histone deacetylases
horseradish peroxidase
N-2-hydroxyehtylpiperazine-N'-2-ethanesuIfonic acid
insulin-like giowth factor
insulin-like giowth factor-1 receptor
insulin receptor substiate-1
kilodalton
litre(s)
longissimus dorsii
lithium chloride
lithium dodecyl-sulphate
Luria-Bertani medium
mitogen-activated protein kinase
MCMl, Agamous, Deficiens and SRF domain
molar
myocyte enhancer factor 2 
mitogen-activated protein kinase/ERK kinase 
MOPS-EDTA-sodium acetate 
millilitre(s) 
milligram(s)
3 -moipholinopropanesulphonic acid
magnetic particle collector
myogenic regulatory factor
mammalian target of Rapamycin
myosin heavy chain
messenger RNA
neural cell adhesion molecule
15
NFAT nuclear factor of activated T-lymphocytes
NFk-B nuclear factor kappa beta
nm nanometre
oligo(DT) oligodeoxythymidylic acid
ORF open reading frame
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
PDKl phosphoinositide-dependent protein kinase 1
PEG polyethylene glycol
periMyHC perinatal myosin heavy chain
pfu plaque forming units
PG C-la peroxisome proliferator-activated receptor 7 coactivator l a
PI3-K phosphatidylinositol 3-kinase
PIP2 phosphatidylinositol (4,5)-bisphosphate
PIP3 phosphatidylinositol (3,4,5)-trisphosphate
PKB protein kinase B
PMSF phenylmethylsulfonyl fluoride
poly(A)"' polyadenylated (mRNA)
PPARy peroxisome proliferator-activated receptor 7
PP2A protein phosphatase 2A
PVDF polyvinylidene fluoride
PTEN phosphatase and tensin homologoue on cliromosome 10
RACE rapid amplification of cDNA ends
RT-PCR reverse-transcriptase polymerase chain reaction
SDS sodium dodecyl-sulphate
Slih sonic hedgehog
SMART switching mechanism at 5’ end of RNA transcript
SoS son of sevenless
SO slow-oxidative
SRF serum response factor
SURE slow upstream regulatory element
TCA trichloroacetic acid
16
TEMED telTamethyl-1 -,2-diaminomethane
Tris tris (hydroxymethyl) aminomethane
Tris HCl dis hydrochloride
TBS tris buffered saline
TSR template suppression reagent
UTR unti'anslated region
Wnt wingless/int
17
C h a p t e r  O n e  - G e n e r a l  In t r o d u c t io n
18
1.1 In t r o d u c t io n
Skeletal muscle-fibres may be divided into a number of subtypes that exhibit markedly 
different physiological properties, such as conhaction velocity or resistance to fatigue. 
These propeities are conferred by fibre-specific patterns of gene expression that control 
both the enzymes involved in energy metabolism and the characteristic protein 
isoforms of the contractile apparatus. The population of fibre types within a muscle is 
not fixed, however, and can be altered by extrinsic factors such as motor neiwe activity, 
mechanical load or hormonal levels, allowing the muscle to adapt to changes in 
physiological demand.
Currently, the mechanisms of transcriptional control by which these extrinsic factors 
are transduced into changes in fibre-specific patterns of gene expression remain 
incompletely understood. One pathway recently implicated in the acquisition and 
maintenance of fibre-phenotype is the Ca^ëcalcineurin/NFAT pathway. While this 
pathway is well known and studied in a range of tissue types, its role in muscle has 
been the subject of considerable, recent debate. It is the investigation into the role of the 
transcription factors involved in this pathway that forms the basis of the study 
described herein.
It is the aim of this chapter, then, to provide an overview of the following: Firstly, the 
different fibre-types and the underlying muscle-biology that gives rise to them. 
Secondly, the manner in which various transcriptional pathways, particularly 
calcineurin/NFAT, are thought to regulate fibre-specific patterns of gene expression. 
Finally, to relate this background infoimation to the shidy undertaken and the 
immediate strategies employed.
1.2 A n  O v e r v ie w  o f  m u s c l e  F ib r e s
1.2.1 M u sc l e  F ib r e s  a n d  F ib r e  T y pes
Skeletal muscle is a hierarchical structure made up of bundles of long, terminally- 
differentiated cell-syncitia, called muscle fibres (Figure 1.1), These fibres contain the
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Sarcomere
Filaments 
Myofibril
Myonucl Sarcoplasmic Reticulum
T-tubule
Muscle fibre
Sarcolemma
Bundle of fibres
B.
Actin filament
Myosin filament
< — >  H-zone
1-Band -X - A-Band Z-disc
Muscle
endon
Figure 1.1. Levels of organisation in skeletal muscle. A. Cross-section of an 
anatomical muscle, showing the composition of individual muscle fibres and their 
relationship to whole muscle. B. Detail of an individual sarcomere, showing the 
arrangement of the contractile actin (thin) and myosin (thick) filaments.
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protein filaments of the contractile apparatus, arranged in a series of functional units, or 
sarcomeres, of overlapping thick (myosin) and thin (actin) filaments. During 
contraction, cross-bridges are formed between these myosin and actin filaments in a 
cyclical, ATP-dependent manner. The thin filaments are drawn in over the thick 
filaments, resulting in a shortening of the sarcomere and the generation of force 
(Huxley, 1969).
Muscle fibres are not identical, however, but may be classified into different types 
according to physical or metabolic properties (Pette and Staron, 1990), such as power 
output or resistance to fatigue. Traditionally, fibre types are classified into three main 
groups, these being slow-oxidative (SO), fast oxidative-glycolytic (FOG) and fast- 
glycolytic (FG), based on histochemical stainings (Brooke and Kaiser, 1970; Handel 
and Stickland, 1987). These are also sometimes referred to as type I, type Ha and type 
Ilb fibres. The remainder of this section will consider the different fibre properties that 
are a consequence of factors intrinsic to the different fibre type. That is to say, 
independent of the properties conferred by extrinsic factors, such as neuronal or 
hoimonal control, which are covered in Section 1.2.2.
1.2.1.1 Fibre Properties
Power output, measured as work done per unit time, is largely dependent on the 
velocity of sarcomere contiaction ( V m a x )> which is in turn related to the specific 
activity of the myosin ATPase (Barany, 1967). A greater rate of ATP hydrolysis results 
in a greater rate of actin-myosin cross-bridge formation and a higher V m a x - Fast fibres 
possess myosin that hydrolyses ATP quickly, and thus have a faster cycle time and 
greater Vmax and power output. The downside of this is an increased demand for ATP. 
ATP may be supplied at high rate by glycolysis, and fast glycolytic fibres typically 
possess large stores of glycogen. This process results in the build-up of lactic acid, 
however, a by-product that inhibits muscle function (Brooks and Mercier, 1994). Slow 
fibres, on the other hand, have a lower velocity of contraction and hence a lower power 
output, but as a result are more economical in ATP usage and capable of sustaining 
isometric force for longer periods of time. Low intensity force generation may be 
supplied by oxidative metabolism of carbohydrate or lipid stores, which is a more 
efficient process than glycolysis (Hargreaves, 2000). Oxidative fibres are characterised 
by their larger lipid stores, and higher mitochondrial and oxidative enzyme content
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(Goldspink, 1985). Oxidative metabolism is limited, however, by the requirement for 
adequate perfusion of oxygen and nutrient substrate from the blood, which limits the 
size of predominantly oxidative fibres. This places another limit on the amount of force 
that slow oxidative fibres can generate, since larger fibres have more contractile 
proteins in parallel (see also Section 1.2.2.5 on muscle fibre hyperfrophy). Oxidative 
metabolism is less useful during high intensity exercise, when the levels of oxygen and 
substrate in the blood become limiting. Oxidative metabolism, and the fibres best 
adapted for it, therefore tends to be used for low-intensity activity. As the force 
requirement increases, fast fibres and glycolytic metabolism are recruited for the 
generation of the necessary speed and power (Brooks and Mercier, 1994; Goldspink, 
1996). A summary of the properties of different fibre types is presented in Table 1.1.
Fibre Type SO FOG FG
Vmax Slow Intermediate Fast
Size ++ (++) +4-4-
Glycogen (+) (++) +++Lipid +++ (++) (+)Fatigue Resistant Intermediate Sensitive
Table 1.1. The properties of different fibre types. ( ) indicates variable levels.
1.2.1.2 Fibre Distribution
Each anatomical muscle is composed of a mosaic of these different fibre types, but the 
predominant type depends on the muscle’s physiological role. Postural muscles such as 
the soleus are activated continuously during standing or walking, and are characterised 
by efficient, slow oxidative fibres better suited for producing slow, repetitive 
movements (Hnik et a l, 1985). Conversely, the muscles used in locomotion are 
composed of FG or FOG fibres, with their greater capacity for force generation, but 
lower fatigue resistance. Given the mosaic nature of muscle tissue, accurate 
determination of the fibre content within muscle has proved difficult with more 
traditional methods. Fibre type may be more accurately identified by reverse 
ti’anscriptase-PCR (RT-PCR), characterising fibre-specific expression of different 
iso forms of metabolic and contractile proteins (Ennion et a l, 1995). Of these, perhaps 
the most useful and most commonly used markers for fibre type are the isofoims of 
myosin heavy chain (MyHC) (reviewed in Schiaffino and Reggiani, 1996).
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1.2.1.3 Myosin Heavy Chain
The sarcomeric MyHC proteins are a component of the thick filament of the contractile 
apparatus (reviewed in Weiss and Leinwand, 1996). The MyHCs expressed in muscle 
are a subset of the class II, or conventional two headed myosins, which are composed 
of two non-identical pairs of myosin light chains (MyLC) and two, paired MyHC 
subunits. It is the MyHC component that is of most interest when considering muscle 
fibre type, since it is these proteins that mediate both the myosin motor function and 
filament formation. Each MyHC is made up of two functional domains, as illustrated in 
Figure 1.2; a globular head domain (the SI proteolytic fraction), and a long, helical rod 
domain (S2 and LMM proteolytic factions). The head contains the actin binding 
domain and ATPase, while the rod domain is required for filament formation.
Essential Light Chain
Regulatory Light Chain
LMM
SI
Figure 1.2. Myosin heavy chain dimer with bound myosin light chains (from Weiss 
and Leinwand, 1996). The blue-shaded SI proteolytic fragment/myosin head domain 
contains the actin binding and ATPase sites. S2 and LMM proteolytic fragments both 
correspond to the alpha helical coiled coil rod domain.
There are eight MyHC genes, expressed in skeletal muscle in a temporal-spatial 
specific manner. These are the l/slow/(3, 2a, 2x/d, 2b, embryonic, perinatal, a  and 
extra-ocular MyHCs. The properties of the actin binding domain and ATPase, and 
therefore the speed of the filament cross-linking cycle, are unique to each MyHC 
isoform. The MyHC isoform present in a muscle fibre therefore plays a large part in 
conferring its speed of contraction and power output. Of the eight skeletal muscle 
MyHCs, the 1/(3, 2a and 2x/d isoforms (listed in ascending order of V m ax) are of the 
greatest importance in post-natal skeletal muscle, the others being developmental or
23
specialist forms. A fourth, faster adult isoform, the 2b, is expressed in the fast fibres of 
rodent and porcine muscle (Pette and Staron, 2000), but is absent from many other 
mammalian species such as the cow or horse (Chikuni et a l, 2004a, 2004b). The 
expression of 2b MyHC in humans is limited to the extraocular and masseter muscles, 
with only niRNA detectable in the latter (Horton et a l, 2001). The presence of 2b 
MyHC in porcine muscle makes the pig, at the time of writing, somewhat unique 
among large animals. It has been suggested that the high expression of the 2b isofoim 
in porcine muscle is related to intensive breeding for leaner meat (Chang et a l, 2003b), 
a subject that shall be covered in more detail in Section 1.2.4.2.
It should be noted that the expression of MyHC isofomis do not always correlate with 
the ti*aditional, histocheniical-based fibre-type nomenclature of the fibres in which they 
are expressed. In addition to fibres expressing a single MyHC isoform there exists a 
continuous spectrum of intermediate forms, Ifom combinations of type 1/(3 with 2a, 2a 
with 2x/d, and 2x/d with 2b (Schiaffmo and Reggiani, 1994). The properties of the fibre 
types in which these four isoforms are predominantly expressed are summarised in 
Table 1.2.
MyHC Isoform Fibre Type
Slow/1/(3 SO
2a FOG
2x FOG
2b FG
Table 1.2. Fibre-type specific expression of MyHC isofomis in porcine, adult muscle.
It is worthwhile mentioning the four remaining MyHC family members. Two of these 
isofomis (embryonic and perinatal MyHC) are expressed during development (Lu et 
a l, 1999; see also Section 1.2.2.3). They are normally downregulated after birth, but 
are activated in muscle satellite cells during the regeneration of damaged muscle 
(Webster et a l, 1988; Karsch-Mizrachi et a l, 1989) and are therefore also expressed in 
differentiating myoblasts in primaiy cell culture (Torgan and Daniels, 2001). The last 
two isofomis are found in the specialised fibres of the extra-ocular and mandibular 
muscles (eoMyHC and MyHC-a, respectively). As a final note, the a  and 1/(3 isofomis 
are also the major MyHCs in cardiac muscle. Cardiomyocytes and slow skeletal muscle
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fibres share more than just the 1/p MyHC, however, and in fact a number of other 
muscle-gene isoforms found specifically in slow muscle are also expressed in the heart.
1.2.2 M u sc l e  G r o w t h  a n d  D e v e l o p m e n t
The complex, hierarchical structure of skeletal muscle is derived from its 
undifferentiated, mesodermal precursors by a tightly regulated cascade of events, 
triggered in response to a variety of signalling molecules secreted by neighbouring 
tissues. This chain of events begins with the commitment of progenitor cells to the 
myogenic lineage, followed by withdrawal from the cell cycle and terminal 
differentiation. Differentiation events include the fusion of myocytes into myotubes and 
their subsequent maturation into muscle fibres, with the development of the contractile 
apparatus and the complex stinctures already discussed. The same process of 
embryonic myogenesis is also, to some extent, reiterated in adult muscle stem cells 
during the adaptive responses to muscle training or regeneration following injury 
(reviewed in Parker et a l, 2003).
Since the myogenic process plays a role in post-natal muscle adaptation, it is 
worthwhile considering the events of embryonic myogenesis. The puipose of this 
section, then, is to introduce key transcription factors central to the myogenic process, 
namely the members of the myogenic regulatory factor (MRP) family, and to 
summarise the developmental networks that give rise to committed muscle progenitors.
1.2.2.1 MRF Proteins
Perhaps the best studied of all muscle transcription factors (reviewed in Pownall et a l, 
2002), the MRF family are central to the development of muscle, both during 
embiyogenesis and in post-natal regeneration and repair. The MRFs are basic helix- 
loop-helix (bHLH) transcription factors consisting of four known proteins, MyoD, myf- 
5, myogenin and MRF-4, all noted for their ability to initiate the expression of myoblast 
markers in virtually any cell-type (Davis et a l, 1987; Braun et a l, 1989; Rhodes and 
Konieczny, 1989; Wright et a l, 1989; Braun et a l, 1990; Miner and Wold, 1990). 
Experiments with loss-of-function knockout mice have demonstrated a division of the 
four MRF proteins into two gioups, each operating at different stages of myogenesis 
summarised in Table 1.3 below. MyoD and myf-5 are important in the initial myogenic
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specification and for this reason are known as muscle determination factors (Choi et al,  
1990; Weintraub, 1993). Myogenin and MRF-4 act downstream of the other two 
factors, and are responsible for mediating terminal differentiation and the expression of 
stiuctural and functional proteins.
Gene Knockout Phenotype References
MyoD No skeletal muscle defects (Rudnicki et al ,  1992)
Myf-5 No skeletal muscle defects, but 
abnormalities in rib formation.
(Braun et al ,  1992)
MyoD & Myf-5 Embryos devoid of myoblasts and 
differentiated muscle
(Rudnicki et al ,  1993)
Myogenin Defects in skeletal muscle (Hasty et al ,  1993; Nabeshima et
differentiation al ,  1993)
MRF4 No skeletal muscle defects, but mild 
abnormalities in rib formation.
(Zhang et al ,  1995)
Table 1.3. Summary of the investigation into the roles of MRF proteins in myogenesis 
discovered through the generation of homozygous knockout mice.
MRF proteins are controlled through the formation of heterodimers with various Helix- 
loop-helix enhancer or repressor molecules (reviewed in Molkentin and Olson, 1996). 
For example, MyoD is transcriptionally inactive until it can form a heterodimer with 
various E-proteins, splice products of the E2A gene (Lassar et a l,  1991). The active 
complex binds to the E-box enhancer (CANNTG), a common motif in the control 
regions of muscle-genes (Blackwell and Weintraub, 1990). An indirect inhibitor of 
MyoD is the Inhibitor of Differentiation (Id) protein, which competes with MyoD for 
binding with the E-proteins (Benezra et a l ,  1990). MRF proteins display a degree of 
auto regulation, in that once activated they are capable of promoting their own 
expression. This positive feedback is reinforced by co-factors such as myocyte 
enhancer factor-2 (MEF-2) family of transcription factors (Section 1.3.4). In this way, 
the cell maintains its developmental choice even after the signal that triggered it is no 
longer present.
1.2.2.2 Embryonic Myogenesis
The majority of skeletal muscles, with a few exceptions such as those of the head, 
originate from transient, mesodermal structures called somites. These are paired, 
spherical blocks of epithelial cells formed early in embryogenesis, adjacent to the 
neural tube from the paraxial mesoderm (reviewed in Pourqirie, 2001). As shown in
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Figure 1.3. Compartmentalisation in the somite (from Molkentin and Olson, 1996). 
EM, epaxial dermomyotome. HM, hypaxial dermomyotome. Factors controlling cell 
determination include: Shh, sonic hedgehog, Wnt, wingless/int family members, 
BMP-4, bone morphogenetic protein-4.
Figure 1.3, the somites are rapidly compartmentalised into groups of cells with veiy 
different developmental fates. The lower, or ventral half, becomes the sclerotome and 
will form the axial skeleton. The dorsal half gives rise to the dermomyotome from 
which skeletal muscle and dermis are formed. The dermomyotome is further 
compartmentalised into different muscle lineages: the epaxial dermomyotome that 
gives rise to the muscles of the deep back, the hypaxial dermomyotome that forms the 
muscles of the body wall, and a migratory sub-population of hypaxial dermomyotome 
that forms the limb muscles.
At this stage of muscle development the muscle precursors are highly proliferative, 
with epaxial and hypaxial cells extending under the dorsal and ventral lip of the 
epithelial dermomyotome layer respectively (Denetclaw et a i, 1997). Here they form 
the first pre-muscle mass, the myotome, which eventually forms the trunk musculature. 
As the myotome condenses, myoblasts exit the cell cycle, fuse and differentiate. Other 
pre-muscle masses require the chemotactic migration of precursor myoblasts from the
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somite to their eventual site of differentiation (reviewed in Buscher and Izpisua 
Belmonte, 1999).
Experiments in explanting somitic tissue and altering somite orientation in chick 
embryos (reviewed in Brand-Saberi and Christ, 1999) have shown that the cells in the 
early somite are not yet committed to specific cell fates. The specification of somitic 
cells is mediated by a network of different signalling factors secreted from 
neighbouring tissues (reviewed in Pownall et a l, 2002). The ventral half of the somite, 
the sclerotome, forms the axial skeleton and cartilage, and is determined by signals 
flom the floor plate of the neural tube (Pourquie et a l,  1995), most notably sonic 
hedgehog (Shh). The dermomyotome, from which skeletal muscle is derived, is formed 
largely in response to Wnt family signals from the neural tube and dorsal ectoderm. 
Myogenic precursors in the dermomyotome express the homeobox transcription factors 
Pax-3 and Pax-7, and low levels of the MRF member, Myf5. In differentiating cells of 
the developing myotome, this is quickly followed by MyoD expression, which 
regulates the onset of the myogenic cascade. In myoblasts of the hypaxial lineage, 
however, MyoD expression is down-regulated by bone morphogenetic protein-4 (BMP- 
4) signalling from the lateral plate mesoderm (Pourquie et a l ,  1996). The opposing 
signals of Wnt and BMP-4 are a part of the balance required during embryonic muscle 
growth, between proliferation and withdrawal from the cell cycle and differentiation 
(Amthor et a l,  1999), which is more apparent still during the migmtion of linib-muscle 
myoblasts.
1.2.2,3 Limb-muscle formation
The migration of limb-muscle precursors from the somitic dermomyotome to the pre­
muscle mass in the limb bud is shown in Figure 1.4. Myoblasts delaminate from the 
epithelium of the hypaxial dermomyotome opposite the limb buds, following a path 
delineated by non-somitic mesodermal cells (reviewed in Buckingham et a l ,  2003). 
This is thought to be an evolutionary holdover from fish, whose paired fins are 
controlled by long myotome processes extended from the trunk (Grim, 1973). The 
migration of limb-muscle precursors is a modification of this simpler scheme, to 
generate the increased complexity of higher vertebrate limbs.
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Figure 1.4. Delamination of limb-muscle precursors and migration. Cells migrate in 
response to SF/HGF secreted by mesodermal cells within the limb field, sensed through 
the receptor c-met. Expression of c-met is, in turn, dependent on the myogenic marker 
Pax-3. SF/HGF, scatter factor/hepatocyte growth factor. MT, myotome. EM, epaxial 
dermomyotome. HM, hypaxial dermomyotome.
Pax-3 plays an important role in the migration, as demonstrated in mice homozygous 
for the Splotch mutation that lack a functional Pax-3 gene and which fail to develop 
limb musculature (Bober et a l, 1994; reviewed in Birchmeier and Brohmann, 2000). 
Pax-3 is essential for the expression of c-met, a tyrosine kinase receptor, the ligand for 
which being hepatocyte growth factor (HGF), otherwise known as scatter factor (SF). It 
is SF/HGF secretion by mesodermal cells that defines the migratory pathway through 
the limb field (Dietrich et a l, 1999). The importance of both c-met and HGF is 
illustrated by null-mutants for both genes, either of which result in an absence of limb 
muscles (Bladt et a l, 1995; Schmidt et a l, 1995). The phosphorylation of tyrosine 
residues by tyrosine kinases such as c-met is important in a variety of protein-protein 
interactions with factors such as phosphatidylinositol 3-kinase (PI3K) and Grb2. PI3K 
is involved in many cellular responses, including muscle fibre hypertrophy as will be 
discussed later (Section 1.3.3.2), and cytoskeletal organisation and cell motility. Grb2 is 
part of the Ras-signalling pathway involved in mitogen activated protein (MAP)
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kinases, and ultimately in cell growth and proliferation (Rodrigues et al., 1997). C-met 
mediated signalling is important for maintaining myoblast populations as well as 
moving the cell along the coiTcet path.
Other factors involved in limb-muscle formation include Lbxl, another homeobox 
transcription factor, though its role is less completely understood. In Lbxl mutant 
embryos the progenitors of dorsal limb muscles delaminate from the somite, but exhibit 
abnormal migration into the limb bud (Schafer and Braun, 1999; Brohmann et al,
2000). Specifically, muscles in the distal, dorsal portion of the limb failed to foim, 
while ventral muscles were formed but in an abnormal manner. It may be that Lbxl has 
a role in recognising the cues that guide chemotaxis along the correct migratory 
pathway (Brohmann et al,  2000). A third homeobox factor, Mox2, is also required for 
the correct formation of limb muscle groups (Mankoo et a l,  1999). While mutations in 
Mox2 do not appear to cause problems with the delamination of cells from the somite 
epithelium or cell migration, the levels of both Pax-3 and Myf5 are lower. This may 
affect the proliferation and survival of certain populations of migrating myoblasts.
1.2.2.4 Fibre Formation
The waves of migrating cells aggregate to form the pre-muscle masses, exit the cell 
cycle and fuse to form multinucleated myotubes. Down-regulation of Pax-3 would 
seem to be essential in the differentiation process. During cell migration, myogenic 
markers such as Myf-5 and MyoD are repressed (Tajbaklish and Buckingham, 1994), 
but are both upregulated if Pax-3 is artificially repressed (Pourquie et a l ,  1995). The 
formation of myotubes, and ultimately muscle fibres, occurs in two waves to form the 
primary (embryonic) and secondary (foetal) muscle fibres. The secondary fibres form 
in parallel to the primary fibres and are the predominant fibres in both later stages of 
development and in postnatal muscle (Ashmore et a l,  1972; Swatland and Cassens, 
1973; reviewed by Stockdale, 1992). The two waves of fibre formation is a means of 
generating the highly ordered structure of fibre bundles, with the primary fibres 
forming a scaffold for the orderly assembly of subsequent waves of myoblasts 
(Wigmore et a l ,  1996). Myoblasts have been shown to line up with substrate grooves 
in vitro (Evans et a l,  2003), which would suggest that topographic cues are used for the 
corTect alignment of myoblasts.
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During embryonic development, the predominant MyHC isofoims are the embryonic 
and perinatal forms (Weydert et a l ,  1987). Primaiy myotubes express emMyHC first, 
then co-express perinatal and p/slow MyHCs (Hams et al,  1989; Condon et al,  1990). 
Secondary myotubes similarly express emMyHC first, and then subsequently co­
express the perinatal isoform (Harris et a l ,  1989). Not all secondary fibres co-express 
the p/slow isoform, and this may possibly reflect a developmental commitment to a 
post-natal slow fibre type (Gunning and Hardeman, 1991). More recently, the 
expression of the adult 2a, 2x and 2b MyHCs was also characterised in developing 
murine and porcine muscle, though at much lower levels than the developmental forms 
(Lu et al, 1999; Da Costa et a l ,  2003). Later in gestation, the perinatal isoform 
predominates over the embryonic, but is in turn downregulated at birth and replaced by 
adult isoforms, 2a, 2x, 2b and, in slow fibres, the slow/p isoform. In skeletal muscle 
culture, in the absence of innervation, the embryonic, perinatal and 2b isoforms 
accumulate (Weydert et a l ,  1987).
1.2.2.5 Muscle Fibre Hypertrophy
Hypertrophy is the primary mechanism of post-natal gr owth in muscle and an adaptive 
response to increased muscle activity or the removal of atrophic stimuli. Hypertrophy 
may be induced as an adaptive response to resistance training, such as weight training, 
consisting of high-intensity, low-repetitive exercise. The hypertr'ophic response results 
in an increase in muscle volume and contractile protein, and greater muscle strength 
(MacDougall et al,  1979). While all fibre types tend to increase in size during 
hypertrophy, the greatest increases in muscle mass are associated with type 2 fibres 
(Hortobagyi et a l ,  2000). A similar situation is observed in cardiomyocytes, in which 
hypertrophy may be observed under a number of pathological conditions that impose 
stress upon the heart (reviewed in Frey and Olson, 2003). While initially a 
compensatory response, this hypertrophy can rapidly lead to a loss of cardiac function 
if  the conditions underlying the response are sustained. In cardiomyocytes, hypertrophy 
is defined as an increase in cytoplasmic volume without increase in the number of 
nuclei. In multinucleated skeletal muscle fibres, however, the situation is a little more 
complex (Paul and Rosenthal, 2002). In muscle fibres, hypertrophy involves both an 
increase in size and an accompanying increase in the number of myonuclei.
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A. Hypertrophy of muscle with one endplate band
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m uscle fibre
B. Hypertrophy of muscle with two endplate bands
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Figure 1.5. Different modes of skeletal muscle hypertrophy (from Paul and Rosenthal,
2002). A. Skeletal muscle with a single endplate zone, showing hypertrophy through 
increase in fibre diameter. B. Muscle with multiple endplate bands and interfascicularly 
terminating fibres, showing hypertrophy through fibre elongation, causing an increase 
in the number of fibres in transverse section (TS).
This may occur by one of two distinct mechanisms, depending on the number of motor- 
neuron endplate bands present in the muscle (Figure 1.5).
Muscles may be innervated either singly or by multiple endplate bands (Paul, 2001). In 
singly innervated skeletal muscles, the fibres extend throughout the length of the 
muscle from one tendon to the other and hypertrophy occurs through an increase in 
fibre diameter (Gollnick et a l, 1981; Paul and Rosenthal, 2002). Singly innervated 
muscles are the norm for rodents and similar small mammals, but in larger mammals 
the increased length of the muscle presents a problem with regard to the slow 
conduction of action potentials along the fibre. A large number of studies on various 
large mammals (summarised by Paul, 2001) have shown that the longer muscles are 
multiply innervated, with fibres that do not extend the entire length between the two
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tendons. In such muscles, hypeitrophy occurs tlirough the elongation of the fibres, 
resulting in an increase in the number of fibres in transverse section in a foim of 
indirect hyperplasia. No studies have been done in the pig, but it would seem likely that 
porcine muscle shares the same architecture with other animals of similar size. Humans 
and primates have muscles with singly innervated, extremely long fibres, though this 
seems to be a unique feature, possibly conferring finer motor control (Paul, 2001). Both 
mechanisms of hypertrophy result in an increase in the number of myofibrils in parallel, 
and an increase in muscle volume and mass.
The increase in the fibre size associated with hypertrophy requires an increase in the 
number of myonuclei, since a constant ratio of nuclei to cytoplasmic volume is 
maintained throughout the hypeifrophic response (McCall et a l ,  1998; Allen et al, 
1999). Since muscle fibres are terminally differentiated, this nuclear increase must 
come from the recruitment of newly proliferated myoblasts (Rosenblatt et a l ,  1994). 
These are generated from the proliferation of non-differentiated muscle cells known as 
satellite cells.
1.2.2.6 Skeletal Muscle Satellite Cells
Satellite cells are found in the spaces and grooves between the basal lamina and 
sarcolemma of muscle fibres (Mauro, 1961). Under normal conditions, satellite cells 
remain in a quiescent, non-proliferative state, but muscle trauma or hypertrophic 
stimuli induce extensive proliferation and the expression of muscle markers. Following 
multiple rounds of cell division the progeny myoblasts undergo differentiation and 
fusion to form mature muscle fibres, either with each other or through incorporation 
into existing fibres as post-mitotic nuclei. In addition to contributing to hypertrophy 
and repair, satellite cells provide the primaiy source for post-natal muscle growth 
(Schultz, 1989, 1996), and comprise 32% of muscle nuclei at birth, in the mouse 
(Bischoff, 1994). This drops to a reserve of 5% of muscle myonuclei in the adult 
mouse.
The pathway of commitment, proliferation and differentiation of satellite cells largely 
parallels that of embryonic muscle precursors in the dermomyotome. As with other 
myogenic precursors, satellite cells are thought to originate in the somite, though there 
is some evidence skeletal myogenic cells originating from vascular tissue, in particular
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the dorsal aorta (De Angelis et a l ,  1999). The homeobox factor Pax-7 is essential for 
the development of the satellite cell lineage, as Pax-7 deficient animals show a 
complete lack of satellite cells (Seale et a l ,  2000). As with embryonic myogenesis, the 
c-met/HGF pathway is also important in the activation of satellite cells, and mediates 
the chemotaxis to sources of injury or hypertrophy (Allen et a l ,  1995; Tatsumi et a l,  
1998).
MRP expression is largely absent in quiescent satellite cells, with the exception of low 
levels of myf-5 (Beauchamp et a l,  2000). The role of Myf-5 would appear to be 
maintaining the cells in a proliferative state (Parker et al,  2003). MyoD is required for 
the activation of the differentiation pathway, and differentiated satellite cells are 
characterised by an accumulation of MyoD protein. In mutants deficient in MyoD the 
differentiation of satellite cells is severely impaired, as evidenced by an increased 
number of satellite cells produced in response to injury without subsequent 
regeneration (Megeney et al,  1996). Differentiating satellite cells initially express the 
embryonic and perinatal forms of MyHC (Miller, 1990; LaFramboise et a l,  2003), as 
do muscle myoblast cell lines, such as mouse C2C12 myoblasts, that fomi the basis of 
many in vitro studies. Such in vitro studies suggest that satellite cells do not inherit the 
fibre-type specific phenotype from their host muscle, predominantly expressing MyHC 
2a or slow. This suggests that further specialisation in fibre-type specific isoforms is 
doubtless dependent on external factors such as nerve stimulation or muscle activity 
(LaFramboise et a l ,  2003).
Satellite cell populations are self-renewing (reviewed in Parker et al,  2003), as 
demonstrated by the maintenance of the satellite cell pool in old muscle after repeated 
cycles of degeneration and regeneration. Proliferating satellite cells are characterised by 
an asymmetric distribution of the Numb protein (Conboy and Rando, 2002), a regulator 
of asymmetric division in the central nervous system (Shen et a l ,  2002). Numb is an 
antagonist of the Notch-1 receptor, the Notch genes being a family of surface receptors 
important in determining cell fate in a number of systems (reviewed in Kimble and 
Simpson, 1997; Lai, 2004). Activated Notch receptors are cleaved, such that the Notch 
internal component (NIC) is released into the cytoplasm where they form complexes 
with transcription factor targets. These complexes are then nuclear translocated, driving 
patterns of gene expression associated with proliferation and the down-regulation of
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differentiation. Conboy & Rando (2002) found that Notch-1 was activated in satellite 
cells in response to injury, while attenuation of Notch-1 by Numb accumulation led to 
the expression of differentiation and myoblast commitment markers, such as Pax-7 and 
MRFs. The presence of the Notch-1 system in satellite cells implies that these 
precursors are able to generate distinct daughter cells for differentiation or maintenance 
of the satellite cell pool.
While the regenerative capacity of satellite cells is well studied, there remain some 
questions regarding the presence of populations of truly multipotent muscle stem-cells. 
Both Ferrari et al. (1998) and Gussoni et al. (1999) demonstrated the ability of cells 
derived from bone maiTow to take part in the regenerative program. Fenari et a l  (1998) 
further demonstrated the presence of low, but detectable, levels of blood-borne 
myogenic cells. These cells have been shown to differentiate into satellite cells (La 
Barge and Blau, 2002). The converse is true in that cells derived from muscle have 
been shown to differentiate along a number of non-muscle pathways, such as 
adipogenesis (Csete et a l ,  2001), haematopoiesis (Jackson et al,  1999) and 
osteogenesis (Lee et a l ,  2000). It has been proposed that a distinct population of stem 
cells, resident either in muscle or in non-muscle tissue, can participate in muscle 
regeneration and replenish the existing satellite cell population (Parker et a l ,  2003). 
However, the possibility that the satellite cells themselves may be multipotent has also 
been raised (Seale and Rudnicki, 2000). The study by Csete et al. (2001) observed 
adipogenesis in satellite cells specifically, and it may be that the distinction between 
satellite cell and stem is something of an artificial one.
1.2.3 S k e l e t a l  M u s c le  A d a p t a t io n
Skeletal muscle is a highly adaptive tissue, capable of radical changes in fibre 
composition, with consequent alteration of physical and metabolic properties, as a 
response to changes in functional demand (reviewed in Fluck and Hoppeler, 2003). 
This allows muscle tissue to adopt the most energy-efficient configuration for the 
demands placed on it at any given time. For example, in humans the most extensively 
studied fibre transformation is that resulting from changes in exercise regime (reviewed 
in Pette and Staron, 1990). As might be expected, endurance training regimes increase 
the proportion of slow fibres (Gollnick et a l ,  1972; Jansson and Kaijser, 1977), while
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sprint training results in a slow to fast fibre transformation (Jansson et a i, 1990; 
Esbjomsson et a i, 1993). Changing requirements brought about by factors such as 
exercise regime, nutrient intake and even disease conditions are converted into changes 
in muscle physiology through the response to extrinsic signalling factors. The best 
studied of these extrinsic factors are innervation (Buller et al., 1960), patterns of nerve 
stimulation (Pette, 1998) and hormone signalling (Florini, 1987; Florini et al., 1991a). 
A summary of these factors and their effect on fibre expression of MyHC isoform is 
shown in Figure 1.6.
1.2.3.1 Innervation
Perhaps the most important influence on fibre-type specific expression is innervation 
by motor neurons, first demonstrated by Buller et al. (1960) through cross-innervation 
experiments. Grafting the motor neurons associated with fast-twitch muscles to postural 
slow muscles, and vice versa, resulted in a switch to the phenotype associated with the 
transplanted motor neuron. This crucial role of nerve activity in the acquisition and 
maintenance of fibre type, along with the long term survival of muscle fibres, was 
confirmed by further studies (Lomo, 2002; Schiaffmo and Serrano, 2002). These 
included the observation that muscle inactivity following spinal cord injury results both 
in muscle atrophy and in a slow to fast switch in fibre phenotype.
Thyroid
hormone
Inactivity & 
Denervation
Fast nerve 
firing pattern
1/B 2a 2x 2b
Endurance Slow nerve
Exercise firing pattern
Figure 1.6. Summary of the extrinsic factors influencing MyHC expression and fibre 
type (from Fluck and Hoppeler, 2003).
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Electrical activity is the main mechanism by which the nervous system exerts conti'ol 
over fibre phenotype, though there are also the local effects of neurochemicals, such as 
neural agrin and neuregulin, at the neuromuscular junction. Direct electiical stimulation 
of denervated muscle, using implanted electrodes, has been found to mimic the effects 
of cross-innervation in mediating a fast-slow or slow fast fibre transition (Eken and 
Gundersen, 1988). Low-ffequency (10-20 Hz), continuous (tonic) stimulation, which 
mimics the firing pattern observed in slow motor neurons, results in slow-fibre specific 
gene expression. Conversely, short bursts (phasic) of high-frequency (100-150 Hz) 
stimulation pattern, characteristic of fast motor neurons, results in a slow-to-fast fibre 
transition.
A likely pathway for transforming such patterns of electrical stimulation into control of 
gene expression is the detection of fluctuating, intiaeellular calcium (Ca^ "^ ) levels 
(reviewed in Talmadge, 2000). Calcium influx is an essential part of muscle function, 
required for the activation of muscle contraction through the ti'oponin-tropomyosin, and 
for secondaiy roles such as the regulation of ATP provision (Tate et al,  1991). 
However, different patterns of nerve stimulation result in different concentrations of 
Ca^^ in the cytosol. Slow-type signalling patterns result in a sustained intracellular Ca^ "^  
concentration of 100 to 300 nM (Chin and Allen, 1996), while fast patterns result in 
short-lived Ca^^ elevations of up to 1 jaM . The role of Ca^^ concentration has been 
further demonstrated by Kubis et al (1997), in experiments using the calcium 
ionophore A23187. This group found that the expression of slow myosin was activated 
in primary muscle cells cultured in the presence of the ionophore, and hence subjected 
to sustained elevation of Ca^ .^
Changes in Ca^ "*" concentration are sensed by calcium binding proteins such as 
calmodulin, a primary component of a number of calcium-response pathways. A major 
target for calmodulin is the serine-threonine phosphatase calcineurin, and the role of 
this signalling intermediary and its associated signal transduction pathway is a matter of 
some considerable debate, discussed in detail in Section 1.4.
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1.2.3.2 Hormones
Hormonal signalling exerts a major influence on skeletal muscle in development, but 
also plays a significant role in post-natal adaptation (reviewed in Florini, 1987; Florini 
et a l ,  1991a). Hormonal signals are particularly important in regulating changes in 
protein turnover, and consequent changes in muscle mass. Anabolic hormones, 
including gi'owth hormone, insulin-like growth factors (IGFs) and testosterone, 
contribute greatly to increases in muscle mass by increasing protein synthesis or 
preventing protein breakdown (Rooyackers and Nair, 1997). Conversely, catabolism of 
protein and loss of muscle mass are mediated by such factors as glucagon, 
glucacorticoids and catecholamines. In the contiol of fibre-type, two hormones in 
particular stand out for their effect on the isoform-specific expression of different 
MyHCs. These are the IGFs, IGF-1 and IGF-2, and the thyroid hormone, 
triiodothyronine (T3).
1.2.3.2.1 IGFs
IGF-1 and IGF-2 are involved both in muscle development (Florini et al,  1991a) and in 
post-natal hypeitrophy and regeneration (Barton-Davis et a l,  1999). Both are primarily 
synthesised in liver, in response to growth hormone, but are also synthesised locally in 
muscle tissues, acting in an autocrine/paracrine manner in response to damage, 
mechanical loading or stretch (Adams, 2002; Fiorotto et a l,  2003). The IGFs are 
stabilised in serum through binding to six known IGF binding proteins (IGFBPs), 
which also serve to regulate their access to target tissues (reviewed in Jones and 
Clemmons, 1995; Rosenfeld a/., 1999)
IGF-1 is particularly well-studied in muscle growth and adaptation (reviewed in Florini 
et al,  1996; Singleton and Feldman, 2001). There are two IGF-1 isoforms known to be 
of major importance in muscle. In addition to the systemic IGF-lEa form synthesised 
both in the liver and locally, a splice variant termed mechano growth factor (MGF) is 
also induced in muscle following tissue damage (Yang and Goldspink, 2002; Hill and 
Goldspink, 2003). IGF-1 function, together with that of its binding proteins and 
receptors, has been uncovered through studies using knockout mice (reviewed in 
Kitamura et a l ,  2003). Mice deficient in IGF-1 fail to develop muscle and die at birth, 
in a similar manner to mice deficient in myf-5 (Liu et al., 1993). In vitro experiments 
(Florini et a l ,  1977; Ewton and Florini, 1981) have shown that the IGF-1 is important
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both for the survival and proliferation of myoblasts, but also, unlike other mitogenic 
factors, for their subsequent differentiation into non-proliferating fibres (Quinn et a l ,  
1994). MGF, in contrast, is activated early in the response to muscle damage, and is 
likely to be more of a contributing factor in satellite cell proliferation (Hill and 
Goldspink, 2003).
This dual ability of IGF-1 to promote both proliferation and differentiation in myoblasts 
underlies its role as a potent enhancer of hyperhophy. This role has been demonstrated 
in vivo, where direct infusion or overexpression of IGF-1 in muscle results in 
hypertrophy (Adams and McCue, 1998). IGF-1 mediated hypeitrophy has been 
associated with a slow to fast-glycolytic shift in fibre type both in vivo (Semsarian et 
al,  1999a; Semsarian et al,  1999b) and in vitro, in C2C12 myoblast culture (Semsarian 
et a l ,  1999a). The basis for this reasoning is the obsei*vation that the viral transfection 
of IGF-1 prevents the age-related atrophy of type 2x fibres (Barton-Davis et a l,  1998), 
and Semsarian et a l  ( 1999a) did indeed note an increase in glycolytic enzymes such as 
lactase dehydrogenase (LDH) following treatment with IGF-1. However, a direct, 
causative role for IGF-1 in the promotion of the fast fibre phenotype, as opposed to 
general hypertrophy, is still far fi-om clear.
IGF-2 plays a similar role to IGF-1 in the differentiation of myoblasts (Florini et a l,  
1991b; Prelie et al,  2000; Wilson et a l ,  2003) and the regeneration of damaged muscle 
(Kirk et a l ,  2003). In myoblast cell culture, IGF-2 is secreted in an autocrine/paracrine 
manner following inducement of the differentiation pathway through transfer to low 
serum conditions (Florini et a l,  1991b). Myoblasts in which IGF-2 expression was 
silenced through the transfection with an antisense construct proliferated normally, but 
died upon transfer to low serum conditions (Stewart and Rotwein, 1996). Taken 
together, this would indicate that IGF-2 reinforces and amplifies the commitment to the 
myogenic process, and protects the myoblasts form apoptosis as they exit the cell cycle.
The relationship between the IGFs and their individual contribution to the myogenic 
process remains unclear. Complicating matters, the effects of both IGF-1 and -2 are 
mediated through the same surface receptor, insulin-like growth factor-1 receptor (IGF- 
IR: reviewed in Singleton and Feldman, 2001). The functions of IGF-IR, and the 
signal tiansduction pathways leading fiom it, are discussed in detail in Section 1.3.3.
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1.2.3.2.2 Thyroid Hormone
Skeletal muscle is a major target of thyroid hoimones. The effect of thyroid signalling 
would appear to be mediated by T3, produced by de-iodination of thyroxine (T4) in the 
liver. T3 has been shown to be involved in the induction of differentiation through 
MyoD activation (Downes et a l ,  1995). Though thyroid hormones are essential during 
muscle growth and development, both excess or deficiency in thyroid hormones result 
in an overall loss of muscle strength (Zurcher et a l,  1989). These muscle wasting 
effects are most commonly seen in muscles rich in slow-oxidative fibres. T3 also has a 
strong influence on the expression of MyHC isoforms (reviewed in Baldwin and 
Haddad, 2001). In development, thyi'oid hoimone influences the timing of the switch 
from embryonic or perinatal MyHC to adult foims, with the repression of 
developmental isoforms coinciding with the increase in T3 concentration in rat 
embryos (reviewed in Soukup and Jirmanova, 2000). Hyperthyroidism in developing 
rats was found to result in an earlier or switch, with the converse true for hypothyroid 
rats. In addition to a role in regulating developmental timing, T3 is also involved in 
changes in adult fibres. Hyperthyroidism or elevated doses of T3 result in upregulation 
of MyHC 2x and 2b isoforms, and the repression of the slow/I. Hypothyroidism results 
in a fast to slow fibre tiansition (Nwoye et a l,  1982), with a shift in MyHC expression 
along the direction of 2b/2x to 2a to type 1, in all muscle types. But while the influence 
of thyroid hormone on the fast fibre phenotype seems clear, the mechanism by which 
the fast MyHCs are induced by T3 remains unclear. Thyroid hormone has been shown 
to interact with MyoD in mice (Anderson et al,  1998), though the evidence for an 
effect of MRFs on fibre type remains inconclusive (see Section 1.3.2). While thyroid 
hoimones are necessary for the fast phenotype, it would seem that their role is 
permissive, rather than instructive (Soukup and Jirmanova, 2000).
1.2.4 P r a c t i c a l  I m p l ic a t io n s
The biology and fibre composition in muscle has a number of implications in a wide 
range of fields from sports and exercise to the breeding of animals for sporting 
performance or meat quality, to the treatment of myopathies, such as muscular 
dystrophy or age-related muscle loss. Two such fields are considered here as examples 
of the interactions between the various intrinsic and extrinsic factors already covered.
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The first of these is the physiology of ageing muscle, which could perhaps be viewed as 
a demonstration of the effects of a breakdown in the regulation and adaptation of 
muscle. The second is the effect of fibre phenotype on the quality of post-slaughter 
pork, which shows the biochemical consequences of muscle fibre composition, as well 
as the necessity for an undeipinning knowledge of muscle biology in modern animal 
husbandly.
1.2.4.1 Ageing
Ageing muscle undergoes an inexorable decline in strength and speed, in a 
characteristic process known as sarcopenia (Lauretani et at,  2003). Sarcopenia is 
associated with a loss of muscle mass (Gallagher et al,  1997), the accumulation of 
intramuscular lipid content (Poggi et al,  1987) and changes in fibre composition and 
patterns of MyHC expression (Andersen, 2003). Age-related decline in growth 
hormone signalling, motor neuron control and satellite cell regenerative capability have 
all been investigated as contributing factors.
1.2.4.1.1 Deteriorating Signals
The levels of circulating growth hormone/IGF-1 decline with age, as does tissue 
sensitivity to IGF activation (Renganathan et al,  1997). The key roles played by 
growth hormone, IGFs and IGF receptor in the proliferation and differentiation of 
satellite cells (Section 1.2,3.2.1) make their decline a logical candidate for a role in 
muscle deterioration, and artificially elevated IGF-1 has indeed been shown to delay 
muscle senescence in mice (Barton-Davis et al,  1998). IGF-1 has also been observed to 
increase the replicative life-span of satellite cells in vitro (Chakravarthy et a l,  2000). 
Treatment with growth hormones in humans has reversed sarcopenia to some extent 
(Hennessey et a l,  2001), although this is associated with severe side effects, such as 
diabetes, high blood pressure, fluid retention and joint and muscle pain (reviewed by 
Hintz, 2004).
The loss of motor neurons is also associated with ageing (reviewed in Delbono, 2003). 
The interactions between nerve and muscle are vital to the survival and function of 
either tissue, so it is likely that an element of age-related muscle wasting is related to 
the loss of neural tissue. Ageing fibres may be denervated or re-innervated, with 
coiTesponding switches in fibre gene-expression or complete atrophy (reviewed in
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Larsson and Ansved, 1995). As with muscle fibres, survival of motor neurons is 
influenced by IGF-1 (Neff et al., 1993). While the majority of studies on IGF-1 in 
neurogenesis focus on the developmental role, IGF-1 and its receptor show similar 
expression patterns in the adult central nervous system and neurons to that in 
embryonic neivous tissue (Bondy et a l ,  1992). The extent to which IGF-1 signalling 
maintains muscle mass through the survival of innervating neurons as opposed to the 
direct stimulation of muscle gi'owth and regeneration is as yet unknown.
1.2.4.1.2 Ageing and Fibre Type
The adaptive (or maladaptive) response of ageing muscle fibre to these factors, in terms 
of composition of fibre type and MyHC expression, has been a source of controversy. 
In humans, the loss of strength associated with sarcopenia was first atti’ibuted to the 
selective loss of fast, type II fibres (Grimby et a l ,  1982). This condition is well studied 
in rodents, and seems to tie in well with the decrease in physical activity and muscle 
loading late in life (Tseng et a l,  1995). However, it appears the situation in humans is a 
little more complex (reviewed in Porter et al,  1995). Andersen et a l  (1999) found that 
while there was an increase in the number of type I fibres at ages 60 to 70 relative to 
young adults, their observation was that this trend had disappeared in subjects over the 
age of 80.
By examining longitudinal sections, Andersen (2003) also demonstrated a greatly 
increased number of hybrid fibres in aged muscle, including a greater preponderance of 
hybrid types that are rare or even entirely absent in younger muscles. In ATPase 
staining of longitudinal sections of muscle fibres, changes in fibre-type specific 
expression were obseived along the length of the muscle section, and small, localised 
regions corresponding to a single myonuclear domain were observed to have distinctly 
different fibre-specific expression to the remainder of the fibre (Figure 1.7). The 
mechanism proposed for this particular type of change in fibre composition is a loss in 
co-ordination between myonuclear domains, in that the communications between 
myonuclei breaks down in older tissue. The mechanism for the co-ordination between 
myonuclei, and how this might be compromised by the ageing process, is cunently 
unclear.
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Figure 1.7. Correlation of patterns of ATPase staining with myonuclear domains in the 
longitudinal sections of hybrid fibres taken from very old subjects (over 80 years). 
Mechanism proposed by Anderson (2003) associates myonuclei (shown in black) with 
regions of different ATPase staining (dark and light regions). Dark shaded areas 
correspond to ATPase staining (pH 4.3) for type I fibres. A. Apparent fibre phenotype 
switch along the length axis of the fibre. B. Isolated myonuclear domain.
1.2.4.2 Porcine Meat Quality and Quantity
In the breeding of animals raised for meat, such as the pig, the composition of muscle 
fibres can have a marked effect on the quality and quantity of the final meat product 
(Chang et a l, 2003b). For example, intensive pig breeding for increased muscle growth 
resulted in the inadvertent selection for a condition known as malignant hyperthermia 
(MH), caused by a mutation in the ryanodine receptor (RyR) (MacLennan and Phillips, 
1992). RyR is a calcium release channel, releasing Ca^  ^ from the sarcoplasmic 
reticulum during muscle contraction. In the MH susceptible animals, the RyR channel 
is ‘leaky’, resulting in excessive Ca^  ^ release during stress. This leads to lactic acid 
build-up, hypermetabolism and high temperature, and can result in the death of the 
animals. However, a side effect of the condition is an increase in the rate of increase of 
muscle mass and so the MH condition has been unwittingly selected for in the drive for 
increased meat production.
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Similarly, pig breeding has also had a marked effect on the fibre composition of 
porcine muscle (Essen-Gustavsson and Lindholm, 1984; Karlsson et a l,  1999). Modern 
breeds have a far greater predominance of fast-glycolytic fibres, which while lower in 
lipid content, and hence ‘leaner’, are associated with a number of undesirable meat 
traits. In studies canied out by Crouse et al  (1991) the ‘tenderness’ of the final product 
was found to be lower fi’om muscles with a high content of fast-glycolytic fibres, while 
a high percentage of slow-oxidative fibres correlated to high tenderness. Other negative 
qualities such as low pH, high drip loss, poor texture and colour are also associated 
with a high percentage of fast fibres (Maltin et al, 1997; Chang et al, 2003b). This 
post-slaughter condition is known as the pale soft exudative pork (PSE) syndrome 
(Schmidt et al,  1972; Gregoiy, 1998). The association with PSE and fast fibres makes 
it perhaps unsurprising that this trait is associated with the pig, rather than other 
animals raised for food such as cattle, given that the pig is the only large animal to 
express 2b MyHC (Pette and Staron, 2000).
Also caused by the RyR mutation in MH, PSE is a result of the switch to glycolytic 
metabolism following the cessation of blood-flow and resulting anaerobic conditions. 
Lack of blood-flow also causes a rapid build-up the end product of glycolysis, lactic 
acid, causing protein dénaturation and a resulting, characteristic loss of water and 
coloration and a distinctly unsightly final product. Since fast fibres have gieater stores 
of glycogen, it follows that the incidence of PSE will be higher in muscles with a 
higher percentage of these fibres. Such considerations make a rational understanding of 
the mechanisms of fibre type switching of considerable economic importance to the pig 
breeding industry.
1.3 P o s t - N a t a l  M u s c l e  T r a n s c r i p t i o n  F a c t o r s
1.3.1 Tr a n sc r ip t io n a l  C o n t r o l
The previous sections have dealt with the properties of different muscle fibre types, and 
the factors extiinsic to muscle that result in fibre adaptation in response to biological 
changes. The main focus of this study, however, is centred on transcription factors, 
intiinsic factors whose activities ti'ansduce external stimuli into changes in gene
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expression. These intrinsic factors are the end-points in signal transduction pathways. 
In skeletal muscle, one of the most important regulators of fibre-phenotype is in the 
control of fibre-specific gene transcription. The following section will introduce the 
three better studied muscle-specific transcription factors/signal transduction pathways; 
these being the myogenic regulatoiy factors (MRFs), the insulin-like growth factor-1 
receptor (IGF-IR) pathways and myocyte enhancer factor 2 (MEF-2), to review what is 
known of their roles in the control of muscle gene expression. The other major signal 
transduction pathway, the calcineurin/NFAT pathway, is a focus of the thesis and is 
covered in greater detail in Section 1.4.
1.3.2 MRFs AND F ib r e  T y pe
As discussed in Section 1.2.2, members of the MRF family play a vital role in the 
differentiation of myoblasts and the formation of mature muscle fibre. But while the 
role of the MRFs is well documented both in embryonic development and in the 
activation of satellite cells, their role in post-natal specification of fibre type is 
incompletely understood. Loss of function experiments with myoD -/- mice (Hughes et 
al, 1997) have been less conclusive in determining a role in fibre specification, 
showing only a slight trend towards the fast phenotype. This is perhaps unsurprising 
given that MyoD and other MRFs are essential for many steps in myogenesis. It is 
difficult to conclusively demonstrate a muscle-plasticity effect independent of the 
defects in myoblast determination, fibre development and maturation.
There have been several studies on the relative levels of different MRFs in fast and 
slow muscle (Hughes et a l ,  1997; Walters et al, 2000). Hughes et al (1997), in studies 
in the rat, demonstrated a higher level of myogenin in muscle regions with 
predominantly slow fibre types, with MyoD higher in predominantly fast muscles. 
Walters et al also demonstrated a higher level of MRF-4 in slow fibres of the rat 
gastrocnemius muscle, but found no such results in the soleus, a postural muscle. 
Overexpression studies have similarly failed to demonstiate a master role for the MRFs 
in fibre specification. Overexpression of myogenin in the fast muscles of transgenic 
mice showed a switch towards oxidative metabolism, but no increase in the levels of 
slow MyHC expression (Hughes et a l,  1998). So while it would seem there is
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something of a conelation between different MRFs and fibre type, a direct, causal 
relationship has yet to be conclusively demonstrated.
1.3.3 IGF-IR Sig n a l  T r a n sd u c t io n
As discussed in Section 1.2.3.2, IGF-1 signalling is involved in both myocyte 
proliferation, and in differentiation/fibre hypertiophy. These two pathways, reviewed in 
Singleton & Feldman, (2001), both have their origins in a chain of phosphorylation 
events beginning with the IGF-1 receptor (IGF-IR). The start of the cascade is the 
conformational change in the tyrosine kinase of IGF-IR following the binding its 
ligand. This results in autophosphoiylation and the binding of cytosolic substrate 
proteins including, among others, insulin receptor substrate (1RS). Once bound, 1RS is 
phosphorylated and subsequently acts as a docking platform for a number of further 
signalling intermediaries containing the Src homology-2 (SFI2) domain. This is a 
protein motif that recognises and binds tyrosine-phosphorylated sequences. SH2- 
mediated signalling pathways include two factors of particular importance to muscle 
signal-transduction (Moelling et ah, 2002). The first is growth factor receptor bound 
protein 2 (Grb2), which activates the small G protein, Ras, in conjunction with son of 
sevenless (SoS). The second is phosphatidylinositol 3-kinase (PI3-K), activated by its 
SH2-domain containing p85 regulatoiy sub-unit. A slightly simplified way at looking at 
these two pathways is to divide them between Ras-mediated myoblast proliferation, 
versus PI3-K mediated hypertrophy, as summarised in Figure 1.8. Also indicated is the 
degree of cross-talk that exists between the two pathways, which serves as an additional 
level of control (Rommel et ah, 1999). This section will briefly review the divergent 
pathways following from Ras and PI3-K activation.
1.3.3.1 Ras and Proliferation
The Ras/Raf/MEK7ERK pathway is a well-studied signal transduction pathway, one of 
a number of mitogen-activated protein kinase (MAPK) signalling systems used for a 
wide variety of roles in different cell types (reviewed by Kolch, 2000). The Ras 
signalling pathway is known more for its role in regulating haemopoietic cell growth in 
response to cytokine signalling and consequent role in leukaemia when dysfunctional 
(reviewed in Chang et a l,  2003a). Ras proteins belong to an extended family of small 
(21 kDa) proteins that cycle between activated, GTP-bound states, and inactive, GDP-
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Figure 1.8. Summary of IGF-IR mediated pathways in myoblast proliferation and 
differentiation (from Singleton and Feldman, 2001). A. PI3 kinase inactivation and 
Ras/Raf activation of MAPK during myoblast proliferation. B. PI3 kinase/Akt 
activation during muscle hypertrophy.
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bound states. As with other MAPK pathways, Ras signalling continues along a series of 
serine/threonine phosphorylation events, in this case via Raf, mitogen-activated protein 
kinase/ERK kinase (MEK) and extracellular signal regulated kinase (ERK). Ras 
signalling is complex, and a full account of the regulation of this pathway can be found 
in the review by Kolch (2000). In myoblasts, the Ras MAPK pathway is primarily 
associated with proliferation and the prevention of differentiation (Olson et a l ,  1987). 
It has been suggested that Ras-mediated inhibition of muscle differentiation operates 
via NFkB, a member of the Rel family of hanscription factors (Mitin et al, 2001).
Though involved in myoblast proliferation, Ras-MAPK signalling has also been 
implicated in later stages of muscle development and differentiation (Bennett and 
Tonks, 1997; Gredinger et a l ,  1998). Ras also involved in slow fibre specification 
(Murgia et a l,  2000), and muscle fibre hypertrophy (Haddad and Adams, 2003). In 
their investigation in the control of fibre type, Murgia et al  (2000) employed two forms 
of constitutively active Ras mutants, using in vivo transfections in regenerating muscle. 
A Ras mutant that specifically activated the MAPK pathway was found to activate a 
switch to slow-fibre gene expression, while a dominant-negative Ras repressed the 
effect of slow-neuron firing patterns. By conhast, a second mutant that activated the 
PI3-K pathway (see below) resulted in increased muscle hyperhophy, but had no effect 
on fibre phenotype. While this would seem to indicate that the two separate pathways 
play distinct roles, it would appear that the situation is a little more complex. The study 
by Haddad and Adams (2003), involving specific inhibition of ERK, blocked IGF-1 
related hypertrophy, indicating that the Ras-MAPK pathway is important in both the 
slow fibre phenotype and hypertrophic muscle growth.
The manner by which Ras can play a role in such a variety of sometimes contradictory 
pathways remains ineompletely understood. One theoiy is that the outcome of the Ras 
pathway may be influenced by the timing of the extracellular signals, with a transient 
activation having a different effect to a sustained one (Marshall, 1995; Gredinger et a l,
1998).
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1.3.3.2 PI3-K and Hypertrophy
Phosphatidylinositol 3-kinase (PI3-K) consists of two sub-units, the SH2 domain 
containing regulatory unit, also known as p85, and a catalytic sub-unit, p i 10 (reviewed 
in Vivanco and Sawyers, 2002). The PI3-K signalling pathway is shown in Figure 1.9. 
PI3-K acts through a class of membrane phospholipids, the inositol phospholipids. PI3- 
K produces phosphatidylinositol (3,4,5)-trisphosphate (PIP3) through the addition of a 
phosphate group to the inositol sugar ring of phosphatidylinositol (4,5)-bisphosphate 
(PIP2). PIP3 subsequently seiwes as a docking station for protein kinase B (PKB), also 
known as Akt, and phosphoinositide-dependent protein kinase 1 (PDKl), permitting 
Akt phosphoiylation and activation (Downward, 1998). The activation of Akt is 
inhibited by phosphatase and tensin homologoue on chromosome 10 (PTEN), which 
dephosphorylates PIP3 (Stambolic et al,  1998), and by protein phosphatase 2A (PP2A), 
which dephosphorylates Akt (Andjelkovic et a l,  1996; Pankov et a l,  2003). PP2A is a 
trimeric complex consisting of catalytic, regulatoiy and scaffold sub-units (Sontag,
2001). While the catalytic sub-unit of PP2A is ubiquitous, there is evidence for a 
muscle-specific regulatory sub-unit, indicating tissue specific regulation of Akt 
(Tehrani et a l,  1996).
Activated Akt is translocated into the nucleus, where it acts upon a large number of 
phosphoiylation targets containing the common motif RXRXX(SZT) (Zimmermann and 
Moelling, 1999; reviewed in Coffer et a l,  1998). Well documented targets of Akt in 
muscle include mammalian target of rapamycin (mTOR), a protein kinase and an 
activator of protein translation (Gingras et a l ,  2001). Akt also represses the activity of 
glycogen synthase kinase 3 (GSK3), which regulates a variety of physiological 
properties including glycogen and protein synthesis (Cross et a l ,  1995). Inhibition of 
GSK3 leads to an upregulation of protein synthesis (Welsh et a l ,  1997; Jefferson et a l,
1999), and targeted inhibition of GSK3 leads to marked muscle hypertiophy (Rommel 
et a l,  2001). Akt also represses Raf, thus inhibiting the Ras-MAPK pathway 
(Zimmeimann and Moelling, 1999), as part of the Ras/PI3-K pathway cross-talk 
already discussed (Figure 1.8). In addition to activation via IGF-IR, PI3-K has also 
been known to act downstream of Ras in some settings, such as regulation of the actin 
cytoskeleton (Rodriguez-Viciana et a l ,  1997).
49
A.
Fatty acids ■
Glycerol ___
backbone
_ G O[
Inositol 
head group
PTEN
PDKl
PI3-K PP2A
PI3-K
M T O
Wortmannin
LY294002
Increased protein 
synthesis
Activation of Translation
Figure 1.9. Details of the PI3-K/Akt pathway. A. The structure of phosphatidylinositol 
(4,5)-bisphosphate (PIP2), the substrate of PI3-K. PIP2 is phosphorylated to form 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3), as part of the PI3-K signalling 
pathway (adapted from Vivanco and Sawyers, 2002). B. Activation of PI3-K by 
phosphorylated IRS-1 (adapted from Glass, 2003a). GSK3, glycogen synthase kinase 3, 
IRS-1, insulin receptor substrate-1, mTOR, mammalian target of rapamycin, PDKl, 
phosphoinositide-dependent protein kinase 1, PP2A, protein phosphatase 2A, PTEN, 
phosphatase and tensin homologoue on chromosome 1 0 .
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PI3-K is sensitive to inhibition by the small-molecule inhibitors Wortmannin and 
LY294002 (Powis et a l ,  1994; Vlahos et a l,  1994). Though these inhibitors are 
commonly used to study PI3-K function, this sensitivity is shared with the downsti*eam 
signalling element, mTOR (Bmmi et al,  1996). Use of PI3-K and mTOR inhibitors has 
highlighted the pivotal role played by the PI3-K pathway in IGF-1 mediated 
hyperhophy (Bodine et a l ,  2001; Pallafacchina et a l,  2002). Genetic studies using Akt 
mutants also confirmed these findings, dispelling doubts arising from the relative 
uncertainty of the chemical inhibitors used (Rommel et a l,  2001; Bodine et a l,  2001). 
Expression of a dominant-negative form of Akt blocked hypertrophy in cultured 
myotubes, while a constitutively active form, conversely, was sufficient to cause 
hypertrophy. This would suggest that the PI3-K/Akt pathway is the primaiy trigger for 
IGF-1 mediated muscle hypertrophy. The findings of Haddad and Adams (2003), that 
hypertrophy can be inhibited in vivo through inhibition of the Ras-MAPK pathway, 
indicates that this the response is regulated by cross-talk from Ras-MAPK.
Pallafacchina et a l  (2002) found inhibition of muscle hypertrophy through chemical 
inhibition of the PI3-K/Akt/mTOR pathway by rapamycin, but this treatment had no 
effect on fast-slow switching of fibre type. Their conclusion was that PI3-K did not 
mediate fibre-specific gene expression. Instead, it was found that fibre switching was 
blocked by the inhibition of another signalling pathway, mediated by calcineurin 
(Section 1.4).
1.3.4 Th e  M E F -2  F a m il y
The myocyte enhancer family-2 (MEF-2) of transcription factors consists of four genes 
in vertebrates, mef-2a, b, c and d  respectively, further subdivided by alternative splicing 
(reviewed in Black and Olson, 1998). In skeletal muscle, the mef-2 genes are expressed 
in distinct, temporal-spatial patterns. MEF-2 A, C and D have been characterised in 
cultured myoblasts, with MEF-2D expressed before the onset of differentiation 
(Breitbart et a l ,  1993), and MEF-2 A and MEF-2C are expressed early and late, 
respectively, in the differentiation process (Yu et al, 1992; McDermott et al,  1993).
The MEF-2 family belongs to the larger family of MCMl, Agamous, Defîciens and 
Semm response factor (MADS) box proteins, and possess the characteristic MADS-box
51
domain. This is an N-terminal 57-amino-acid region responsible for DNA binding. An 
adjacent, 29 amino-acid region, the MEF-2 domain, mediates high affinity binding to 
the target transactivation site, and interactions with other co-factors (Molkentin et al,  
1996). The MEF-2s are best known for their role in skeletal, cardiac and smooth 
muscles and as co-activators in the myogenic program (Olson et a l ,  1995). However, 
MEF-2 members are also found in a number of other tissues as part of a wide variety of 
processes, some of which would seem diametrically opposed (reviewed in McKinsey et 
al,  2002). For instance, in neurons MEF-2 mediates protection from apoptosis, 
(Okamoto et a l,  2000), yet promotes apoptosis in negatively selected thymocytes 
(Woronicz et al,  1995).
While MEF-2 has heen described as having a ‘paradoxical’ airay of different functions 
(McKinsey et al,  2002), it is worth remembering the different MEF-2 members and 
splice variants are not necessarily identical in function. Many studies postulating a role 
for MEF-2 proteins in cellular processes have as their evidence the presence of a MEF- 
2 consensus binding sites in the relevant gene promoter regions or reporter conshucts 
(e.g. Chin et a l ,  1998; Wu et al,  2000; Friday et a l,  2003). While good evidence of 
MEF-2 involvement, this does not specify the exact MEF-2 isoform involved. This 
section will review the regulatory mechanisms controlling MEF-2 activation that link 
these proteins into a number of other signalling pathways, and the roles played by 
MEF-2 family members in skeletal muscle.
1.3.4.1 The Regulation of MEF-2 Activity
The MEF-2 proteins are controlled by a number of major signalling pathways, with 
perhaps the most important being intracellular calcium. MEF-2 activity is up-regulated 
by a number of upstream, calcium-responsive signalling factors (Passier et a l,  2000; 
Wu et a l,  2000). These include two signalling proteins dependent on calmodulin 
(CaM), calcium/calmodulin-dependent kinase (CaMK) and the serine-threonine 
phosphatase, calcineurin (covered in more detail in Section 1.4). CaMK and 
calcineurin have different mechanisms of action: CaMK acts by relieving MEF-2 
repression, while calcineurin interacts directly with MEF-2 proteins.
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Figure 1.10. The activation of MEF-2 transcription factors by calcium/calmodulin- 
dependent protein kinase (CaMK) (from McKinsey et ai ,  2002). HAT, histone 
acetyltransferases, HDACs, histone deacetylases.
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As shown in Figure 1.10, the activation of MEF-2 involves the removal of an inhibitory 
complex with histone deacetylases (HDACs), bound to the MEF-2 sites on the 
promoter regions of target genes (Lu et al., 2000). HDACs inhibit transcription through 
the deacetylation of core histone proteins and subsequent chromatin condensation. 
There are three classes of HD AC (I, II and III), of which a number of class II members 
are able to interact with all MEF-2 family members through direct association with the 
MADS/MEF-2 regulatory domains (reviewed by McKinsey et a l, 2001b; Han et a l,
2003). The removal of the inhibitory complex is mediated by CaMK (Lu et a l, 2000; 
Corcoran and Means, 2001). CaMK mediated phosphorylation of the HD AC proteins 
creates docking sites for the 14-3-3 chaperone protein (McKinsey et a l, 2000), 
facilitating their export from the nucleus. Activation is further enhanced by the 
association of histone acetyltransferases (HATs), such as the co-activator protein p300. 
These directly antagonise HDAC activity, acetylating core histones and relieving 
transcriptional repression (Strahl and Allis, 2000). HAT proteins bind directly to MEF- 
2, in a manner competitive with HDAC binding (McKinsey et a l, 2001a).
Calcineurin enhances MEF-2 activity by different mechanisms, the first of these being 
via its main downstream target, nuclear factor of activated T-cells (NFAT). Covered in 
greater detail in Seetion 1.4, the NFAT family consists of a number of isofoims, of 
which NFAT-1 has been shown to interact directly with MEF-2 A and D (Blaeser et a l,
2000). NFAT-1 enhances MEF-2D activity through the recruitment of the HAT, p300 
(Youn et a l, 2000). Calcineurin also directly dephosphorylates MEF-2 A and D, 
enhancing MEF-2 DNA binding (Mao and Wiedmann, 1999; Wu et a l, 2001). As a 
final note on calcineurin/MEF-2 interactions, the inhibitor of calcineurin, cain (also 
known as cabin), is also an inhibitor of MEF-2 (Youn and Liu, 2000). Cain has been 
shown to bind directly to MEF-2B, where it is thought to recruit the inhibitoiy HDAC 
complex (Youn and Liu, 2000; Han et a l, 2003). The same MEF-2 binding site on cain 
is also the binding site for CaM.
MEF-2 is also a signal integrator for a number of different pathways, including IGF-1 
receptor signalling via PI3-K (Xu and Wu, 2000). Xu and Wu (2000) found that MEF-2 
sites in the myogenin enhancer were required for PI3-K mediated activation of this 
gene, though the mechanism is unclear. While direct phosphorylation of MEF-2 has yet 
to be demonstrated, loss of MEF-2 A and C activity was observed following inhibition
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of PI3-K (Tamir and Bengal, 2000), This inhibition of MEF-2 was rescued by p38 
MAPK, another parallel pathway responsible for MEF-2 activation in skeletal muscle 
differentiation and cardiac hypertrophy (Kolodziejczyk et a l, 1999; Zetser et a l, 1999; 
reviewed in Han and Molkentin, 2000). MEF-2C and A can be activated by p38 
MAPK, which involves direct phosphorylisation of the DNA binding domain (Han et 
a l, 1997). This is in marked contrast to a second MAPK activator of MEF-2, external 
receptor kinase-5 (ERK-5), which phosphorylates the MADS-box regulatory domain 
(Yang et a l, 1998). Unique among MAPKs, ERK-5 possesses a domain for the 
transactivation of expression (Kasler et a l, 2000), and may function as a co-activator of 
MEF-2 activity. Finally, MEF-2 activity is regulated by Notch-1, the promoter of 
proliferation covered in Section 1.2.2.6. Constitutively active Notch-1 blocks the DNA 
binding of MEF-2C (Wilson-Rawls et a l, 1999). This inhibition was found to be MEF- 
2C specific, requiring a 12 amino acid stretch adjacent to the DNA binding domain not 
found in other MEF-2 proteins.
1.3.4.2 MEF-2 and Muscle Development
Unlike the MRFs, MEF-2 proteins cannot induce myogenesis on their own, but are 
important co-factors for the MRFs and other transcription factors. It was the interaction 
with MyoD that led to the discovery of the MEF-2 family, first isolated through binding 
with the basic domain of MyoD (Davis et a l, 1990). MEF-2 proteins form 
transcriptional complexes with MRF/E-protein heterodimers (Molkentin et a l, 1995), 
and MEF-2 binding sites are found in the enhancer and promoter regions of the 
majority of muscle-specific genes (Cserjesi and Olson, 1991). The critical importance 
of MEF-2 in myogenesis was demonstrated by Omatsky et a l (1997) using a dominant- 
negative form of MEF-2A, which completely ablated MyoD-mediated transformation 
of cultured fibroblasts into myotubes.
Several of the signalling factors discussed above affect MEF-2 activity in an isoform 
specific manner. Together with the stage-specific pattern of expression of MEF-2 
members, it would seem likely that different MEF-2s perform different functions. 
MEF-2D is the clearest example, an early marker of the myogenic lineage (Breitbart et 
a l, 1993). MEF-2D is most likely involved in involved in proliferation, through the 
activation c-Jun (Han and Prywes, 1995). A MEF-2 binding site in the promoter region 
of c-Jun was found to be essential for transcriptional activation in HeLa cells. C-Jun is
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one of the Jim sub-family of basic-region leucine zipper proteins, that dimerise to form 
the activator protein 1 (AP-1) complex with leucine zippers from the Jun, Fos, Maf and 
ATF sub-families (reviewed in Shaulian and Karin, 2002). C-Jun is known to be a 
major factor in the activation of cell proliferation (Schreiber et a l, 1999).
1.3.4.3 MEF-2 and Fibre-phenotype
In addition to skeletal muscle growth and differentiation, MEF-2 members are involved 
in calcium-dependent, muscle fibre-type specification (Chin et a l, 1998; Wu et a l, 
2000). Wu et a l (2000) reported that MEF-2 and NFAT binding sites were required in 
the enhancer region of the slow-fibre-specific isofoim of troponin I, and that a MEF-2 
reporter construct in transgenic mice was selectively active in the soleus muscles. One 
of the factors known to interact with MEF-2, and likely to mediate a role in the slow 
fibre phenotype, is PPAR-y-coactivator-la (PGC-la) (Michael et a l, 2001). PG C -la 
is a transcriptional co-activator first isolated through its interaction with peroxisome 
proliferator-activated receptor y (PPARy) (Puigsei-ver et a l 1998). PG C -la is known to 
upregulate mitochondrial biogenesis in a wide range of tissues (Wu et a l, 1999),. 
Muscle-promoter driven transgenic expression of PG C -la results in a fast to slow fibre 
phenotype switch and the co-activation of MEF-2C and D, but not MEF-2 A (Lin et a l, 
2002). Handschin et a l (2003) also found that PG C -la foims part of an auto-regulatory 
loop, mediating its own transcription in conjunction with MEF-2. This feature helps to 
reinforce slow fibre-specification once tiiggered.
1.3.4.4 MEF-2 Summary
In conclusion, the members of the MEF-2 family are involved in the activation of 
almost all muscle-specific genes and as such serve to integrate a wide variety of 
signalling pathways in muscle. Though the diversity of MEF-2 regulated processes 
seems at first to be almost mutually exclusive, the specificity is confeixed not only by 
the MEF-2 isoform involved, but also in interactions with specific co-factors 
(McKinsey et a l, 2002). In this respect, the MEF-2 family is similar to NFAT, the 
family of tmnscription factors downstream of calcineurin. It is the calcineurin/NFAT 
pathway that is the last major signalling pathway dealt with in this review.
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1.4 C a l c in e u r in  a n d  N F A T
The calcineurin/NFAT pathway is involved in the conversion of a generic, widely 
distributed signal, the influx of calcium, into specific patterns of gene expression 
(reviewed in Crabtree and Olson, 2002). This pathway was first described in cells of the 
immune system (Flanagan et a l, 1991; Liu et a l, 1991), where it governs the 
expression of cytokines. Since then, calcineurin signalling has been found to play a role 
in signal transduction in a wide range of different tissue types (reviewed in Rusnak and 
Mertz, 2000). An overview of calcineurin/NFAT signal transduction is shown in Figure 
1.11. To summarise, a sustained increase in the levels of intracellular calcium results in 
the sequestration of Ca^ "^  ions by calmodulin. This leads to a conformation change 
exposing two hydrophobie patches on calmodulin that bind to the calmodulin-binding 
domains on target proteins, including the protein phosphatase calcineurin. Once 
activated, calcineurin interacts with and dephosphorylates NFAT transcription factors 
present in the cytoplasm. The calcineurin/NFAT complex is translocated to the nucleus 
where it forms further interactions with one of a wide range of other factors collectively 
termed NFAT-n (Flanagan et a l, 1991). NFAT-n factors include Fos/Jun (AP-1) 
complexes and members of the MEF-2 and GATA families of transcription factors, the 
end-points of different signal transduction pathways. It is this convergence of the 
calcineurin pathway with other signalling mechanisms that confers transcriptional 
specificity from the generic signal of calcium influx.
1.4.1 St r u c t u r e  a n d  F u n c t io n  o f  C a l c in e u r in
Calcineurin consists of two subunits: a catalytic- and calmodulin-binding subunit, 
calcineurin A (CnA), and a regulatory, Ca^ "^  binding subunit, calcineurin B (CnB) 
(Crabtree, 1999; Rusnak and Mertz, 2000). There are three isoforms of calcineurin A: 
a , p and y, ranging from 58-64 kDa in size, and two isoforms of calcineurin B, both 19 
kDa in size. Calcineurin is, in general, widely distributed tliroughout different tissue 
types, with the greatest abundance in brain tissue. Different sub-unit isoforms, 
however, can exhibit distinct patterns of expression. For calcineurin A, the Ay isofoim 
is restricted to brain and testis while A a and Ap are more ubiquitously expressed (Klee 
et a l, 1998; Rusnak and Mertz, 2000). Similarly, CnBl is widely expressed, in 
association with calcineurin A a and p, but CnB2 is expressed only in testis. While both
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Fig. 1.11. Summary of the calcineurin/NFAT signalling pathway, as is present in a 
number of cell types (from Crabtree and Olson, 2002). Activation pathway is shown in 
blue, inhibition and NFAT re-phosphorylation and nuclear export shown in red. CaM, 
calmodulin. CnA and CnB, calcineurin subunits A and B respectively. MAPK, 
mitogen activated protein kinase. GSK3, glycogen synthase kinase 3.
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subunits are common to many tissues, the relative abundance of A a and Ap isoforms 
can vary, in a tissue specific manner. For example, CnAa is more abundant in rat brain 
and heart than CnAP, a pattern reversed in spleen, thymus and lymphocytes (Kuno et 
a l, 1992; Jiang et a l, 1997). A study by Parsons et a l (2003) in the muscles of the 
mouse showed CnAa to be the predominant isoform in almost all the muscle types 
analysed.
1.4.1.1 Calcineurin Inhibitors
Calcineurin activity is controlled by a number of endogenous regulatory proteins. 
Foremost of these is the ealcineurin inhibitor protein (cain, or cabin) which non- 
competitively blocks calcineurin activity (Lai et a l, 1998). Another specific inhibitor is 
the calcineurin B homologous protein (CHP), a competitive inhibitor that binds to CnA 
without activating catalytic activity (Lin et a l, 1999). Calcineurin is also the target of 
the modulatory calcineurin interacting proteins (MCIPs). There are three MCIP genes, 
MCIP-1, -2 and -3 (reviewed in Rothermel et a l, 2003). They are well studied in 
humans were they are encoded on different chromosomes MCIP-1 is encoded within 
the Down syndrome critical region (DSCR) on chromosome 21, and is also known as 
DSCRl. MCIP-1 is highly expressed in brain, heart and skeletal muscle, and over­
expressed in Down syndrome foetuses (Fuentes et a l, 2000). MCIP-2, also known as 
ZAKI-4, is similarly highly expressed in brain, heart and skeletal muscle, and is known 
to be upregulated by thyroid hormone (Miyazaki et a l, 1996). As discussed in Section 
1.2.3.2.2, thyroid homione is recognised as a major modulator of cardiac and muscle- 
flbre specific expression. MCIP-1 has been shown to be activated by calcineurin 
signalling (Yang et a l, 2000), which would suggest some form of negative feedback 
mechanism.
1.4.1.2 Immunosuppression through Calcineurin
Given the role of calcineurin/NFAT signalling in the immune system, it is perhaps 
unsurprising that it is a target for a number of viral pathogens that can dampen the 
immune response by disabling calcineurin activity. For example, the A238L protein of 
the African swine fever virus has been shown to interact with calcineurin (Miskin et a l, 
1998). Two phaimacological immunosuppressive agents that target calcineurin activity 
are cyclosporin A (CsA) and FK506, originally developed to suppress tissue rejection
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in organ transplant patients. Both act by blocking substrate access (Griffith et a l,  1995; 
Kissinger et a l, 1995), forming complexes that mask the CnA catalytic site, together 
with cyclophilins and FK506 binding proteins respectively (Klee et a l, 1998; Rusnak 
and Mertz, 2000). As shall be seen, the ability of these drugs to inactivate calcineurin 
activity has played a major part in many studies into the role of calcineurin/NFAT in 
skeletal muscle.
1.4.2 T h e  NFAT F a m ily
NFAT stands for Nuclear Factor of Activated Thymocytes, and it was in cells of the 
immune system that members of this multi-gene family were first isolated (Shaw et a l , 
1988; Rao, 1994). There are cuirently four NFAT family members known to interact 
with calcineurin (a fifth NFAT has been characterised, but is not a substrate for 
calcineurin; Lopez-Rodriguez et a l, 1999). NFAT 1, 2 and 4 are known to exist as a 
number of different isoforms, derived from alternative splicing. NFAT-2, for example, 
has been characterised as having three isoforms, referred to as 2a, 2b and 2c (Serfling et 
a l, 2000). These variants differ primarily in the length of their C-teiminal domains 
(Park et a l, 1996; Chuvpilo et a l, 1999). There are a number of nomenclature schemes 
describing NFAT-family members. A single nomenclature system is shown in Table 
1.4, correlating the various alternative naming systems (Rao et a l, 1997; Serfling et a l, 
2000). Splice variants of the four isoforms are lettered alphabetically, as for the 
example of NFAT-2 above. This nomenclature scheme is used throughout this thesis.
Since their isolation from cells of the immune system, NFAT family members have 
been found in a range of different tissue types (reviewed in Rao et a l, 1997), as 
summarised in Table 1.5. The structural features of an NFAT protein are shown in 
Figure 1.12. The DNA binding domain is the region of highest homology among NFAT 
proteins, and also bears similarity with the Rel homology region of Rel-family 
transcription factors (Wolfe et a l, 1996). Also shown in Figure 1.12 are the SP-repeat 
motifs and serine-rich regions of the NHR/CAT domain, which are dephosphoiylated 
by calcineurin during NFAT activation (Beals et a l, 1997a; Zhu et a l,  1998).
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Alternative Nomenclature ( i f  any)
NFAT-1
NFAT-1 a NFATc2, NFATp
N F A T -lb
N F A T -lc
NFAT-2
NFAT-2a NFATc/A , N F A T c.a, N F A T cl, NFATc
NFAT-2b N FATc/B , NFATc.p,
NFAT-2C NFATc/C,
NFAT-3 NFATc4
N FAT-4
NFAT-4X NFATc3, NFATx
NFAT-4a, b & c
Table 1.4. Nomenclature for NFAT family members.
Family member Tissue References
NFAT-1 Thymus, spleen, T cells, B cells, NK (Aramburu et al., 1995; R uff and
cells, m onocytes, macrophages Leach, 1995; W ang et al., 1995; 
W eiss et ai,  1996)
Olfactory bulb and endothelium {Ho et ai,  1994)
Endothelial cells (Cockerill et ai,  1995)
Myoblasts (Abbot et ai,  1998)
NFAT-2 M uscle, thymus, spleen, testis, PBL (H oey et ai,  1995; Masuda et ai.
(peripheral blood lymphocytes), 
testis, ovary, colon
1995)
NFAT-3 Placenta, lung, kidney, testis, ovary, 
heart, colon
(H oey et a/., 1995)
NFAT-4 Heart, thymus, leukocytes (H o et a/., 1995)
Table 1.5. Tissue distribution of NFAT family members.
Calcineurin binding motifs 
Serine-rich region
V
SP-repeat motifs
I II
INLSI011
- >  M -
NHR DBD
Figure 1.12. Structural features of NFAT proteins (from Crabtree and Olson, 2002). 
SP-repeat motif: SpxxSPxxSPxxxxx(E/D)(E/D). NHR, NFAT homology region (also 
known as the calcineurin dependent translocation, or CAT, domain). DBD, DNA 
binding domain. NES, nuclear export signal. NLS, nuclear localisation signal (nuclear 
import signal).
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Nucleus
Figure 1.13. Model for the activation of NFAT proteins and the formation of a 
transcriptional complex with calmodulin/calcineurin, emphasising the conformational 
changes involved (from Rao et al., 1997). 1. Inactive calcineurin/NFAT complex in the 
cytoplasm. 2. The binding of calmodulin in response to an increase in intracellular 
calcium results in a conformational change in calcineurin, unmasking the catalytic site. 
3. The dephosphorylation of NFAT by active calcineurin results in a conformational 
change in NFAT in turn, which exposes the NLS and results in nuclear import. 4. 
Active calcineurin/NFAT in the nucleus, which binds with other co-activators of gene 
expression.
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In the resting form of NFAT, the nuclear localisation signal is masked by the 
phosphorylated SP-repeat motif and serine-rich region. Dephosphorylation by 
calcineurin is thought to result in the dissolution of intra-protein interactions and a 
possible conformational change in the protein. The latter is supported by the 
obsei*vation of (Loh et a l, 1996), that the phosphorylated form of NFAT binds DNA 
less efficiently than the de-phosphorylated. The mechanism of NFAT-activation by 
calcineurin, the formation of the transitionally active complex and the conformational 
change in NFAT is represented in Figure 1.13. In addition to being blocked upstream 
by inhibitors of calcineurin, NFAT activity is also regulated by re-phosphorylation and 
nuclear export mediated by protein kinases such as p38, mitogen activated protein 
kinase (p38-MAPK) and glycogen synthase kinase 3 (GSK3) (Beals et a l, 1997b).
1.4.3 T h e  GATA F a m ily
The GATA family of zinc-finger transcription factors are named after their consensus 
DNA binding site, (A/T)GATA(A/G) (reviewed in Patient and McGhee, 2002). There 
are six family members, which have often been grouped as two separate sub-families. 
GATA 1, 2 and 3 are predominantly associated with the haematopoietic system, and 
regulate the expression of T-lymphocytes, eiythroid cells and megakaryocytes 
(reviewed in Orkin, 1995). GATA 4, 5 and 6 are associated with various mesoderm- 
and endoderm-derived tissues, and with development and tissue-specific expression. 
GATA-4 and GATA-6 are co-factors with NFAT family members in cardiac 
hypertrophy (Charron et a l, 2001; Liang et a l, 2001). Recently, GATA-2 has also 
been associated with hypeiti'ophy in skeletal muscle (Musaro et a l, 1999; Paul and 
Rosenthal, 2002). This would suggest that there is some degree of overlap between the 
two GATA sub-families, at least with regard to muscle function. The known functions 
of the different GATA factors are summarised in table 1,7.
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Family member Role References
GATAI Erythropoiesis (Mead et al., 2001)
Platelet development (Shivdasani et a l ,  1997)
GATA2 Erythropoiesis (Kumano et a l ,  2001)
Skeletal muscle hypertrophy (Musaro et a l ,  1999; Paul and 
Rosenthal, 2002)
GATA3 T helper cell differentiation (Mullen et a l,  2001)
Cytokine production (Kimura et a i ,  2001)
TGF“P signalling (Blokzijl et a l ,  2002)
Ectoderm development (Van Esch et a l ,  2000)
GATA4 Cardiac hypertrophy (Charron et a l,  2001; Liang et al,  
2001; Yanazume et a l ,  2002)
Endoderm development (Fujikura et a l ,  2002)
GATA5 Cardiogenesis (Reiter et a l ,  2001)
Endoderm development (Stainier, 2002)
GATA6 Cardiac hypertrophy (Liang et a l ,  2001)
Smooth muscle transcription (Wada et a l,  2002)
Endoderm development (Fujikura et a l,  2002)
Table 1.6. Multiple, possibly overlapping functions of GATA family transcription 
factors.
The mechanisms by which GATA proteins are activated are not as well studied as 
NFAT. However it is apparent that GATA is also conholled to some extent by 
compartmentalisation, being cytoplasmic in its resting state and translocated to the 
nucleus when activated (Briegel et a l, 1996). As with NFAT, the activity of GATA 
family members is regulated by phosphorylation, as shown by (Morisco et a l, 2001) in 
a study demonstrating re-phosphorylation of GATA4 by GSK3j3 in cardiac myocytes.
1.4.4 R o l e s  f o r  C a lc in e u r in /N F A T  S i g n a l l i n g  in  M u s c le
1.4.4.1 Muscle Growth and Development
The calcineurin signalling pathway has been identified as playing a major role in the 
differentiation of myoblasts in a number of studies, the first of these by (Abbott et a l , 
1998) using cyclosporin A (CsA). In cultured human myoblasts, CsA inhibited 
differentiation, while peimitting normal proliferation. In mouse regenerating muscle, 
CsA administration blocked the process of fibre repair from satellite cells. The 
conclusion was that calcineurin was required for myoblast differentiation, and this was 
supported by further studies in cells transfected with a constitutively active calcineurin
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(Delling et a l, 2000; Friday et a l, 2000). Friday et a l (2000) also demonstrated 
inhibition of differentiation through the physiological inhibitor of calcineurin, Cain.
The role of NFAT in the process of muscle development is more complex. The study 
by Abbot et al (1998) identified three NFAT isoforms active in muscle, NFAT-1, -2 
and -4. The study showed no evidence of NFAT-3 activity in skeletal muscle, and at the 
time of writing, none has been reported since. The three isoforms observed were found 
to be activated and nuclear localised in a stage-specific manner at different points of 
muscle development. NFAT-4 was found to be activated only in myoblasts, NFAT-1 in 
nascent, immature myotubes and NFAT-2 only in mature myotubes. Since then, 
(Sakuma et a l, 2003) have also found evidence of NFAT-2 activity in differentiating 
satellite cells in regenerating muscle, in conjunction with GATA-2. The role of NFAT- 
2 in mature myotubes is discussed below (see Section 1.4.4.3), while activity of the 
other NFAT isoforms in muscle giowth and regeneration is discussed in detail here. A 
summary of the stage-specific involvement of NFAT isoforms in muscle is shown in 
Figure 1.14.
NFATl has been shown to be a requirement for myotube growth (Horsley et a l, 2001). 
In nfatl-/- mice, muscles develop noimally but with a greatly reduced cross-sectional 
area and myonuclear number. Such mice also show reduced myotube formation during 
recovery from local freeze damage. Both of these defects were rescued by the retroviral 
expression of NFATl in nfatl-/- myoblasts in vitro. Since myonuclear number and 
fibre giowth is dependent on the addition and fusion of myoblasts to the growing 
myotubes, the implication is that NFATl mediates myoblast fusion.
Sakuma et a l (2003) found increased levels of NFAT-2 protein in regenerating, adult 
rat and mouse muscle following tissue damage by injection with bupivacaine. This was 
accompanied by an increase both in co-precipitating calcineurin and NFAT-2, and in 
co-precipitating NFAT-2 and GATA-2, in the regenerating tissue. CsA was found to 
inhibit the regeneration of bupivacaine-damaged muscle, further supporting a role for 
calcineurin in the process. This study is interesting for the relatively short time scale at 
which NFAT-2 and GATA-2 co-precipitate following bupivacaine-induced damage (8
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Figure 1.14. A summary of the different myogenic processes mediated by calcineurin 
(from Schulz and Yutzey, 2004). Acting through different isoforms of NFAT and MEF- 
2 (see also Section 1.3.4), calcineurin plays different roles at different stages of 
myotube formation and maturation.
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to 12 hours), which would suggest a role for NFAT-2 far earlier than suggested in the 
previous study by Abbot et al (1998).
The role of NFAT-4 in myoblasts is even less clear. Delling et a l (2000) proposed a 
role for NFAT-4 in differentiation, after their finding that NFAT-4 co-transfection 
greatly enhanced MyoD-directed myogenesis. However, Friday et a l (2000) found that 
specific inhibitors of NFAT failed to abolish myoblast differentiation in the same 
manner as calcineurin inhibition, and suggest that the calcineurin-mediated control of 
myoblast differentiation is via different downstream intermediates. Further work by 
Friday et a l (2003) indeed pointed to MEF-2 as a likely candidate, and the indirect 
activation of MyoD through the inhibition of Egr-1, a ftanscriptional activator of Id 
proteins. NFAT-4 was instead found to be involved in the upregulation of myf-5 by 
activated calcineurin (Friday and Pavlath, 2001). As discussed Section 1.2.2.6, myf-5 is 
a marker of proliferating satellite cells, which points to NFAT-4 directly antagonising 
differentiation, by maintaining myoblasts in a proliferative state.
This would point to calcineurin signalling playing a role in two pathways, proliferation 
and differentiation, generally held to be mutually exclusive. Such an anangement could 
allow a single signal of calcium influx in response, for example, to muscle injury to 
simultaneously generate a rapidly proliferating pool of satellite cells and use cells from 
this pool to differentiate and fuse with the injured/hypertrophying muscle. The 
pathways that modulate this generic signal into the specific outcomes of proliferation or 
differentiation are, at the time of writing, largely unknown. One possible upstream 
regulator, already mentioned in Section 1.2.2.6, is the asymmetric accumulation of 
Numb, antagonist of the Notch-1 receptor in the daughter cells of proliferating satellite 
myoblasts destined for teiminal differentiation. In haematopoietic cells, Notch-1 over­
expression was found to sustain the expression of GATA-2 (Kumano et a l, 2001). It 
may be that by upregulating GATA-2, Notch-1 enhances the action of NFAT-4 in 
promoting the proliferation pathway. To summarise, calcineurin has been shown to 
regulate a number of processes in the proliferation of myocytes and their differentiation 
and maturation into muscle fibres (Schulz and Yutzey, 2004). While calcineurin is 
common to all of these processes, different downstream mediators are involved in each. 
While NFAT-4 is involved in proliferation and NFAT-la in fibre maturation (Figure 
1.14), the initial stages of differentiation are calcineurin dependent, but NFAT-
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independent. The role of NFAT-2 in muscle development and regeneration is presently 
unclear, and NFAT-2 is better studied in fibre type switching and in contributing to 
muscle hyperh'ophy.
1.4.4.2 Calcineurin and NFAT in Muscle Hypertrophy
The calcineurin/NFAT signalling pathway has long been associated with 
cardiomyocyte hypertrophy. As with skeletal muscle hypertrophy, this is an adaptive 
response to a variety of stimuli that impose increased biomechanical stress (reviewed in 
Frey and Olson, 2003). However, if such stimuli are prolonged, cardiac hypertrophy 
can lead to heart failure. Administration of CsA has been shown to block cardiac 
hyperhophy, and the expression of a constitutively active form of calcineurin in heart 
muscle induces a massive hyperhophic response (Molkentin et a l, 1998). GATA 
factors are also involved, with GATA-4 having been shown to induce cardiac 
hyperhophy (Liang et a l, 2001).
Naturally, the discovery of this role of calcineurin signalling in cardiac muscle 
hyperhophy leads to the hypothesis that a similar pathway might be involved in skeletal 
muscle hyperhophy, such as that mediated by IGF-1. Indeed several groups have 
demonshated the inhibition of skeletal muscle hyperhophy through the administration 
of CsA, pointing to a key role of calcineurin in this process (Dunn et a l, 1999; Musaro 
et a l, 1999; Semsarian et a l, 1999b; Mitchell et a l, 2002). The case for calcineurin in 
muscle hyperhophy was furthered by the observation of Musaro et a l (1999), of 
nuclear hanslocation of NFAT-2 during hyperhophy. It should also be noted that 
GATA-2, the GATA family member found in skeletal muscle, is also expressed in 
muscles undergoing hyperhophy (Musaro et a l, 2001). GATA-2 has previously been 
reported as being expressed at no other time in adult muscle (Paul and Rosenthal, 
2002).
However, as already stated, proposed roles for calcineurin/NFAT in skeletal muscle, 
and skeletal muscle hyperhophy in particular, have proven to be conhoversial. Other 
groups found no inhibition of hyperhophy by administering CsA in vivo, despite 
delivering a sufficient dose to inhibit other markers of calcineurin activity (Serrano et 
a l, 2001; Dupont-Versteegden et a l, 2002), and indeed Rommel et a l (2001) 
demonshated inactivation of NFAT in response to the hyperhophic higger of IGF-1.
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Some of these differences may be attributed to differences in experimental design, such 
as choice of target muscle. For instance, positive evidence for a role for 
calcineurin/NFAT in muscle hypertrophy discovered by Mitchell et al. (2002) was 
more evident in fast-twitch muscle than slow muscle, such as the soleus. The work of 
Dupont-Versteegden and others (2002) was done in the soleus muscle alone, and may 
have missed the effect observed by other groups.
Other lines of evidence, however, are harder to discount. For instance, it has been 
shown that transgenic animals expressing a constitutively active form of calcineurin do 
not exhibit elevated skeletal muscle hypeitrophy, despite an increase in calcineurin 
phosphatase activity detected in the transgenic muscles (Dunn et a l, 2000; Naya et a l, 
2000). This is in marked contiast to the evidence supporting the involvement of 
calcineurin cardiomyocyte hypeifrophy. Secondly, calcineurin activity is not increased 
in muscles undergoing IGF-1 induced hypertrophy, as might be expected if it were to 
play a key role (Bodine, 2001).
It is clear then that the role of calcineurin in skeletal muscle hypertrophy is not as clear- 
cut as either its proponents or dehactors would maintain. This is similar to the situation 
in cardiac hypertrophy, a condition caused by a number of different factors (such as 
hypertension, cardiac arrhythmias, endocrine disorders and genetic mutation in cardiac 
contractile proteins), some of which have been shown to occur independently of 
calcineurin signalling (Zhang et a l, 1999). But perhaps a more satisfactory explanation 
would be that calcineurin/NFAT/GATA pathways are involved in a subsidiary role of 
hypertrophy, such as the proliferation and differentiation of satellite cells discussed 
above which could contribute towards a hypertrophic change.
1.4.4.3 Fast to Slow Fibre Switching
A role for calcineurin signalling in the switch from fast to slow fibre phenotype was 
first suggested by (Chin et a l, 1998), in a further investigation into the well-known 
association between motor neuron activity and fibre type specification. Chin et al. 
(1998) observed that CsA adminisfration in whole animals resulted in a slow to fast 
fibre transition. Chin et al. also observed a difference between fast- and slow-fibre 
specific genes in their responsiveness to constitutively active calcineurin. Reporter 
constmcts based on the promoter regions of the slow specific genes, troponin 1 slow
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(Tnls) and myoglobin, showed elevated expression. This was found to be dependent 
on a combination of NFAT and MEF-2 upstream response elements. Similar constructs 
for muscle creatine kinase (MCK), a gene predominantly found in fast fibres, showed 
no similar response to active calcineurin. These initial findings have since been 
supported by further studies demonstrating a calcineurin-mediated activation of slow- 
fibre genes, as summarised in Table 1.7. Furthermore, the slow upstream regulatory 
element (SURE) of the Tnls gene, which contains the MEF-2 and NFAT binding sites, 
has also been found in another fibre-type specific gene, the slow splice-variant of 
collagenous protein (ColQ) (Lee et a l, 2004). The response of the ColQ SURE element 
was found to be inhibited by CsA.
Experimental Model Effect on fibre phenotype Reference
Calcineurin over-expression in C2C12 
culture
Increased l/p MyHC in 
differentiated myotubes.
(Delling et at., 2000)
Transgenic mice expressing 
constitutively active calcineurin
Increased number of slow- 
staining fibres.
(Naya et al., 2000)
CsA-treated rats Decreased percentage of slow 
fibres in soleus muscle.
(Bigard et a l ,  2000)
Calcineurin A and B gene-targeted 
mice
Reduction in slow fibres (Parsons et a l,  2003)
Table 1.7. Studies supporting the role of calcineurin signalling in the acquisition of the 
slow fibre phenotype.
However, as with other proposed roles for the calcineurin/NFAT pathway in skeletal 
muscle, a role in slow-fibre switching has also been the subject of some debate. Swoap 
et a l (2000), in studies using activated calcineurin and NFAT, found no specific 
upregulation of slow-gene reporter constmcts, and no upregulation at all in transfected 
muscle in whole animals. However, this study was reliant on direct injection of plasmid 
DNA into the whole muscle, and a co-tiunsfection of both reporter conshuct and 
activated calcineurin, so this anomaly may be explained by poor or variable efficiency 
of DNA uptake using this method (Mitchell-Felton and Kandarian, 1999).
Even in studies supporting the role of calcineurin in the slow fibre phenotype, there 
seems doubt as to the role of NFAT. Parsons et a l (2003) argued that an NFAT- 
independent pathway, though still involving MEF-2, is involved. Supporting their 
argument was the finding by Delling et al (2000) that NFAT over-expression in
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cultured cells did not stimulate the slow programme, in contrast to calcineurin over­
expression. However, the study by Delling et al. (2000) was focussed on NFAT-4 in 
immature myocytes, and in no way ruled out a role for NFAT-1 and -2 in mature 
myotubes. Even the study by Parsons et a l (2003) demonstrated that greater NFAT 
activity was found in slow fibres than fast fibres, all of which points to a role for 
calcineurin signalling via NFAT.
Harder to account for is the observation by Calvo et a l (1999), in studies on hansgenic 
mice. They demonstrated, in direct contradiction to the work by Chin et a l (1998), that 
an NFAT binding site in the SURE region of Tnls was not required for fibre-type 
specific expression. Rather, a different transcription factor, muscle TFII-I repeat 
domain-containing protein 1/general transcription factor 3 (MusTRD 1/GTF3) was 
found to be required for Tnls activation. One explanation proposed by (Schiaffmo and 
Serrano, 2002) was that MusTRD 1/GTF3 is required for nerve-independent activation 
of the Tnls gene in the embryo, while NFAT is required in the mature miiscle-fibre.
The activity of NFAT-2 in fibre switching has been best demonstrated in studies clearly 
showing NFAT-2 nuclear tianslocation during fast to slow fibre-switching (Liu et a l, 
2001; Rubis et a l, 2002). Liu et a l (2001) created a transgenic adult muscle-fibre 
culture with an adenovirus-delivered GFP-labelled NFAT2 construct. During patterns 
of electrical stimulation specific to slow-muscle (continuously at 10 Hz or 5 second 
trains at 10 Hz every 50 seconds), the GFP signal was found to be localised in the 
nucleus. This nuclear transport was found to be abolished by treatment with CsA, and 
was absent in electrical stimulation patterns consistent with fast motor neuron firing 
(0.1 second tiains at 50 Hz every 50 seconds) or continuous 1 Hz stimulation. One 
possible mechanism for the differences observed in NFAT activity is the rapid nuclear 
export of NFAT. This has been put forward as a mechanism by which the cell can 
distinguish between different types of calcium signalling (Klemm et a l, 1997). 
Depending on the stimulus, changes in the levels of inhacellular calcium can occur as 
sustained elevation, transient spikes or oscillations (Berridge, 1993). Nuclear 
localisation of NFAT requires a sustained calcium elevation, while a brief ‘spike’ 
results in only temporary nuclear translocation (Timmerman et a l, 1996).
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To summarise, there is a large body of evidence suggesting a role for calcineurin/NFAT 
in the control of fibre type, specifically in the promotion of the slow fibre phenotype in 
response to physiological signalling. This has been demonstrated through the inlhbition 
of the calcineurin/NFAT pathway and through direct observation of labelled NFAT 
during the switch to the slow fibre type.
1.5 Su m m a r y
The manner by which physiological signals, such as patterns of motor neuron activity 
or hormone signalling, can induce a change in muscle phenotype is well studied. It is 
less clear, however, how such external stimuli are converted into the specific patterns 
of gene expression required for the associated adaptive response. The possible 
signalling pathways have been the subject of numerous recent studies, as reviewed in 
this chapter.
It is clear that the signal transduction from external stimulus to gene involves several 
inter-linking pathways. Many of the individual pathways involved play a part in a range 
of different or even mutually exclusive muscle responses. A common theme that 
emerges is that it is the interactions between the the different signal transduction 
pathways that generate specific outcomes from generalised signals. For example, the 
single event of calcineurin activation and NFAT dephosphorylation can induce the 
muscle to proliferate, differentiate or activate the slow fibre phenotype, depending on 
which downstream NFAT isofoim is involved (see Figure 1.14).
While the role of the calcineurin/NFAT pathway in muscle has been under 
considerable, recent debate, several aspects remain relatively unknown at the time of 
writing. In particular, the transcriptional targets of effectors downsti'eam from 
calcineurin remain largely uncharacterised. NFAT-binding sites have been identified in 
some isoform-specific regulatory regions, such as the SURE regions (Chin et a l,  1998; 
Lee et a l, 2004), but not in other isofoim markers such as the MyHC family. The long­
term goal of the work described in this thesis was to investigate this area further, and 
determine what direct effects the calcineurin pathway and associated transcription 
factors might have in the regulation of stage- and isoform-specific gene expression.
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1.6  P r o j e c t  A im s
The aim of the project work described herein was to focus on two of the downstream 
effectors of calcineurin, the NT AT and GATA families of transcription factors. The pig 
was chosen as the target species for this investigation given its importance both as a 
large animal model for muscle development and as a commercially important meat 
animal. The NFAT and GATA family members important in porcine muscle were to be 
cloned, in order to determine their effect on fibre-type specific gene expression. This 
work formed part of a wider collaboration between the Molecular Medicine Laboratory 
and pig-breeding company, Sygen International, intended to generate an underpinning 
knowledge of muscle development.
These overall aims were broken down into a number of more immediate objectives, 
summarised as follows:
1. To isolate cDNA sequences from NFAT- and GATA-family transcription factors 
present in porcine skeletal muscle, thi'ough FOR homology cloning.
2. To use the PGR fragments obtained from such an approach to screen for full-length 
cDNA sequences, and to then fully characterise and sequence any novel clones 
isolated.
3. To identify patterns of expression through quantitative real-time RT PGR both 
across different tissue types and stages of pre-natal development.
4. To conduct in vitro studies into the downstream targets of GATA and NFAT in 
skeletal muscle.
This final goal was, in the first instance, to be accomplished by over-expression of the 
newly isolated muscle GATA or NFAT in primary myoblast culture, using a real-time 
RT-PGR approach to quantify any resulting changes in the expression of different 
MyHG isoforms. The following chapters will describe in further detail the approaches 
used to meet these aims, and the results obtained.
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C h a p t e r  T w o  -  G e n e r a l  M a t e r i a l s  a n d  M e t h o d s
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2.1 In t r o d u c t io n
The general methods in use throughout the project are detailed in this chapter. More 
specialised protocols are listed in the relevant methods section. For the most part, the 
general methods described in this chapter were derived from standard methods that 
could be found in common laboratoiy manuals (Maniatis et a l,  1989). Where 
commercial kits were used, the manufacturer’s protocol is presented in summaiy 
though it should be noted that some of the reagents and buffers are proprietary and their 
constitiuents cannot be disclosed.
2.2  M e t h o d s
2.2.1 R e c o m b in a n t  DNA T e c h n iq u e s
2.2.1.1 Growth of Bacteria
Plasmids were maintained in Escherichia coli commercially available, competent 
strains supplied by Stratagene. Specifically, XL2-blue MRF’ strains were used for most 
plasmids, with the XL 10-Gold ultracompetent cells used for cloning sti'ategies where 
the transformation efficiency was expected to be low. Some PCR products, cloned into 
the Topo-TA cloning system (Invitrogen), were maintained in Invitiogen’s ‘One-shof 
DH5-a cells.
Cells were cultured on LB-agar supplemented with the appropriate antibiotics to 
maintain the selection of plasmid-containing cells (100 pg/ml ampicillin, 12.5 pg/ml 
chloramphenicol, 50 pg/ml kanamycin or 15 jug/ml tetracycline).
2.2.1.2 Extraction and Purification of Plasmid DNA
Isolation of plasmid DNA was earned out in all instances by a modified version of the 
alkaline lysis technique (Bimboim and Doly, 1979).
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2.2.1.2.1 Small Scale Plasmid Preparations
Cells picked from single colonies were gi'own in 5 ml LB, overnight at 37 °C in an 
orbital shaker. For each overnight culture, 1.5 ml of cells was spun down in a 
microcentrifuge tube, 10,000 x g for 1 min and the supernatant discarded. A further 1.5 
ml from the same culture was added to the pellet and the centrifugation step repeated, 
for a total of 3 ml of culture processed per overnight culture. The final pellet was spun 
again briefly, and as much of the remaining LB medium removed as possible, using a 
pipette.
Plasmid DNA minipreps were prepared using the Spin Miniprep Kit (Qiagen). The 
manufacturer’s protocol was used, re-stated briefly as follows: Each cell pellet was 
thoroughly resuspended, by pipetting, in 250 pi Buffer PI. Cell suspensions were lysed 
by the addition of 250 pi Buffer P2, mixed by inversion. Protein was precipitating out 
of solution with the further addition of 350 pi Buffer N3, the solution mixed thoroughly 
to prevent localised precipitation. The resulting precipitate was centrifuged for 10 min 
at 10,000 X g, and the supernatant from each tube applied to a Qiaprep spin columns. 
DNA was bound to the column by spinning down at 10,000 x g for 1 min, and 
discarding the flow through. To remove tiace endonuclease activity, each column was 
washed with 500 pi Buffer PB, and the centrifugation step repeated. Columns were 
further washed by adding 750 pi Buffer PE and spinning the columns down again. To 
remove residual ethanol from this wash step, the centrifugation step was repeated a 
final time and the columns transfeiTed to a clean 1.5 ml microfrige tube. The plasmid 
DNA was then eluted from the column by the addition of 50 pi of 10 mM Tris-Cl, pH 
8.0. The columns were left to stand for 1 min, before centrifuging 1 min, 10,000 x g. 
Plasmid DNA was stored at -20 “C until required.
2.2.1.2.2 Large Scale Plasmid Preparations
Cells picked from overnight colonies were grown in 5 ml LB at 37 °C, overnight, in an 
orbital shaker. From this overnight culture, 2 ml was used to used to inoculate 400 ml 
LB medium, supplemented with the relevant antibiotics, in a 1 L conical flask, cultured 
overnight at 37 °C, shaking at 200 rpm. At this level of aeration, the cells were 
approximately mid-log phase when harvested the following morning. Cells were 
pelleted by centrifugation, 6,000 x g for 15 min at 4 °C.
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Cell pellets were processed using the Qiagen Maxiprep kit. The Qiagen protocol is 
summarised as follows: First the cell pellets were resuspended in 10 ml buffer PI, 
resuspending by pipetting until no cell clumps were visible. The cells were then lysed 
with the addition of 10 ml buffer P2, mixing vigorously by inversion. Ten ml of pre­
chilled buffer P3 was added and the resulting suspension spun down at 20,400 x g for 
40 min at 4 °C. During the spin a Qiagen maxiprep column was prepared, equilibrated 
with 10 ml buffer QBT. The supernatant from the centrifugation step was applied to the 
column, poured through a 0.2 pm cell strainer (Falcon) to remove residual particulate 
matter. The columns were washed through twice with 30 ml buffer QC, the flow­
through discarded.
Plasmid DNA was eluted with 15 ml buffer QF, into a clear, polycarbonate, 30 ml 
centrifuge tube. DNA was precipitated with the addition of 10.5 ml isopropanol, mixed 
by inversion and centrifuged at 20,400 x g for 30 min at 4 °C, carefully pipetting off the 
supernatant. The pellet was then carefully washed with 5 ml of 70% ethanol, pre­
chilled to —20 °C, and spun again at 20,400 x g for 15 min, 4 °C. The supernatant was 
pipetted off, and the pellet air-diied. DNA was resuspended in 200 pi 10 mM Tris HCl, 
pFl 8.0 and stored at -20 °C.
2.2.1.2.3 Determination of DNA Concentration bv Snectronhotometi-v
The concentration of DNA preparations, principally from large scale plasmid 
preparations, was deteimined spectiophotometrically with optical density 
measurements at 260 and 280 nm against a distilled-water blank. Plasmid samples were 
diluted 1:200 in Millipore-pure water, total volume 800 pi, and tiansferred to a quartz, 
optical cuvette. An OD260 measurement of 1.0 was taken to indicate a double-sti'anded, 
plasmid DNA concentration of 10 pg/pl. The ratio of OD readings at 260:280 nm was 
used to estimate the purity of the DNA preparation, with a ratio approaching 2,0 being 
the ideal. Lower ratios were indicative of protein contamination.
2.2.1.3 Restriction Endonuclease Digestion
For most restriction digests, between 1 and 2 pg of DNA was digested in 20 pi of 
reaction mix containing 5 to 10 units of appropriate restriction enzyme (Invitiogen,
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Promega) and the required enzyme buffer. The reactions were incubated for a minimum 
of two hours.
2.2.1,4 DNA Electrophoresis
2.2.1.4.1 Agarose Gel Electrophoresis
Size fractionation of DNA samples was typically earned out in 0.8% agarose gels, 
made up in TAE buffer (40 mM Tris acetate, 1 mM EDTA). The agarose was melted in 
a microwave, mixed thoroughly and allowed to cool to around 55 °C. Ethidium 
bromide was then added to a concentration of 75 pg/ml, and the whole gel mix poured 
into the casting plate and a gel comb appropriate to the volume of sample added. Once 
the gel had been allowed to set the casting comb was carefully removed and the 
solidified gel immersed in TAE buffer. Gel suiplus to the requirements of the run was 
pared away and stored at 4 °C until needed.
DNA samples were prepared for loading by adding the appropriate volume of 10 x gel 
loading buffer, together with a molecular size standard DNA, typically a 1 kb ladder 
(Invitrogen). After loading, gels were mn for 60 to 120 minutes at 70 volts, and 
visualised on a UV transilluminator.
2.2.1.4.2 Excision of DNA Bands
Where a particular DNA fragment was required for a particular cloning strategy, the 
relevant restriction digest was performed, and size fractionated on an agarose gel. The 
agarose containing the desired band was visualised on a UV transilluminator and 
quickly excised fiom the gel using a scalpel, keeping excess agarose to a minimum.
DNA was recovered from the gel slice using the QIAquick Gel Extraction Kit provided 
by Qiagen. The kit protocol was followed, as summarised; Each gel slice was 
transfeiTed to a 1.5 ml microcentrifuge tube and weighed. For each gel slice, 3 pi 
Buffer QG was added for eveiy mg of sample (3 gel volumes). Samples were then 
heated for 10 min in a 50 °C waterbath. Once the gel slice was completely dissolved, 
one gel volume of absolute isopropanol was added, and the mixture transferred to a 
Qiaquick spin column/collection tube assembly. Column assemblies were spun at
10,000 x g in a Beckman microcentrifiige for 1 min. Flow throw was discarded, and
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750 pi of PE wash buffer added to the column. The columns were spun at 10,000 x g 
for another 1 min, and the flow through discarded. To remove all traces of ethanol 
present in Buffer PE, the centiifiigation step was repeated, and the columns transferred 
to clean, 1.5 ml microcentrifuge tubes. To elute the DNA from the column 30 pi 10 
mM Tris HCl, pH 8.5, was added and the column left to stand for 1 min, before being 
spun again at 10,000 x g for 1 min. The extracted DNA was either used immediately or 
stored at -20 “C
2.2.1.5 DNA Ligation
T4 DNA ligase (Promega) was used for most of the cloning strategies. The multiple 
cloning site of the relevant plasmid vector was cut with the appropriate restiiction 
enzymes (2.2.1.3) and treated with calf alkaline phosphatase (Roche) for 1 hour at 37 
^C. Between 50 to 100 ng of vector DNA was mixed with the target insert, at a molar 
ratio of 1:5, together with an appropriate volume of ligation buffer and 4.5 units of T4 
DNA ligase (Promega), in a final volume of between 10 to 20 pi. Reactions were left 
overnight at 14 °C, before proceeding to the transfoimation step, described below 
(2.2.1.6).
2.2.1.6 Transformation of Bacteria With Plasmid DNA
2.2.1.6.1 Transfonnation of Commerciallv Available Ultracomnetent Cells 
As previously stated, most transfoimations utilised the XL2-Blue MRF’ and XL 10- 
Gold ultracompetent cells supplied by Stratagene. Plasmid DNA transformation of 
these cells was carried out according to the supplier’s guidelines, summarised as 
follows: Competent cells were thawed on ice, and |3-mercaptoethanol added to a final 
concentration of 25 mM, mixed gently and incubated for 10 min on ice. Plasmid DNA 
was then added to the cells, at a concentration of between 0.1 to 50 ng of DNA per 100 
pi of competent cells. The mixtures were incubated on ice for 30 min, then the cells 
heat-shocked for 30 s at 42 ®C. Bacteria were put back on ice for 2 min, before diluting 
ten-fold in pre-heated (42 ®C) NZY broth, and incubated in an orbital shaker for 1 hr at 
37 ^C. Following the incubation, 200 pi of the transformation reaction was plated on 
LB agar plates containing appropriate antibiotics.
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2.2.1.6.2 Topo-TA cloning
The Topo-TA system was a specialised cloning kit (Invitiogen) specifically designed 
for the cloning of PCR products (section 2.2.2), taking advantage of non-template 
terminal tiansferase activity of Taq polymerase that leaves a single deoxyadenosine 
residue overhang on PCR products. The linearised vector in the kit possesses a single 
deoxythymidine residue overhang, allowing any PCR product to be ligated into the 
vector.
As per protocol, 4 pi PCR product was added to 1 pi Topo-TA vector, mixed gently 
and left for 5 min. This was added to an aliquot of One Shot cells, mixed gently and 
incubated on ice for 30 min. The cells were heat-shocked for 30 s at 42 ”C, put back on 
ice for 2 min and 250 pi room-temperature SOC medium added. Cells were incubated 
in an orbital shaker for 30 min at 37 °C. At the end of the incubation, 50 pi was plated 
out onto LB agar supplemented with ampicillin, and incubated overnight at 37 °C.
2.2.2 P o ly m e r a s e  C h a in  R e a c t io n
The polymerase chain reaction (PCR), a means of amplifying small amounts of specific 
DNA template from a complex mixture is reviewed extensively by (Innis and Gelfland, 
1990). A general overview of how this method was applied to DNA amplification 
throughout the project is given below. Where appropriate, the details of more specific 
PCR experiments will be given in the relevant chapter.
2.2.2.1 Primer Design
Custom oligonucleotide synthesis was by MWG Biotech. Most of the oligonucleotide 
primers were between 20 to 30 deoxynucleotide residues in length, with a base 
composition of roughly 50 to 60 % guanine or cytosine where possible. Primer pairs 
with complementaiy sequences were avoided, and both primers designed so as to have 
matching annealing temperatures (T^).
2.2.2.2 Reaction Conditions
PCR reagents were supplied by Promega. Amplification reactions were typically set up 
in a reaction mix of the following: 200 pM of dNTP, PCR buffer (50mM KCl, lOmM 
Tris-HCl, pH 9.0, 0.1% Triton® X-100 and 1.5mM MgCl2) and 2.5 units of Taq DNA
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polymerase. The appropriate amount of DNA or cDNA template varied between PCR 
reactions, but was generally between 10 to 100 ng. Thermal cycling was earned out on 
an Applied Biosystems GeneAmp 2400. For standard PCR, the template was denatured 
for 3 min at 95 °C, followed by 30 to 35 cycles of a 1 min, 95 °C dénaturation step, 1 
min at 55 to 60 °C annealing (the annealing step being greatly dependent on the primer 
sets used) and an extension step at 72 °C. This was followed by a final 5 min extension 
step, before holding at 4 °C. PCR amplification products were stored at -20 °C if not 
used immediately.
Amplification products were visualised by agarose gel electiophoresis, as described in 
section 2.2.1.4.1. Up to 10 pi of the PCR reaction was loaded onto each well, more if 
the product was to be used in TopoTA cloning.
2.2.3 DNA S e q u e n c e  A n a ly s i s
The majority of clone and plasmid sequence data was obtained using the ABI 
sequencing kits (Applied Biosystems), based on the chain teimination method (Sanger 
et a l, 1977) with cycle sequencing modifications described by Innis et a i (1988). Early 
in the project, the LI-COR system was used for emMyHC regulatory region 
sequencing. This is covered in the specific methods section (3.2.5.1). Two versions of 
the ABI thermal cycle sequencing system were used in the course of the project work. 
Versions 1.0 and 3.0 respectively, with the latter being an improved version available 
later in the project.
2.2.3.1 Primer Design
As for PCR, custom oligonucleotides for cycle sequencing were supplied by MWG 
biotech. Sequencing primers were typically 20 to 25 oligonucleotides in length, with at 
least 50% G/C content, roughly 50 bp upstream (5’) of the region to be sequenced. A 
last (3’) base of either adenosine or thymidine was avoided, with a 3’ stretch of four or 
five guanidine or cytosine residues preferred.
2.2.3.2 Preparation of DNA samples for Cycle Sequencing
Plasmid DNA was used as the template for all of the sequencing done in the course of 
the project work, whether prepared by small (2.2.1.2.1) or large scale (2.2.1.2.2)
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preparations. Manufacturer’s protocols (Applied Biosystems) were followed in both 
versions of ABI cycle sequencing. They are summarised as follows:
2.2.3.2.1 Version 1.0 Chemistrv
The cycle-sequencing reaction mixture consisted of ABI PRISM Big Dye reagent 
mixture (Applied Biosystems) and appropriate buffer, together with 200 to 500 ng of 
DNA template and 3.2 pmol sequencing primer, made up to 20 pi with Millipore-pure 
water. Cycle sequencing was canied out on an Applied Biosystems GeneAmp 2400, 
using the following program: one denaturing step at 96 °C for 2 min, followed by 25 
cycles of 10 s dénaturation at 96 °C, 5 s annealing at 50 "C and 4 min extension at 60 
°C, with a final hold at 4 °C. Reaction products were kept at -20 °C if not immediately 
processed for loading.
The reaction mixture was purified by ethanol precipitation to remove unincorporated 
dye-labelled nucleotides. The samples were transferred to 1.5 ml microcentrifuge tubes, 
and ethanol added to a final concentration of 96%. The tubes were vortex mixed briefly 
and then left to stand at room temperature for fifteen minutes. The tubes were spun at
10,000 X g in a Beckman microcentrifuge for twenty minutes at room temperature. 
After the centrifugation step, the supernatant was immediately aspirated and the DNA 
pellet washed with 250 pi 70% ethanol. Samples were spun again at 10,000 x g for ten 
minutes, and the supernatant carefully aspirated as before. Samples were then dried by 
placing them in a heat block at 90 ^C for one minute.
The dried samples were resuspended in 25 pi Template Suppression Reagent (TSR), 
mixed by vortexing and briefly spun down in the Beckman microcentrifuge. The 
samples were then denatured by heating in a heat block at 95 for IV-i minutes, and 
then chilled on ice. The samples were vortexed again, briefly spun down and 
transferred to ABI sample vials. The samples were stored at -20 °C until ready to load.
Visualisation of the cycle sequencing products was carried out on an ABI Prism 310 
Genetic Analyser (Applied Biosystems). Loading was largely automated and the set-up 
carried out according to manufacturer’s instructions.
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2.2.3.2.2 Version 3.0 Chemistrv
The reaction mixture comprised of the version 3.0 Big Dye reagent mixture and 
appropriate buffer, together with 200 to 500 ng DNA template and 3.2 pmol sequencing 
primer as before. Cycle sequencing was carried out on an Applied Biosystems 
GeneAmp 2400, using the following programme: one denaturing step at 96 for 2 
min, followed by 25 cycles of 10 s dénaturation at 96 °C, 10 s annealing at 50 “C and 4 
min extension at 60 °C, with a final hold at 4 °C. Reaction products were kept at -20 °C 
if not immediately processed for loading.
For the ABI version 3.0 chemistry, DNA purification was carried out by column 
filti'ation, in filter cartridges provided by EDGE Biosystems (Perfoima™ DTR gel 
filtration cartridges). Before loading the samples, each cartridge was spun at 750 x g in 
the microcentrifuge for two minutes, to remove the storage buffer. The cartridge was 
removed to a fresh tube (provided in the kit), and the sample applied to the gel matrix. 
The cartridge was spun for another two minutes at 750 x g, and the cartridge discarded. 
The samples were dried by vacuum desiccation. The dried samples were stored at -20 
°C until loading, at which point they were resuspended in formamide.
Visualisation of the cycle sequencing products was carried out on an ABI Prism 3100 
Genetic Analyser. As for the ABI Prism 310, loading was largely automated and the 
set-up carried out according to manufacturer’s instructions.
2.2.3.3 Data analysis
Data analysis was done by GCG and Chromas software packages. Sequence pileups 
and comparisons were done using either Blast (NCBI), AliBee Multiple Alignment 
(GeneBee) or ALIGN (Pearson et a l, 1997) software.
2.2 .4  S o u t h e r n  a n d  N o r t h e r n  B l o t  H y b r id is a t io n
2.2.4.1 Preparation of Radiolabelled DNA Probes
All legal requirements and local procedures governing the safe use of radioisotopes 
were adhered to in the course of the project work.
83
Typically, the radioisotopes used were Redivue preparations provided by Amersham 
Bioscience. These contain a red dye for ease of handling and a stabilising solution, 
allowing storage in liquid form, at 4 °C. Early in the project, these Redivue preparations 
were not available and the standard solutions (Amersham Bioscience) were used 
instead. Since these were stored at -20 °C it was necessary to thaw the pot containing 
the isotope for one hour prior to labelling.
2.2.4.1.1 Random Hexamer Labelling
Large, double stranded templates were labelled by the random hexamer method of 
Feinberg and Vogelstein, (1983). Using random hexanucleotide sequences as primers, 
and denatured DNA as a template, a complementaiy strand incorporating the 
radiolabel, ^^P-dCTP, can be generated with the Klenow fragment of DNA polymerase 
I.
This random hexamer labelling was carried out using the Re diprime II DNA labelling 
kit (Amersham Pharmacia). The procedure is summarised as follows: DNA was diluted 
to a suitable concenti'ation (between 2.5 to 25 ng) in 45 pi TE buffer. The sample was 
denatured by heating to 100 ”C for 5 min in a heating block, snap cooled on ice for 5 
min and spun down briefly. The DNA was added to a Rediprime-kit reaction tube 
containing a pre-aliquoted reaction mix of nucleotides (minus dCTP), random primers 
and exonuclease-free Klenow enzyme in the appropriate buffer. Finally, 5 pi of a^^P- 
dCTP (50 pCi) was added and the tube mixed thoroughly, and the reaction was 
incubated for 10 to 30 min at 37 °C, and stopped by the addition of EDTA to a final 
concentration of 20 pM.
Unincorporated ^^P-labelled oligonucleotides were separated from the reaction mix by 
use of NICK columns (Pharmacia Biotech) containing Sephadex G-50 gel. The column 
was equilibrated with distilled water during the incubation, before applying the reaction 
mix. The column was washed once with 400 pi distilled water, and the radiolabelled 
probe eluted by the addition of a further 400 pi distilled water. A 2 pi aliquot was taken 
off for liquid scintillation counting. Probes were typically used at a concentration of 10  ^
cpm/ml of hybridisation buffer. The remaining probe aliquot was either used directly or 
stored at -20 °C until required. Probes were denatured by boiling for 5 min before use.
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2.2.4.1.2 End Labelling of Oligonucleotides
Small oligonucleotide probes were made by the addition of a ^^P-labelled phosphate 
gi’oup to the unphosphorylated 5’ end found, by nature of their manufacture, on all 
oligonucleotides. The addition of the labelled phosphate group is mediated by T4 
polynucleotide kinase.
The reaction mixture was made up with 0.8 pmol/pl oligonucleotide template, together 
with 20 units of T4 polynucleotide kinase, forward reaction buffer and 50 pCi of y^^P- 
ATP, in a final reaction volume of 50 pi. The reaction mixture was incubated at 37 “C 
for 1 hour.
Unincorporated labelled oligonucleotides were removed by passing the reaction mix 
through NAP-5 columns (Pharmacia Biotech) containing Sephadex G-25. These were 
equilibrated three times with distilled water before use. The 50 pi reaction volume was 
mixed thoroughly and applied to the column. The column was washed with 450 pi of 
distilled water, and the labelled probe eluted with a further 1 ml distilled water 
collected in a screw-cap vial. An aliquot of 2 pi was removed for liquid scintillation 
counting, with the probe typically used at a concentration of 10*^  cpm/ml hybridisation 
buffer. End-labelled probes were heated to around 90 °C for 1 min, to remove any 
secondary structures.
2.2.4.2 Southern Blot Hybridisation
The Southern blot tiansfer method of detecting specific DNA sequences among 
fragments separated by gel electrophoresis was used as previously described (Southern, 
1975). The protocol is summarised here, including the more general variations 
employed during the project work.
2.2.4.2.1 Blotting
DNA samples were run out on agarose gel as described in section 2.2.1.4.1. The gel 
was briefly visualised on a UV transilluminator. The gel was then incubated in three 
buffers in turn: 15 min in depuiination buffer (0.25 M HCl), 30 min in dénaturation 
buffer (1.5 M NaCl, 10.5 M NaOH), and 15 min equilibrating in 0.4 M NaOH. The gel
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was then ‘blotted’ to a Hybond-N nylon membrane (Amersham) overnight, wicking the 
0,4 M NaOH solution up through Whatman filter paper, gel and filter by paper towels. 
After the incubation, the filter was briefly washed, DNA side up, in 2 x SSC and left to 
dry, before cross-linking the blotted DNA to the nylon filter by UV. Filters were stored 
in Saran wrap at room temperature until use.
2.2.4.2.2 Hvbridisation and Autoradiographv
The filters were first pre-washed to remove any remaining pieces of agarose that might 
interfere with hybridisation in 5 x SSC, 0.5% SDS for 30 min. The wash buffer was 
then replaced with hybridisation solution. For routine applications, a commercially 
available buffer was used, the Quickhyb solution from Stratagene. Filters were 
incubated in Quickhyb at 50 °C for 1 hr for pre-hybridisation before the addition of the 
radiolabelled probe. After the addition of probe, the hybridisation incubation was 
continued for 60 to 90 min, temperature dependant on the annealing temperature (Tm) 
of the particular probe sequence.
For more sensitive applications requiring a lower level of background caused by non­
specific probe-binding, a ‘home-made’ buffer was used. This comprised of 50% 
formamide, 5 x SSC, 5 x Denhardt’s solution, 1 mM EDTA, 1% SDS, 50 mM sodium 
phosphate solution, pH 7.0, and 100 mg of sheared salmon sperm ssDNA. Pre­
hybridisation using this buffer was carried out overnight, at 42 °C, as was the 
subsequent hybridisation.
Following hybridisation, filters were subjected to a series of washes of increasing 
stringency. Stiingency was increased by decreasing salt concentration and increasing 
temperature. Again, the wash temperature depended on the Tm of the probes involved, 
typically between 50 to 65 ^C. After the last wash, the filters were rinsed, placed in 
saran wrap, and exposed to autoradiography film (Amersham Pharmacia) in an 
intensifier cassette. The films were left at -70 °C for a period of typically 3 days to a 
week before developing.
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2.2.4.2.3 Genomic DNA Preparation
The above procedure was used for DNA plasmid preparations. Some alterations were 
required for identifying specific DNA sequences in genomic DNA preparations, the 
biggest of these being the preparation of the DNA samples from porcine tissue. Pigs 
were slaughtered by captive bolt, and tissue samples quickly dissected from various 
tissues (section 2.2.4.4 for a full list). These tissue samples were placed in cryotubes 
and immediately snap-frozen in liquid nitrogen, and kept in liquid nitrogen storage until 
required.
Tissues were removed from liquid nitrogen storage and kept on dry ice as much as 
possible. Approximately 100 mg tissue was weighed out, and ground into fragments 
using a mortar and pestle chilled in liquid nitrogen. The fragments were collected in a 
microcentrifuge tube, and to them was added ten volumes of extraction buffer (10 mM 
Tris, pH 8.0, lOOmM EDTA, 0.1 % SDS and 20 pg/ml Pancreatic RNase). This 
mixture was incubated for 1 hour in a 37 °C waterbath, after which proteinase K was 
added to final concentration of 100 pg/ml. The tubes were incubated for a further 3 
hours at 50 ®C. Phenol chloroform extraction was used to purify the DNA. The 
supernatant was removed to a clean, 2 ml screw-cap micro centrifuge tube, and a half- 
volume of 1:1 phenol/chloroform added. Tubes were vortex mixed, and centrifuged for 
15 min at 10,000 x g, room temperature. The aqueous phase was removed to a fresh 
tube, taking care not to disturb the interface. An equal volume of 1:1 phenol/chloroform 
was added, and the tube vortex mixed and centrifuged as for the first round of 
extraction. This was repeated again for a third extraction step.
The DNA was precipitated from the final aqueous phase by the addition of 0.2 volumes 
of 3M sodium acetate, pH 8.0, and 1 volume of isopropanol. This mixture was left at 
room temperature for a few minutes until the formation of a white DNA precipitate. 
Samples were then spun at 10,000 x g for 5 min, and the supernatant removed. Pellets 
were left to air-dry, and then resuspended in 100 pi Millipore-pure water. For genomic 
Southern blots, a 20 pi aliquot of genomic DNA (typically 10 to 20 pg) was digested 
by restriction endonuclease (section 2.2.1.3) in a larger reaction volume of 50 pi for 
several hours, with the amount of reaction mixture components adjusted appropriately. 
The entire restriction digest was mn out on a large-comb gel, the subsequent blot-
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transfer to Hybond-N nylon membranes and autoradiography steps canied out as 
described for normal Southerns above (section 2.2.4.2.2).
2.2.4.3 Colony Lift Hybridisation
Colony lifts were used to detect specific DNA sequences (often cloned PCR products) 
within a mixture of E. coli colonies. Hybond-C nitro-cellulose membranes were placed 
over the surface of the agar plates containing the colonies of interest. The filter was 
marked asymmetiically with India ink to allow subsequent location of positive 
colonies, and the filter lifted with care so as to preserve the relative positions of 
colonies on the plate. The nitro-cellulose filters were then incubated on Whatman filter 
paper soaked in the following three buffers, for 5 min each: denaturing buffer (0.5 M 
NaOH, 1.5 M NaCl), neutralising buffer (0.5 M Tris, pH 7.4, 1.5 M NaCl) and finally 
equilibrating in 2 x SSC, 1.5 M NaOH. Since niti'o-cellulose is inflammable, the filters 
were not cross-linked by UV, but baked at 80 °C for 2 hours. Hybridisation and 
autoradiography were carried out as for standard Southern blotting (section 2.2.4.2.2).
2.2.4.4 Northern Blot Hybridisation
2.2.4.4.1 Extraction of Total RNA from Porcine Tissues
Pigs were slaughtered by captive bolt, and tissue samples quickly dissected from liver, 
kidney, brain, spleen, heart, uterus, and from the psoas and longissimus dorsi (ED) 
skeletal muscles. These tissue samples were placed in ciyotubes and immediately snap- 
frozen in liquid nitrogen.
As required, tissue samples were removed from liquid nitrogen storage and kept on diy 
ice. Keeping the tissue frozen at all times was essential for preventing RNA 
degradation, and where possible all manipulation was carried out over dry ice or liquid 
niti'ogen. Tissue fragments were ground using a pre-chilled mortar and pestle, and 
around 50 mg of the pieces quickly and carefully weighed into a sterile 2 ml screw-cap 
tube. To the tissue fragments was added 800 pi Denaturing Solution, containing 
guanidine thiocyanate, 0.75 M sodium citrate, pH 7.0, and 10% N-lauroyl sarcosine, 
and the mixture mechanically homogenised using an Ultra-Turrax® T8 homogeniser 
(IKA Labortechnik). Once the tissue was thoroughly lysed, 50 pi of 3 M sodium 
acetate was added to the preparation, along with 800 pi phenol and 160 pi chloroform
(5:1 phenol to chloroform). This mixture was vortexed thoroughly, and spun down. The 
aqueous phase was removed to a fresh tube, and the extraction repeated two or three 
times more with the addition of 1.6 ml 1:1 phenol chloroform, until a clean interface 
was observed indicating minimal protein contamination.
The RNA in the final aqueous phase was precipitated with the addition of one volume 
o f-20 °C isopropanol, leaving the mixture at -20 °C for 20 min. This was spun down at
10,000 X g in a pre-chilled rotor, 4 “C for 30 min. Supernatant was removed, and the 
pellet carefully washed with 500 pi of 70% ethanol, spinning again for 5 min. The final 
pellet was resuspended in 30 pi of RNase-ffee distilled water.
2.2.4.4.2 Running Foimaldehvde Gels
Size fractionation of total RNA was performed essentially as described by Lehrach et 
al (1977). Gels were made up of 0.8% agarose in MOPS-EDTA-sodium acetate 
(MESA) buffer, melting the agarose as normal and allowing to cool, and then adding 
foimaldehyde to the mixture and pouring into the gel casting plate. Since formaldehyde 
is volatile, formaldehyde-containing gels were used immediately, or stored for no 
longer than overnight at 4 °C. For each sample, 15 pg RNA was mixed with RNA 
sample buffer (consisting of 1 ml lOX MOPS, 3.5 ml 37% formaldehyde and 10 ml 
formamide, per sample), made up to 20 pi with DEPC treated water. Samples were 
heated at 68 °C for 5 min, chilled on ice for 5 min, then 2 pi loading buffer (50% v/v 
Glycerol, 1 mM EDTA, 0.25% Bromophenol blue, 0.25% Xylene cyanol in DEPC 
water) and 1 pi 0.4 mg/ml ethidium bromide added. Samples were loaded onto the gel, 
and run overnight at 30 volts in 1 x MESA buffer.
2.2.4.4.3 Blotting and Hvbridisation
The transfer of RNA to Hybond-N nylon filter was similar to the method used for 
Southern Blotting, with the transfer buffer drawn up through gel and filter by means of 
paper towels and Whatman filter paper. In this case, 10 x SSC was used as the transfer 
buffer. The following morning, the filter was dismantled from the transfer apparatus 
and washed for 10 seconds in 6 x SSC. Filters were left to diy, covered in Saran wrap 
and then UV cross-linked. For the most part, hybridisation with the appropriate
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radiolabelled probes and subsequent autoradiography were canied out as detailed in 
section 2.2.4.2.2.
2.2.5 P r im a r y  C e l l  C u l t u r e
2.2.5.1 Isolation and Maintenance of Porcine Muscle Satellite Cells
2.2.5.1.1 Satellite Cell Isolation
Pigs were killed by captive bolt, followed by severance of major neck blood vessels. 
Sections of LD and psoas were dissected from the muscle, taking care to remove 
obvious fatty or connective tissues. Muscle samples were stored in ice-cold tissue 
culture medium until proceeding to the next stage. Muscle pieces were finely dissected 
using a scalpel blade. The finely cut muscle pieces were incubated in 1,4 U/ml dispase 
in PBS for two hours at 37 °C, resulting in a tissue ‘slurry’. This was spun down at 400 
X g, and the single-cell suspension in the supernatant removed to a fresh tube and kept. 
The remaining cell sluny pellet was washed with a further 10 ml of culture medium, 
and the supernatant again removed and transfeiTed to a fresh tube. Both of these tubes 
were spun at 1300 x g, 5 min, to pellet the cells and debris, removing the dispase- 
containing media and replaced with fresh culture media.
To remove the last remaining tissue clumps, the resuspended cell pellets were passed 
through a 100 pm cell strainer, pelleted by centrifugation again and resuspended in 
fresh culture medium. Cells were seeded on 75 cm^ or 175 cm^ flasks and grown at 37 
°C for 3 to 5 day before changing the media. Typically, depending on the growth rate of 
the particular muscle isolate, the cells were passaged at this point into several flasks 
until a sufficient number of cells were reached for cell freezing and storage.
2.2.5.1.2 Culture Media for Satellite Cell Growth and Differentiation
The first satellite cell cultures were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM), supplemented with 15% foetal calf serum (PCS), 1 U/ml penicillin, 1 pg/ml 
streptomycin and 10 pg/ml cyproxin. Subsequent cultures were gi'own in PromoCell 
Skeletal Muscle Cell Growth Medium (cat. N~. C-39360). The basal, serum-free 
medium was supplemented before use with the following growth factors and hormones: 
5% foetal calf serum, 0.4 pg/ml dexamethasone, 10 ng/ml hEGF, 1 ng/ml hbFGF, 50
90
pg/ml Fetuin and 10 pg/ml bovine insulin, together with antibiotics, 50 pg/ml 
gentamicin and 50ng/ml amphoteracin B.
Cells were induced to undergo differentiation by changing the medium to DMEM with 
4% horse serum, in place of the FCS, with the usual antibiotic supplementation of 1 
U/ml penicillin, 1 pg/ml stieptomycin and 10 pg/ml cyproxin. As for growth medium, a 
new PromoCell differentiation medium was made available later in the project. The 
PromoCell basal medium was supplemented with 10 pg/ml bovine insulin and 
antibiotics, 50 pg/ml gentamicin and 50ng/ml amphoteracin B.
2.2.5.1.3 Cell Passaging
Satellite cell cultures were routinely passaged once they had reached around 80% 
confluency. Culture medium was carefully removed, and the cells washed with PBS. 
The cells were detached from the culture substrate by the addition of 0.05% trypsin, 
0.53 mM EDTA, incubating for 3 min at 37 °C, and tapping the flask to dislodge the 
cell monolayer. Cells were resuspended in semm-containing medium, sufficient for a 
ten-fold dilution of the trypsin for serum inactivation of the enzyme, transferred to 50 
ml falcon tubes and spun down. The supernatant was discarded and the cells 
resuspended in flesh growth medium. The suspension was split between fresh flasks, 
chambered slides or culture wells as required.
For maintaining the cells in culture, the cells were typically passaged one in three, 
depending on the observed rate of growth for a particular cell isolate. Care was taken to 
ensure an optimal cell density following cell splitting. Too sparse a coverage of cells 
would deprive the cells of growth factors normally secreted by their neighbours. Too 
dense and the cells could overgiow, which in myoblast culture could result in the 
initiation of differentiation and terminal withdrawal from the cell cycle.
2.2.5.1.4 Cell Storage
Primary cells cannot be maintained indefinitely in culture without undergoing 
senescence and death, and so isolates were periodically taken from the porcine satellite 
cell cultures for storage in liquid nitrogen. Cells were trypsinised, as described for cell 
passaging above, but resuspended in foetal calf serum containing 10% DMSO instead
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of growth medium and transferred to ciyovials (Invitrogen). The cryovials were frozen 
at a controlled rate (1 ^C/min) to -70 °C overnight. Controlled freezing was obtained by 
using an isopropanol-filled freezing container placed in a -70 °C freezer (‘Mr Frosty’, 
supplied by Nalgene). Once frozen, the cells were transferred to liquid niti'ogen storage.
When removing cells from cryostorage, the vials were quickly thawed in a 37 ®C 
waterbath, and added to 10 ml growth medium. The cells were spun down, supernatant 
removed and the cells resuspended in fresh culture medium, to remove the cyto-toxic 
DMSO, before transferring to a culture flask. Cells were typically grown overnight 
before splitting, but this could vaiy up to 48 hours depending on the number of viable 
cells suiwiving ciyo-preservation and thawing.
2.2.5.1.5 Surface coating
In order to improve the culture of primary myocytes, culture flasks, multi-well plates 
and chambered slides were coated with gelatin or collagen.
To coat with gelatin, 0.1% gelatin solution in PBS was added sufficient to cover the 
surface of the culture vessel. This was left to set for 20 min at room temperature, before 
removing the excess with a pipette. After leaving to dry for 1 hr, the coated flasks, 
plates or chambers were ready to use. Gelatin-coated culture materials were stored at 
room temperature, for a maximum of six months.
For collagen coating, 1 ml glacial acetic acid was made up to 180 ml with distilled 
water, sterile filtered (0.2 pm) and added to 20 ml 0.1% calf skin collagen (Sigma) in 1 
N acetic acid. This was added sufficient to coat the surface of the culture vessels, which 
were incubated overnight at room temperature. Excess collagen was removed with a 
pipette and stored a 4 °C for re-use, and the culture vessels washed with PBS and 
allowed to dry. Collagen coated flasks, plates or slides were stored at room 
temperature, up to six months.
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2.2.5.2 Lipofectamine Transfections
The introduction of heterologous DNA into mammalian cell culture was typically done 
through liposome-mediated transfections, specifically using Lipofectamine (Invitrogen) 
as described by Hawley-Nelson et al. (1993).
Cells were transfected in six-well plates, after reaching 60 to 80 % confluency. For 
each transfection experiment, a master mix was made up, sufficient for 2 pg plasmid 
DNA and 10.5 pi Lipofectamine in 200 pi Optimem solution (Invitrogen), per well of 
cells. This mixture was incubated at room temperature for 15 min for the formation of 
DNA-liposome complexes. In the meantime, the growth medium was removed from 
the wells, and the cells washed twice with Optimem. After the incubation period, the 
master mixes were made up to a final volume of 1 ml per well, and this was overlaid on 
the cell monolayer. The transfections were incubated for two hours at 37 °C.
Where stable transfections were required, the tiansfected cells were selected in media 
containing 2 mg/ml Geneticin (G418). To gauge the effectiveness of the selection 
process, a control population of untransfected cells was maintained in identical 
conditions. Once these control cells were completely killed, the surviving transfected 
cells were switched to media containing only 1 mg/ml Geneticin, to maintain selection 
pressure.
To culture populations of transfected cells, the transfection wells were passaged into 75 
cm^ flasks. These cell populations were generally maintained only for a short time, at 
most three or four passages, and were usually stored in liquid nitrogen to preserve 
stocks.
2.2.5.3 C2C12 myoblast culture
Though porcine cells were regarded a better in vitro model for investigating the 
function of porcine transcription factors, for some cell culture applications in the course 
of the project the use of porcine primary culture was unfeasible. In such instances, the 
C2C12 mouse myoblast cell-line (Yaffe and Saxel, 1977) was used in place of the 
primary cultures.
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C2C12 cells have several advantages over the usage of primaiy culture. Firstly, the 
cells are effectively a homogenous population of myoblasts without the risk of 
contaminating populations of other cell types. Secondly, the C2C12 cells are more 
robust and amenable to laboratory manipulation than those isolated from muscle, and 
have a faster growth rate. There were some differences, therefore, between the culture 
conditions used for this cell line and those described for primary cultures above.
All C2C12 cells were cultured in DMEM supplemented with lower concentrations of 
serum: 10% foetal calf seinm (FCS) or 2% horse serum for growth and differentiation 
media, respectively, together with the standard antibiotic supplementation of 1 U/ml 
penicillin, 1 pg/ml stieptomycin and 10 pg/ml cyproxin. Also the C2C12s were able to 
withstand a longer transfection period, for improved transfection efficiency (see section 
2.2.5.2). The incubation step with the liposomes was increased from two to four hours. 
The faster growth rate meant shorter inteiwals waiting for the cells to reach a certain 
degree of confluency. Care was taken not to allow the mouse myoblasts to reach full 
confluency, as this triggered differentiation.
In all other respects (passaging, cell storage, etc) the C2C12 cells were eultured as 
described for the porcine primary cells. Though theoretically capable of being giown 
for many more passages than the primaiy culture, in practice the number of passages 
was kept low with isolates taken frequently for storage in liquid niti'ogen.
2.2.5.4 Immunocytochemistry
Staining cell samples using cell-lineage or differentiation-specific antibodies was used 
several times during the project. This involved the use of two antibodies: a primaiy 
antibody raised against the epitope under investigation, and a secondary antibody raised 
against the animal used in creating the primary.
Cells taken for antibody staining were grown in six-well plates or chambered slides. 
The medium was removed and the cells washed with PBS. Cells were then fixed with 
the addition of 1 ml of 1:1 acetone/methanol, for 20 min, at room temperature. Once the 
fixative was removed, the cells were either used immediately for antibody staining, or 
else could be stored at -20 °C.
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Before incubation with antibody, the slides/wells were rinsed twice in 1 x tiis buffered 
saline (TBS). Primaiy antibody was added, diluted to the appropriate concentration 
(determined experimentally) in Tris containing 0.1% BSA and 0.01% sodium azide. 
This incubation was earned out overnight at 4 °C. The cells were washed, three times in 
TBS-tween, and incubated with 1% serum (from the animal species used in raising the 
secondary antibody) in TBS for 30 min at room temperature. The secondary antibody 
was added and incubated a further 40 min to an hour at 37 °C. Cells were rinsed as 
before, and endogenous peroxidases blocked with the addition of 0.5% hydrogen 
peroxide in methanol for 30 min. The hydrogen peroxide was rinsed off in water, and 
the TBS-tween wash steps repeated. Strep-ABC reagent was added to the cells and 
incubated for 45 min at room temperature. Cells were washed in TBS, DAB chromagen 
was prepared and added to the cells. The slides/wells were monitored under the 
microscope for colour development, typically 2 to 3 min. Following this, the 
slides/wells were washed in water, and the cells counter-stained in Gill’s Haemotoxylin 
(Gill e ta l,  1974).
2.2 .6  Q u a n t it a t iv e  R e a l -T im e  R T -P C R
Real-time RT-PCR is a combination of two techniques. The first of these is reverse 
transcriptase-PCR (RT-PCR), the conversion of mRNA to cDNA that then acts as a 
template for gene-specific amplification by PCR. This is a sensitive technique allowing 
for the detection of low-level gene expression that could be missed by traditional 
methods such as Northern Blot hybridisation. The real-time element comes from the 
monitoring of the progress of the PCR reaction as it occurs, by means of a fiuorogenic 
probe. The probes used in this study were based on TaqMan, or fiuorogenic 5’ 
nuclease, chemistry (Roche). In this method, the probe is labelled with a 5’ 
fluorochrome and 3 ’ quencher. As the DNA polymerase encounters the annealed probe, 
its 5’ nuclease activity cleaves it and separates fluorochrome from quencher. This 
results in an increase in fluorescence that serves as an indicator of the PCR reaction 
progi'ess. The reaction is characterised by the point at which the level of fluorescence, 
and hence the PCR amplification, crosses a set threshold. The higher the target’s copy 
number, the sooner this threshold will be reached. The target is quantified relative to an 
endogenous control, typically a ‘house-keeping’ gene such as glyceraldehyde-3-
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phosphate dehydrogenase (GAPDH) or, as was used in the project work, p-actin. 
Combined, then, these two techniques allow for the sensitive detection and relative 
quantification of gene expression.
2.2.6.1 Messenger RNA isolation
2.2.6.1.1 Extraction from Tissues
The isolation of purified messenger RNA fiom tissue lysate was earned out using 
Dynabeads® Oligo (dT)25 (Dynal Biotech). This method relies on the base pairing 
between the poly-adenylated tails of mRNA transcripts and the oligo deoxythymidine 
sequences bound to the magnetic Dynabeads® beads. The magnetic beads and attached 
mRNA may then be separated out of the tissue lysate, and subsequent wash steps, using 
a magnetic particle collector (MPC).
Tissue samples were taken from -70 °C or liquid nitrogen storage. Tissue was ground 
into smaller fragments in a mortar chilled with liquid nitiogen. About 50 mg of tissue 
fragments were added to 1ml lysis-binding buffer, consisting of lOOmM Tris HCl, pH 
7.4, 500mM lithium chloride (LiCl), lOmM EDTA, 1% lithium dodecyl sulphate 
(LiDS), 5mM DTT in diethylpyrocarbonate (DEPC) treated water. Samples were 
rapidly lysed using an Ultra-Turrax® T8 mechanical homogeniser (IKA Labortechnik). 
Complete and rapid lysis of the samples was essential to prevent RNA degradation. 
After lysis for 1 min the samples were placed on ice. To remove cell debris, the lysate 
was spun for 1 min at 13,000 x g in a microcentrifuge and the supernatant tiansferred to 
a clean tube.
Dynabeads were preconditioned in lysis-binding buffer, and kept on ice until required. 
These preconditioned beads were applied to the MPC, the supernatant removed and the 
sample lysate added. The beads were thoroughly resuspended by pipetting, then 
incubated at room temperature for 12 min. To prevent the beads settling out during the 
incubation period, the tubes were incubated on a rocker. Once the mRNA had been 
bound to the beads, the beads were collected. Tubes were placed in a Dynal MPC for 5 
min, and the supernatant carefully pipetted off. The beads were washed twice in 1 ml of 
Wash Buffer A (lOmM Tris HCl, pH 7.4, 150mM LiCl, ImM EDTA, 0.1% LiDS, 
5niM DTT in DEPC treated water), and once in 1 ml Wash Buffer B (lOmM Tris HCl,
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pH 7.4, 150mM LiCl, ImM EDTA, 5mM DTT in DEPC treated water). For each wash, 
the beads were collected using the Dynal MPC as above. The supernatant was carefully 
removed and the beads completely resuspended in the next wash buffer.
To prevent enzymatic inhibition during the subsequent first-strand cDNA synthesis, the 
beads were washed a further three times in 1 x RT buffer (50mM Tris HCl, pH 8.3, 
8mM MgCL, lOmM DTT, 30mM KCl in DEPC treated water). Care was taken to 
completely remove the supernatant from the last wash, before the mRNA was eluted 
from the beads. To elute, 21 |ul of 10 mM Tris HCl, pH 8.0, was added to the beads and 
the samples incubating at 65 °C for 2 min. The beads were briefly magnetised in the 
MPC, and the supernatant, containing the mRNA, removed to a new, clean 1.5 ml 
microfuge tube. The eluted mRNA was either stored at -70 °C or used immediately for 
first-strand cDNA synthesis.
2.2.6.1.2 Extraction from Cell Pellets
For the most part, cells harvested for mRNA were gi'own in six-well plates. Typically, 
each individual mRNA extraction came from the pooled cell populations of two, paired 
wells. Where larger cell populations were harvested, the procedure described below 
was scaled up as appropriate.
Growth medium was removed, the cells washed in ice-cold PBS and 1 ml of fresh, pre­
chilled PBS was added per well. The cells were scraped free into the PBS, and the each 
pair of cell suspensions pooled into a clean, 2 ml microcentrifuge tube. The cells were 
spun down at 10,000 x g for 5 min at 4 °C in a pre-chilled rotor. The supernatant was 
removed, and the pellet then snap-frozen in dry ice. Cell pellets could be stored at —70 
‘^ C, if not used immediately.
As with mRNA extraction from tissue samples, rapid lysis of the cells was essential for 
preventing RNA degradation. Cells were kept in liquid nitiogen or on dry iee for as 
much as possible during manipulations. Each cell pellet was lysed in 1 ml 
Lysis/binding buffer for 1 min and placed on ice, before being spun at 10,000 x g in a 
microcentrifuge for 2 min and the supernatant transferred to magnetic beads. The
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addition of the lysate to the magnetic beads, and subsequent washes, was carried out 
exactly as for the extraction of mRNA from tissue.
2.2.6.2 Reverse Transcription
The first-strand synthesis of cDNA from mRNA template was carried out using the 
Reverse Transcription System kit (Promega). The procedure is summarised as follows: 
extracted mRNA was incubated at 70°C for lOmin, during which a master mix of the 
various reaction components was prepared. The final reverse transcription mixture 
consisted of 5 niM MgCb, 1 x reaction buffer (containing 10 niM Tris-HCl, pH 9.0, 50 
mM KCl, 0.1% Triton X-100), 1 mM each dNTP, 25 ng/pl random primers and 1 U/pl 
recombinant RNasin ribonuclease inhibitor.
Once the required master mix had been added to the mRNA, a 5 pi aliquot was 
removed as control against possible genomic DNA contamination. To the remainder, 
AMV reverse transcriptase was added to a final concentration of 0.75 U/pl. Samples 
and confrols were then incubated at room temperature for 10 min, to allow for primer 
extension, then at 42 °C for one hour. AMV-RT enzyme was inactivated by heating the 
samples at 95 °C for 5 rain, then on ice for a further 5 min. Samples and controls were 
stored at -20 °C. For most real-time RT-PCR experiments, a 100-fold dilution of the 
cDNA samples was used.
2.2.Ô.3 Real-Time PCR Primer and Probe Design
Probe and primer sequences were designed using Primer Express v2.0 (Applied 
Biosystems). Typically, probe and primer sequences had a G-C content of between 30- 
80%, avoiding long nucleotide repeats. Annealing temperature was typically around 70 
°C for probes, 60 °C for primers. Probes were designed based on TaqMan chemistry 
(fluorogenic 5’ nuclease chemistry: Roche).
2.2.6.4 Reaction Conditions
Reactions were set up in 96-well optical plates, with the following reaction mixture in 
each sample well: 1 x Universal Master Mix (AmpliTaq Gold DNA polymerase, dNTP 
mix and MgCh: Applied Biosystems), cDNA template, and the appropriate 
concentrations of primers and probe (determined experimentally), made up to 25 pi per
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well. Samples were quantified using an ABI Prism 7700 Sequence Detection System, 
using version 1.6 software (Applied Biosystems), using the following programme: 50 
°C for 2 min, 95 °C for 10 min, followed by forty cycles of 95 °C for 15 s and 60 for 
1 min.
2.2.6.S Data Analysis
Quantification data was normalised against the endogenous reference, P-actin, to 
account for variation between cDNA samples caused by differences in the efficiency of 
the mRNA extraction, the reverse tianscription step or sample loading. For each set of 
samples, the target quantity was determined relative to a calibrator sample, typically the 
lowest quantity. All other quantities were expressed as an n-fold difference relative to 
this calibrator. Quantitation relative to the calibrator was canied out by the 
Comparative Ct method, as described in the manufacturer’s protocol (Applied 
Biosystems). It should be borne in mind that this method assumes that the efficiency of 
the P-actin amplification is approximately equal to that of the target genes.
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C h a p t e r  T h r e e  - C l o n i n g  P o r c i n e  M u s c l e  
GATA-2 AND NFAT-2
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3.1  In t r o d u c t io n
The activation of calcineurin-mediated transcription in response to increases in 
intracellular calcium levels is a generic signalling pathway that is widely distributed 
and found in a range of tissues. Its downstream components, GATA and NTAT 
transcription factors, are therefore widely distributed too and modulate the transcription 
of a range of calcium-activated genes. However, specific GATA and NFAT family 
members are distributed in a tissue specific manner (Rao et a l, 1997; Patient and 
McGhee, 2002), and NFAT isoforms are also known to be restricted to specific stages 
of myogenesis even within muscle (Abbott et a l, 1998). The GATA-2 and NFAT-2 
isoforms respectively have been previously described as prevalent in skeletal muscle 
fibres, and as promising candidates for a role in fibre-type specific gene expression 
(Abbott et a l, 1998; Musaro et a l, 1999; Paul and Rosenthal, 2002). The study of these 
two isoforms would therefore form the basis for much of the project work.
A necessary first step in investigating the role of GATA-2 and NFAT-2 in porcine 
muscle, however, is to obtain porcine homologues of these two transcription factors. As 
covered in Chapter One, these factors are already well characterised in other organisms. 
A PCR-homology cloning strategy was therefore employed, using primers designed to 
amplify regions of high homology across different species or family members. For both 
GATA and NFAT, these regions are highly conseiwed DNA binding motifs, the zinc- 
finger domain and Rel-homology region respectively. It is worth considering these two 
functional motifs, before detailing the cloning stiategy that utilised them.
3.1.1 GATA Z in c  f i n g e r s
The zinc-finger DNA binding motif is found in a large number of transcription factors 
(reviewed in Krempler and Brenig, 1999), and consists of looped projections (fingers) 
stabilised by a tetrahedrally co-ordinated ion. There are two classes of zinc finger 
protein, which are distinguishable on the basis of the amino acid residues that interact 
with the zinc and the number of fingers possessed by the protein.
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Figure 3.1. Structure of GATA zinc fingers. A. GATA N-terminal Zinc finger, 
showing four cysteine residues (in green) co-ordinating a zinc atom (in yellow) 
(Kowalski et a l, 1999), B. Line schematic, highlighting the four zinc co-ordinating 
cysteine residues (C).
The first class of zinc finger proteins, the classical type, is also known as ‘C2H2’ zinc 
fingers. The zinc ion is co-ordinated by two cysteine and two histidine residues. The 
C2H2 proteins often have large numbers of repeated zinc finger elements for greater 
binding efficiency. In the second class of zinc finger proteins, to which the GATA 
family belongs, the zinc ligand is chelated by four cysteine residues. These 
transcription factors lack the long, repeated zinc finger motifs of the C2H2 group, 
instead having only two zinc fingers. The structure of this second class of finger is 
shown in Figure 3.1.
Both types of zinc finger interact with their DNA binding site through an a-helix, 
which lies along the major groove when binding to DNA. In GATA, the two zinc 
fingers have slightly different roles. The N-terminal finger has been shown to interact 
with protein, an unusual feature for a domain traditionally associated with DNA 
binding, being necessary for interactions with Friend of GATA (FOG) (Fox et al, 
1998). The C-terminal finger, on the other hand, has been shown to be sufficient for
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DNA binding (Omichinski et al., 1993). It is thought that the N-finger is involved in 
GATA activation, and in modulating the binding affinity of the C-finger. These 
sequences are highly conserved between different GATA members, and make very 
useful targets for PCR homology cloning.
3 .1 .2  NFAT R E L -H o m o lo g y  REGION
As with GATA zinc fingers, the NFAT DNA binding domain (DBD) is highly 
conserved among NFAT family members, across both different family members and 
species. This region is also known as the Rel homology region (RHR), as it shares a 
low level of sequence identity with the characteristic of the Rel family of immune 
response proteins (Jain et a i, 1995; Verma et a i, 1995). The Rel-binding domain 
consists of a number of (3-strands, connected by loops that interact with the DNA major 
groove. Additional interactions are formed between the DNA minor groove and an a- 
helical domain. This structure is illustrated in Figure 3.2.
A. B.
Figure 3.2. Structure of the highly conserved NFAT binding domain. A. Core NFAT 
binding domain/DNA complex, with the alpha helix shown in purple, beta sheet in 
blue. Note the looped connectors interacting with the major groove (from Zhou et a i, 
1998a). B. Co-operative DNA-binding complex of NFAT with the basic leucine zipper 
transcription factors Fos/Jun (from Chen et a i, 1998).
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3.1 .3  C lo n in g  S t r a t e g i e s
The PCR homology cloning strategy may be broken down into two sections: the actual 
PCR-based cloning approach, and the subsequent use of the PCR fragments generated 
to screen a cDNA libraiy.
3.1.3.1 Homology-based PCR
The technique of PCR homology cloning, reviewed extensively by Pytela et al. (1994), 
is best used as a means of isolating unknown members of a well-conserved gene family 
of which several sequences are already known. The target sequence must have two 
regions that are veiy similar to known sequence, as these are the regions on which the 
primers for DNA amplification are based. These target regions can be quite small, as 
little as twelve nucleotides long, but the results of the cloning are more reliable and 
specific with targets of at least eighteen to twenty-four nucleotides in length. Primers 
are typically ‘degenerate’, or made up of a mixture of oligonucleotides with 
substitutions for nucleotides at different positions. Degenerate primers are required to 
compensate for the imperfect sequence conservation found between members of even 
the most highly conserved protein families, particularly on the nucleotide sequence 
level. Due to the degenerate nature of the triplet code in which several codons can code 
for the same amino acid, the third nucleotide of a given codon is often poorly 
conserved.
The use of degenerate primers places constraints on the cloning strategies that can be 
used. Since there will be mismatches between primer and target, the efficiency of the 
PCR will be lower. The optimal size for amplification is typically around 500 
nucleotides, or 0.5 kb. The minimum separation between the two primer regions is 150 
base pairs, since smaller fragments are of scant use in subsequent cloning steps. In any 
case, a few hundred base pairs of sequence are rarely sufficient for characterising a 
novel gene or performing functionality studies. But such a short stretch of novel 
sequence is particularly useful as a labelled probe for screening a library of full-length 
cDNA inserts.
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3.1.3.2 Lambda Library Screening
A cDNA libraiy represents the mRNA molecules of a particular tissue sample, 
converted from its extremely labile fomi into a stable cDNA duplex by reverse 
transcription followed by second strand synthesis. Clones isolated from a cDNA library 
are an extiemely useful resource for further characterisation of a gene. Since cDNA is a 
faithful copy of the mRNA transcript, it contains a continuous coding sequence (cds) 
uninterrupted by inti'ons and is thus an ideal template for the production of recombinant 
protein. The lack of intronic sequence also makes cDNA a more useful ideal template 
for the PCR homology cloning strategy described above. Genomic DNA is seldom 
suitable due to the possibility of large introns intervening between the PCR primers in 
certain family members, which prevents cloning, A major hurdle to be overcome in 
screening cDNA libraries is the presence of incomplete or truncated clones. This arises 
because the reverse transcription used in most cDNA library construction uses the poly- 
A tail as a primer site for the initiation of first strand synthesis. If the reverse 
polymerase is prevented from reaching the extreme 5 ’ end of the mRNA tianscript, the 
result is the loss of 5’ sequence data. If parts of the cds are missing, further 
characterisation of a gene’s function can be virtually impossible.
The cDNA libraries used during the project work were constructed using the ZAP 
Express cDNA synthesis kit (Stratagene) (Short et a l, 1988). Neonatal muscle offered 
the best possibility for obtaining GATA or NFAT cDNA since they are associated with 
muscle development or hypertrophy. The libraiy used in the study was derived from 
mRNA taken from the gastrocnemius muscle of a 3 day-old neonatal Meishan pig.
3.1 .4  A im s
The aim of this part of the study was to obtain full-length, functional GATA and NFAT 
clones. This chapter covers the specific methods used in the cloning strategy and the 
sequence data obtained.
105
3 .2  M a t e r ia l s  a n d  M e t h o d s
3.2.1 P C R -H o m o l o g y  C l o n in g
PCR primers were designed from sequence pile-ups of the conserved GATA and NFAT 
domains, being the zinc fingers and Rel-homology regions respectively. As well as the 
primer pair used for PCR amplification, an internal primer was designed for both 
cloning experiments. This internal primer was used as a radiolabelled probe to identify 
positive clones in subsequent colony-lift hybridisation used to screen TopoTA clones.
3.2.1.1 GATA Primer Design and Conditions
The sequences used for the selection of PCR primers are shown in Figure 3.3. 
Degenerate primers were used for the initial runs, but the PCR efficiency was found to 
be too low, and more specific primers were tried instead. The selected primers are as 
follows:
Sense Primer
5 ' GAA GGC CGG GAG TGT GTC AAC TGT 3 ' Tm66.1 °C 
Anti-sense Primer
5 '  ATT GTG GAG CTT GTA GTA GAG GCC 3 ' T ^ 62.7 °C
The internal primer used to screen the colony lifts was designed as follows:
5 ' GGC GAG TAG GTG TGG AAT GGG T G (G /T ) 3 ' T^ 67.0 °C
The PCR amplification conditions were as follows: template was denatured for 3 min at 
95 °C, followed by 30 to 35 cycles of a 1 min, 95 °C dénaturation step, 1 min at 55 to 
60 °C annealing (the annealing step being greatly dependent on the primer sets used) 
and an extension step of 1 min at 72 °C. This was followed by a final 5 min extension 
step, before holding at 4 ®C. The PCR amplification products were stored at -20 “C if 
not used immediately.
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300---------- -------- -... A - - - .....   C--
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Figure 3.3. Pileup of zinc-finger DNA binding domains from mouse, human and 
chicken GATA-2 (Accession N°s AK004675, M68891 and X56930 respectively), used 
to generate PCR-homology cloning primers. Dashes denote identical sequence to the 
mouse GATA-2. Zinc finger sequences are highlighted in blue; the sequences used for 
primers are underlined.
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3.2.1.2 NFAT Primer Design and Conditions
The known sequences compiled for the Rel-homology region were more degenerate 
than those used for designing the GATA primers, as shown in Figure 3.4. The NFAT 
PCR primers were likewise designed with greater degeneracy, as follows:
Sense Primer
S ' CCG CAC GCC TTC TAC CA(AG) GT (AGC) CAC 3 '  Tm67.3 °C 
Anti-sense Primer
S ' GC (AT) GA(GCT) CGC TG (AG) GA (AG) CAC TCG AT 3 '  T^ 6 5 .4 ‘'C
The internal primer used to screen the colony lifts was designed as follows:
S ' CAC CAA (AG)GT CCT GGA GAT CGC 3 ' Tm 5 9 .8 '’C
PCR conditions for the NFAT homology cloning were largely as described for GATA 
(section 3.2.2.1). The greater degeneracy of the NFAT primers resulted in a significant 
drop in PCR efficiency, and a degree of optimisation was required. Different 
concentrations of magnesium were used, with final concentrations of 1.0, 1.5, 2.0 to 3.0 
mM respectively, and lower annealing temperatures, 50 °C, from the standard 
conditions.
3.2.1.3 Cloning and selection of PCR products
PCR products obtained were cloned into ‘One-shot’ DH5-a E. coli (Invitrogen) using 
the TopoTA cloning kit (section 2.2.1.6.2). Colonies were screened for positive 
fragments by colony lift hybridisation (section 2.2.4.3) using y^^P radiolabelled internal 
primers, prepared by end-labelling (section 2.2.4.1.2). Positive colonies were picked 
and sequenced using ABI PRISM (version 1.0) cycle sequencing (section 2.2.3.2.1). 
For sequencing, primers were used based on the T7 RNA polymerase promoter 
sequence:
5 ' TAA TAG GAG TCA GTA TAG GG 3 '
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Figure 3.4, Pileup of Rel-homology regions from mouse and human NFAT-2 and 
NFAT-1 isofoims (Accession N-s NM O10899, U02079, U08015 and U43341 
respectively), used to generate PCR-homology cloning primers. Dashes denote 
identical sequence to the murine NFAT-2 sequence. The sequences used for primers are 
underlined.
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Multiple clones with high homology to known GATA and NFAT isoforms (as 
determined by BLAST search) were selected for use as radiolabelled probes for 
screening the ZAP-Express™ cDNA library. TopoTA clones were prepared by 
miniprep (2 .2 .1.2 .1), digested with EcoRI (2 .2 .1.3), separated in agarose gel and the 
insert fragments purified (2.2.1.4), pooled and prepared as a mixed probe of GATA and 
NFAT PCR products, using random hexamer labelling (2.2.4.1.1).
3.2 .2  L a m b d a  L ib r a r y  S c r e e n in g
Screening for full-length cDNA clones was carried out using a lambda-vector libraiy 
(Short et a l, 1988), conshncted using the ZAP Express™ cDNA synthesis kit 
(Stratagene). The library was from the gastrocnemius muscle of a 3 day old Meishan 
pig, with an estimated one million primaiy clones.
3.2.2.1 Growth of the Host Strain
A tetracycline-resistant, XL 1-blue m rf strain was used for the titering and screening of 
the lambda library, kanamycin-resistant XLOLR cells for plaque excisions. Cells were 
streaked out on LB-agar plates with appropriate antibiotic selection, and giown 
overnight at 37 °C. A single colony was picked to inoculate a starter culture, 5 ml LB 
with antibiotic selection, which was incubated overnight at 37 °C in an orbital shaker. 
The following day, 1 ml of the starter culture was used to inoculate 100 ml LB 
supplemented with 0.2% (w/v) maltose and 10 mM MgS04 . The culture was giown to 
mid-log phase (Aeoo readings of between 0.5 and 1) before being spun down in 50 ml 
Falcon tubes, 500 x g, 10 min at 4 °C. The cell pellets were re suspended by pipetting in 
10 niM MgS04 , to a final O.D.eoo reading of 0.5. These cell solutions could be stored at 
4 °C for a maximum of one week.
3.2.2.2 Plating and Titering
The phage titre was determined by making serial dilutions of the stock library, 
combining 1 pi of each dilution with 200 pi of host cells and incubating at 37 °C for 15 
min. After incubation, the bacteria/phage mix was added to melted 0.7% NZY top 
agarose, pre-warmed to 48 °C, and poured onto on NZY agar plates, swirling gently to
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ensure an even covering. The plates were incubated for 10 hours at 37 to allow the 
formation of plaques, which were counted for phage titre.
For screening, 50,000 pfu of phage were added to 650 pi of host XL 1-blue m rf cells, 
incubated 15 min at 37 °C, and added to 0.7% NZY top agarose, as described above. 
Larger, 150 mm NZY agar plates were used for the screening process, these being at 
least two days old and pre-warmed to 37 °C for two hours. Once poured, the top 
agarose was left for 10 min at room temperature to set, and then the plates were 
incubated at 37 °C for 10 hours. For the first round of screening, the plaques were quite 
confluent, at 50,000 plaques per plate. Twenty plates were used for this first screen. 
Subsequent rounds of screening were undertaken to ensure monoclonal, discrete 
plaques.
3.2.2.3 Plaque Lift Hybridisation
Hybond-C niti’o-cellulose membranes were used to perform plaque lifts. Plates were 
chilled to 4 °C beforehand to prevent the top agarose layer peeling away during the lift. 
Each membrane was overlaid on its respective plate for 1 min, marked asymmetiically 
using black ink in a needle for subsequent location of positive plaques, and the filter 
slowly peeled from the plate. Two lifts were taken for each plate. Filters were incubated 
in denaturing buffer (0.5 M NaOH, 1.5 M NaCl), neutralising buffer (0.5 M Tris, pH 
8.0, 1.5 M NaCl) and finally washed in 6 x SSC, 5 min each, on Whatman filter paper 
soaked in the respective buffer. Filters were dried by baking at 80 °C for two hours, and 
stored at room temperature until required for hybridisation.
Hybridisation and autoradiography were canied out as described in section 2.2.4,2.2, 
using the mixed probe for GATA and NFAT made up as described above (3.2.2.3). 
Positive plaques were selected for further rounds of screening, and plaque cores taken 
using a Pasteur pipette. Plaque cores were placed in 500 pi SM buffer (O.IM NaCl, 
lOmM MgS04 , 50 niM Tris, pH 7.5, 2% (v/v) gelatin) and 40 pi chloroform, and 
vortexed to release the phage. Phage stocks not immediately used for subsequent 
rounds of screening were stored at 4 °C for up to six months. In order to increase the 
chance of obtaining a monoclonal plaque, the plaque screening process was repeated a 
further two times using phage obtained from the positive plague cores.
I l l
3.2.23 Phage Excision
In order to excise the bacteriophage for conversion to plasmid, the concentration of 
phage was increased by performing a phage tihe as described in section 3.2.2.2.1 and 
pooling ten plaque cores into a single stock of 500 pi SM buffer, 20 pi chlorofoim and 
vortexing as described above, storing overnight at 4 before use. The following day 
XL 1-blue m rf and XLOLR host cells were grown as described in section 3.2.2.1, spun 
down at 1,000 x g for 10 min and resuspended in 10 mM MgS04  to a final A^ oo reading 
of 1. For each of the concentrated phage mixtures, 200 pi of XL 1-blue m rf cells were 
combined with 250 pi phage stock, and 5 pi ExAssist helper phage, supplied by 
Sti’atagene, in a 1.5 ml microcentrifuge tube. Tubes were incubated at 37 °C for 15 min, 
before being transferred to 15 ml Falcon tubes containing 3 ml NZY broth. The Falcon 
tubes were incubated at 37 °C for 3 hours. After this incubation, the tubes were heated 
at 65 °C for 20 min, and then centrifuged at 1,000 x g for 15 min. The supernatant 
containing the filamentous lambda-phage particles was decanted into 20 ml universal 
tubes, where it could be stored at 4 °C for up to 2 months.
For each excision reaction, a microcentrifuge tube containing 200 pi of XLOLR cells 
was prepared. An equal volume of phage supernatant was added to the cells, and the 
mixture incubated for 15 min at 37 °C. Following the incubation, 300 pi of NZY was 
added to the cells and incubated a further 45 min, shaking, at 37 °C before plating out 
200 pi on LB agar plates supplemented with kanamycin. After overnight incubation at 
37 °C, bacterial colonies were picked and the excised ZAP Express™ plasmid clone 
prepared by miniprep.
3.2 .3  NFAT 5 ’ MODIFICATION
A full-length clone of the porcine NFAT was not obtained using the ZAP Express™ 
library. A number of techniques were employed to counter this deficiency, including 
SMART-RACE PCR (see section 3.2.5 below). In the meantime, a PCR cloning 
strategy was employed to produce a functional NFAT from the truncated clone as a 
short-term measure. The cloning strategy, summarised in Figure 3.5, involved the 
replacement of the 5’, 900 bp EcoRl fragment of the clone with one modified by a PCR 
step. Two PCR primers were designed, based on sequences flanking the 5’ EcoKl
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NFAT-2/
PBK-CMV
EcoKl 
E Digestion
HisNFAT.sen
fcoR I.anti
NFAT-2/
PBK-CMV
(His); Tag
EcoKl
Digestion
Ligation
NFATmod/ 
PBK-CMV
Figure 3.5. Summary of the cloning strategy used to modify the 5’ end of the truncated 
NFAT clone. E. EcoKl site. MCS. Multiple cloning site.
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fragment of the NFAT clone.
5 ' HisNFAT.sen
5'AA.G AAT TCG CCA CCA TGC ATC ACC ATC ACC ATC AC G AGG AGT 
TTC CGC CCT TCC AGC 3 ' Tm  >75
3 ' EcoRI.anti
5'A A G  AAT TCG GCT TGC ACA GGT CTC C 3 ' Tm 64.6 °C
The 5’ primer contains an jFcoRI restriction site, Kozak consensus sequence and ATG 
start site, and codons for six histidine residues for ‘tagging’ the resulting protein. PCR 
was caiTied out as described in section 2.2.2. The PCR product was Topo-TA cloned as 
described in section 2 .2 .1.6.2 , and sequenced to verify the identity of the insert (2 .2 .3). 
The insert was released from the Topo-TA clone by F^coRI digestion, and purified by 
gel extraction. The original NFAT clone was digested with E'coRI to remove the 
original EcoRI fragment, treated with calf alkaline phosphatase and ligated with the 
modified PCR product (2.2.1.5).
3.2.4 SMART-RACE PCR
It was subsequently decided that the best option for cloning a full-length NFAT 
transcript was the use of the 5’-rapid amplification of cDNA ends (RACE) technique 
(Frohman et ah, 1988). In the SMART RACE cDNA amplification kit (Clontech), the 
RACE technique is combined with Switching Mechanism At 5’ end of RNA Transcript 
(SMART) described by Zhu et ah (2001). The actual RACE makes use of a variant of 
Moloney murine leukaemia virus (MMLV) reverse transcriptase that exhibits terTninal 
transferase activity upon reaching the end of the RNA transcript, adding 3-5 
deoxycytosine residues to the 3’ end of the first-strand cDNA. A ‘SMART’ 
oligonucleotide with a terminal stretch of deoxyguanine residues anneals to this poly-C 
tail, and serwes as a primer once the RT-enzyrae switches to using the cDNA strand as a 
template. Since the poly-C tailing activity is more efficient if the reverse transcriptase 
has reached the end of the RNA molecule, the SMART oligonucleotide tends to be 
added only to full-length cDNAs. This can be combined with the use of a gene-specific 
primer (GSP) during first-strand synthesis, in order to produce a full-length cDNA of a
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specific mRNA transcript. For the most part, the procedures were carried out as 
recommended in the manufacturer’s instructions. A summary of the technique is 
provided here.
3.2.4.1 Isolation of mRNA
Tissue samples were taken fiom the longissimus dorsi (LD) muscle of porcine embryo 
at 91 days development. Messenger RNA was isolated using Dynabeads, for the most 
part as described for the standard procedure (section 2 .2 .6 .1). In order to increase the 
yield of mRNA obtained, and improve the chances of successful amplification later, the 
RNA extraction was from a total of six 50 mg samples of LD muscle. The washes in 1 
X RT buffer was replaced with only two, and 100 pi TE used in the elution step. After 
heating the samples at 65 °C as standard, the eluates were pooled into a final 600 pi 
volume. In this instance, beads were re-used between sets of three samples by adding a 
further 100 pi of TE, resuspending, and heating at 65 °C for 2 min, and then 
reconditioning with 1 ml lysis/binding buffer. These recycled beads were used only 
once, and not stored.
The pooled, 600 pi mRNA sample was taken to an isopropanol precipitation step, by 
adding 60 pi 3 M Na Acetate and 600 pi isopropanol. The mixture was shaken well and 
incubated at -20 °C for 1 hour. The precipitated mRNA was spun at 10,000 x g for 1 
hour at 4 °C, the supernatant discarded. The pellet was carefully rinsed in 70 % ethanol, 
spun again at 10,000 x g for 15 min at 4 °C. The final pellet was resuspended in 8 pi of 
TE buffer. Quality of the mRNA obtained was tested by spotting 1 pi of the final eluate 
onto agarose, and comparing it to a 50ng/pl DNA standard, under UV 
transillumination.
3.2.4.2 First Strand Synthesis
Two sets of cDNA were prepared for subsequent RACE PCR, one for 5’ RACE and the 
other for 3’ RACE. Both tubes contained between 0.5 to 1 pg of mRNA, together with 
the appropriate CDS primer and, for 5’ RACE reactions, the SMART II 
oligonucleotide. Reaction volumes were made up to 5 pi with distilled water and the 
RNA briefly denatured, heating for 2 min at 70 °C and then on ice a further 2 min. To 
each tube was added First-Strand buffer, DTT, dNTP mix and reverse transcriptase,
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mixing by pipetting. Reactions were then incubated for 90 min at 42 °C. Because of the 
low volume, the tubes were incubated in an air-incubator to prevent evaporation of the 
tube contents. Following the incubation, the reaction was diluted with the addition of 
250 pi Tricine-EDTA buffer and the tubes heated at 72 °C for 7 min. The cDNA was 
stored at -20 “C.
3.2.4.3 RACE PCR
3.2.4.3.1 Primer Design
Gene-Specific Primers (GSPs) were designed according to the recommendations given 
in the Clontech protocol. Custom oligonucleotide synthesis was by MWG Biotech. 
GSPs were designed between 23 and 28 deoxynucleotide residues in length, with a base 
composition of 50 to 70 % guanine or cytosine. GSPs were designed with a Tm of 
greater than 70 ®C, allowing for the use of “Touchdown” PCR (Don et a l, 1991). This 
refinement to the standard PCR conditions allows for greater specificity, by using an 
annealing temperature greater than the universal primer for the initial PCR cycles. This 
ensures that only gene-specific amplification occurs, through the accumulation of gene- 
specific product before the annealing temperature is lowered in subsequent cycles to 
accommodate the universal primers.
The following set of GSPs was designed, based on the previously obtained NFAT clone 
sequence:
GSPl (antisense, for 5’ RACE)
5 '  CGG GAT CTC GAC CAA GGA ATT CGG C 3 '  Tm 71.0 °C 
GSP2 (sense, for 3’ RACE)
5 ' GGA GAC GGA CAT TGG GCG GAA GAA C 3 ' Tm 71.0 "C
3.2.4.3.2 Reaction Conditions
PCR reagents were supplied by BD Biosciences as part of the BD Advantage 2 PCR 
kit. As such, the PCR conditions differed slightly from the standard procedure detailed 
in section 2.2.2 .2. Manufacturer’s protocols were followed, summarised briefly here. 
PCR reactions consisted of 1 x Advantage 2 PCR buffer and polymerase mix, 200 pM 
dNTPs, 1 X Universal Primer Mix (UPM), 200 nM of the appropriate GSP and 2.5 pi of
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the 5’- or 3’-RACE-ready cDNA, as appropriate, made up to 50 pi with PCR-grade 
water.
Thermal cycling was carried out on an Applied Biosystems GeneAmp 2400. Hot start 
and touchdown cycles consisted of 5 cycles of 94 °C for 5 seconds, 72 for 3 min, 
followed by a further 5 cycles of 94 °C for 5 seconds, 70 °C for 10 seconds and 72 “C 
for 3 min. The subsequent, standard PCR consisted of 30 cycles denaturing at 94 ®C for 
5 seconds, annealing at 68 °C for 10 seconds and extension at 72 °C for 3 min. PCR 
amplification products were stored at -20 °C if not immediately visualised by agarose 
gel electrophoresis.
3.2 ,5  S e q u e n c in g
Sequencing of the novel GATA and NFAT clones was carried out largely as described 
in Section 2.2.3. Initial sequencing was performed using sequencing primers derived 
from T3 and T7 polymerase promoters:
T3
5 '  ATT AAC CCT CAC TAA AG 3 '
T7
5 '  TAA TAG GAC TCA CTA TAG GG 3 '
Internal sequences were obtained using custom-designed primers (MWG Biotech) as 
described in section 2.2.3.1. There were a few specific techniques required, however, 
for more problematic stretches of DNA chiefly encountered in the sequencing of the 
porcine GATA clone. The techniques used were as follows: sequencing using increased 
concentrations of DMSO, sequencing from single-stranded DNA (ssDNA) template, 
and the use of the ABI PRISM dGTP Big Dye kit.
3.2.5.1 Sequencing using DMSO
The addition of dimethylsulphoxide (DMSO) can reduce the occuiTence of DNA 
secondary structure. However, the amount that can be added to sequencing reactions is 
limited by its inhibitory effect on Taq DNA polymerase. Typically, a concentiation of
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5% was used in attempts to read-through difficult sequence. In all other respects, the 
sequencing reaction was carried out as for normal ABI version 1.0 chemistiy (section 
2.2.3.2.1).
3.2.S.2 Single Strand Excision
Stretches of DNA that exhibit a high degree of secondary structure can be more easily 
sequenced using single-stranded template. Because the pBK-CMV vector used in the 
cloning of the porcine GATA clone contains the bacteriophage fl origin, it can be 
secreted as single stranded DNA template, in the presence of M l3 helper phage. In E. 
coli bacteria possessing the F’ episome, such as the XL 1-blue strain, the pBK-CMV 
plasmid will be secreted as a single-stranded, packaged phagemid when infected with 
the helper phage.
XL 1-blue cells transformed with the GATA clone were grown at 37 °C overnight in LB 
supplemented with kanamycin. The following morning, Aeoo measurements were taken, 
and an inoculum taken from the starter culture sufficient to give a final A^ oo reading of 
0.1 when added to 50 ml Terrific Broth. For optimal aeration, the 50 ml culture was 
incubated in a 250 ml conical flask, with shaking, at 37 °C. After 1 hour, with the cells 
at log phase, helper phage was added to the culture sufficient for a multiplicity of 
infection of 20 phage particles per host cell. The culture was incubated a further 8 
hours, transferred to a 50 ml Falcon tube and heated at 65 °C for 15 min. The cells were 
spun down at 17,000 x g for 5 min and the supernatant ti'ansferred to a fresh tube. This 
could be stored at 4 for a month.
To extract the ssDNA from the packaged phagemid, 1.2 ml of the supernatant was 
transferred to a microcentrifuge tube and 300 pi of 3.5 M NH4AC (pH 7.5) 20% 
polyethylene glycol (PEG) solution added and mixed by inversion. This was left to 
stand at room temperature for 15 min, and then spun at 10,000 x g for 20 min. The 
supernatant was removed and the tube spun again for 1 min and all remaining 
supernatant removed. The resulting phage pellet was resuspended in 300 pi TE buffer 
(pH 8.0), and 200 pi (1:1) phenol-chlorofoim added. The extraction was mixed by 
vortex for 1 min, and spun in a microcentrifuge for 1 min at 10,000 x g. The aqueous 
phase was removed to a fresh tube, taking care not to disturb the interface. This phenol-
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chloroform extraction was repeated until a clear interface was observed. Finally, 200 pi 
of chloroform was added, mixed by vortexing for 1 min and spun at 10,000 x g for 2 
min, and the aqueous phase again removed to a fresh tube. To precipitate the ssDNA, 
200 pi of 7.5 M NH4AC (pH 7.5) and 800 pi of 100% pre-chilled ethanol was added to 
the recovered aqueous phase. This was left on ice for 15 min and then centrifuged at
10.000 X g for 20 min, in a rotor chilled to 4 ®C. The supernatant was removed and the 
pellet washed in 80% ethanol. This was spun again for 5 min, supernatant was removed 
and the pellet dried completely before resuspending in 20 pi of TE buffer. Excised 
ssDNA was stored at -20 °C.
3.2.53 ABI PRISM dGTP BigDye Sequencing
The ABI PRISM sequencing kits use Inosine, an analogue of guanine, in order to 
reduce band compression. Band compression is usually caused by the formation of 
secondaiy structure in the sequencing products, resulting in an altered mobility through 
the sequencing gel and subsequent misidentification of bands. Inosine incorporation 
reduces such secondary structure formation due to the lower affinity binding to 
cytosine. This is of little use, however, when there is already significant secondary 
structure present in the template sufficient to terminate the Taq polymerase activity. In 
such situations the re-substitution of dGTP in the reaction mix allows for better 
incorporation and improves the ability of the Taq polymerase to ‘read-tlnmigh’ the 
problem area. Naturally this re-inti’oduces the problem of band compression, and so this 
approach should only be used for resolving difficult stretches of sequence, such as 
those encountered in the GATA clone.
For the most part, the preparation of DNA template, sequencing primers, and 
purification of extension products were as described in section 2 .2 .3.2.2 for the version
3.0 ABI PRISM Big-Dye cycle-sequencing. The Big-Dye reagent mixture contained 
dGTP in place of dITP, and a different AmpliTaq DNA polymerase requiring a much 
shorter cycle sequencing programme: one denaturing step at 96 ^C, followed by 25 
cycles denaturing for 10 s at 96 “C, followed by 2 min at 68 °C with a final hold at 4 °C. 
As with other versions of ABI sequencing, loading was largely automated and the set­
up carried out according to manufacturer’s instructions.
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3 .3  R e s u l t s
3.3.1 PCR C lo n in g
The PCR homology cloning yielded a number of positive Topo-TA clones, identified 
by colony-lift hybridisation using the GATA and NFAT internal primers as probes. Of 
these colonies, six each of the identified GATA and NFAT clones were chosen 
arbitrarily for sequencing. Identical sequences were obtained for all the GATA and 
NFAT clones, respectively, as shown in Figure 3.6 below. These sequences showed 
high homology with previously characterised GATA-2 and NFAT-2 factors fiom other 
species, as determined by BLAST search, and were deemed suitable for screening for 
full-length clones fiom the porcine ZAP Express^*^ library. One GATA and one NFAT 
PCR fiagment was taken forward for use in a combined, GATA/NFAT probe.
A.
B.
1 GAAGGCCGGG AGTGTGTCAA CTGTGGGGCC ACAGCCACCC CTCTCTGGCG |
51 CCGAGACGGG ACCGGCCACT ACCTGTGCAA CGCCTGCGGG CTGTACCACA
101 AGATGAACGG GCAGAACCGG CCACTCATCA AGCCCAAGCG GAGACTGTCT Î
151 GCCGCCAGGA GAGCAGGCAC CTGTTGTGCA AATTGTCAGA CGACAACCAC '
201
251
CACCTTATGG
GCCTCTACTA
CGCCGAAACG
CAAGCTGCAC
CCAACGGGGA
AAT
CCCTGTCTGC AACGCCTGTG
■|
1 TCAGGTGCAC CGGATCACTG GGAAGACCGT GTCCACCACC
i
AGCCACGAGG j
51 TCATCCTCTC CAACACCAAG GTCCTGGAAA TCCCGCTTCT TCCGGAAAAT Î
101 AACATGCGCG CAATCATTGA CTGTGCTGGG ATCCTGAAGC TCCGAAACTC 'I
151 TGACATTGAG CTTCGCAAAG GGGAGACGGA CATTGGGCGG AAGAACACCA
201 GAGTGAGGCT GGTCTTCCGC GTCCACATCC CGCAGCCCAA CGGCCGGACA
251 CTGTCGCTGC AGGTGGCCTC CAACCCCATC GAGTGCTCTC AGCGCTCAGC
Figure 3.6. Sequences obtained for the products of PCR homology cloning, for A. 
GATA and B. NFAT.
3.3 .2  L ib r a r y  S c r e e n in g
A representative sample of the plaque-lift hybridisations is shown in Figure 3.7. This 
demonstrates the progressively more discreet plaques required for obtaining 
monoclonal plaques. The first round of library screening resulted in twelve positive 
plaques, which were carried foiward to the next screen. By the time of the third round 
of screening and the subsequent phage excision, this was narrowed down to ten
120
positive, monoclonal plaques. The initial round of sequencing revealed four GATA- 
homologous clones, and six NFAT -homologous clones. These were termed GATA 
clone-1, -4, -7 and -10, and NFAT clone-2, -3, -5, -6, -8 and -9 respectively. 
Comparison of the sequences with known GATAs and NFATs through BLAST 
homology search indicated that the GATA clones-1, -4 and -10 were tmncated at the 5’ 
end. GATA clone-7, however, appeared to represent a full-length cDNA, and it was 
this clone that was used for all further work. All of the NFAT clones examined, 
however, appeared to be truncated, each missing 1 kb of sequence from the 5’ end. The 
first of these, NFAT clone 2, was of poor DNA quality, and so NFAT clone 3 was used 
for further restriction mapping and sequence analysis.
3.3.3 GATA
A restriction map of GATA clone-7, showing the enzymes used in generating the map, 
is given in Figure 3.8. There were few internal restriction sites within the insert, which 
restricted the number of sub-clones that could be generated for sequencing. A single 
Pstl sub-clone was generated for automated, ABI sequencing, in addition to the original 
phage excision product.
3.3.3.1 Primary Sequence Data
Obtaining primary sequence for the GATA clone proved to be problematic, with a short 
stretch of the 5’ region of the coding sequence (bases 696 to 733 of the final sequence) 
proving to be unobtainable by standard sequencing methods. This problem persisted in 
both directions of sequencing. This was attiibuted to the foimation of secondary 
structure in the DNA molecule, likely due to a high G-C content in that particular 
region. In order to reduce the incidence of such secondaiy-structure formation and 
resolve these difficulties, several different techniques were employed.
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1** Screen
2nd Screen
\
# •  • •
►» ‘. 'A -.I'-
/ i '
3"^  ^Screen
Figure 3.7. Results of successive rounds of library screening. Shown here is a 
representative sample of the plates used in screening the ZAP-Express^"  ^ library. The 
white arrows on the first screen denote positive plaques, which can be harder to 
distinguish from background save for the characteristic ‘tails’ caused by lifting the filter 
from the plate. The black triangles denote marks corresponding to those on the filters, 
added to the film to align with the plates.
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Figure 3.8. Restriction map of the full-length GATA clone ligated into the pBK-CMV 
vector. Sites in the multiple cloning site (MCS) are shown in red. Vector features 
shown include: origins of replication and antibiotic selection genes for both prokaryote 
and eukaryote hosts, cytomegalovirus promoter and T3 and T7 primer sites used for 
initial sequencing.
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3.3.3.2 High G-C Sequencing
The first attempt to remove secondary structures was the use of DMSO. This approach 
was unsuccessful, with the sequence terminating at the same region as before. 
Secondly, a single-stranded foim of the plasmid template was prepared in the hope that 
this would exhibit less secondary structure. The single-sti'anded DNA synthesis proved 
successful, but there was no noticeable improvement in sequencing with the change in 
template. However the third and final method using the ABI PRISM dGTP BigDye 
Terminator system did solve the problem of secondary structure in the GATA clone. A 
complete read-through of the problem region was obtained, which completed the 
primary sequence for the porcine muscle GATA.
3.3.3.3 Sequence Characterisation
A number of sequencing runs were made for each set of sequencing primers, with 
comparisons between the multiple sequences sufficient to resolve any sequence 
ambiguities encountered. The final, full-length GATA sequence is listed in Figure 3.9. 
The most likely translation start site is located at nucleotide 256. This ATG codon has 
a flanking G residue at position +4, but lacks the purine residue at position -3 that is 
the other element of a strong consensus site or ATG ‘context’ (Kozak, 1996). 
Nevertheless, this site remains an adequate context according to the criteria described 
by Kozak (1996), of YNNatgG (where Y is pyrimidine). The only other, upstream ATG 
(nucleotide 26) also possesses only one of the two flanking elements, and is followed 
by an in-frame stop codon (nucleotide 92).
Using the ATG at 256 as the presumptive start site, the in-frame stop codon is located 
at nucleotide 1696, giving a deduced peptide of 480 amino-acid residues. Calculating 
the protein size from the deduced amino acid sequence using PeptideMass software 
(Wilkins et a l, 1997) gave a predicted size of 52.98 kD. Also shown in Figure 3.9 are 
putative functional domains on the porcine GATA-2 clone, based on comparison with 
other family members. The zinc-finger DNA binding domains are present at amino acid 
residues 296 - 319 and 349 - 373. The basic region runs from amino acid residues 374 - 
397.
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1
71
141
2 11
GAGCTGGCGC CAGGGCGGCC GGAGGATGCC GAGGGGCCGG 
CTGCCCCTAG CTCACACCCT GTGAGCCCCG CCAGCCGCCC 
CCACCCGGCT CCCGTAGGTG CTGCCGGCTC TGAGGCCGCG 
CGCTGCCACC GCCTCCGCCC AGATCCCGAT CCTCCGCCGC
AGCCGGGCGG GCCTGAGGCC GAGGCGCGTG 
GACGCACTGT CCCTGAGCCC TCAGTCCCCC 
CCCCCCTCCC TGCGGCGCTG CCGCTGCGGA 
CGGCC
256 ATG GAG GTG GCG CCC GAG CAG CCG CGC TGG ATG GCG CAC CCC GCC GTG CTG AAT GCG CAG1 M E V A P E Q P R W M A H p A V L N A Q
316 CAC CCC GAC TCG CAC CAC CCG GGC CTG GCG CAC AAC TAC ATG GAG CCC GCG CAG CTG CTG21 H P D S H H P G L A H N Y M E p A Q L L
376 CCT CCC GAC GAG GTG GAC GTC TTC TTC AAC CAC CTC GAC TCG CAG GGC AAC CCC TAC TAC41 P P D E V D V F F N H L D S Q G N P Y Y
436 GCC AAC CCG GCC CAC GCG CGG GCG CGT GTC TCC TAC AGC CCC GCT CAC GCC CGC CTG ACC61 A N P A H A R A R V S Y S P A H A R L T
496 GGA GGC CAG ATG TGC CGC CCA CAC TTG TTG CAC AGC CCA GGG CTG CCC TGG CTG GAT GGG81 G G Q M C R P H L L H S P G L P W L D G
556 GGT AAA GCA GCC CTC TCG GCT GCT GCA GCA CAC CAT CAC AAC CCC TGG ACC GTC AAC CCC101 G K A A L S A A A A H H H N P W T V N P
616 TTC TCC AAG ACG CCA CTG CAC CCT TCA GCT GCT GGA GGC CCT GGA GGC CCC CTC TCC GTG121 F S K T P L H P S A A G G P G G P L S V
676 TAC CCA GGG GCA GGG GGT GGG GGT GGG GGA GGC AGT GGC AGC TCT GTG GCC TCC CTC ACC141 y P G A G G G G G G G S G S S V A S L T
736 CCC ACC GCA GCC CAC TCT GGC TCC CAC CTC TTC GGC TTC CCA CCT ACA CCA CCC AAG GAA161 P T A A H S G S H L F G F P P T P P K E
796 GTA TCT CCT GAC CCC AGC ACC ACC GGG GCT GCC TCC CCA GCC TCG TCC TCT GCA GGG GGT181 V S P D P S T T G A A S P A S S S A G G
856 AGT GCA GCC CGG GGG GAG GAC AAG GAC GGC GTC AAG TAC CAG GTG TCA CTG ACT GAG AGC201 S A A R G E D K D G V K Y Q V S L T E S
916 ^ G AAG ATG GAA AGC GGC AGT CCC TTG CGC CCA GGT CTG GCT GCC ATG GGC ACC CAG CCT221 M K M E S G S P L R P G L A A M G T Q P
976 GCC ACG CAC CAC CCT ATC CCG ACC TAC CCC TCC TAC GTG CCA GCT GCC GCC CAT GAC TAC241 A T H H P I P T Y P S Y V P A A A H D Y
1036 AGC AGC GGG CTC TTC CAC CCC GGA GGC TTC CTG GGT GGC CCT GCC TCC AGC TTC ACC CCT261
1096281
S
AAGK
S
CAG
Q
G
CGGR
L
AGCS
F
AAGK
H
GCAA
P
CGCR
G
TCCS
G
TGCC
F
TCAS
h
GAAE
G
GGCG
G P A S S F T P
R~ E C* V N C* G A
1156 itgab ü U IHIMk W g g E 3 g g E S B GGG301 T A T p L W R R D G T G H Y L C* N A C* G
1216 CTG TAC CAC AAG ATG AAC GGG CAG AAC CGG CCA CTC ATC AAG CCC AAG CGG AGA CTG TCG321 L Y H K M N G Q N R P L I K P K R R L S
1276 GCC GCC AGG AGA GCA GGC ACC TOT E 3 B E I B a n k W a l a a i ^ s E S S 9341 A A R R A G T C c* A N c* Q T T T T T L w
1336 ggg p s a B E Q M M E g IsUulIsJulilg g E g t g g o I S S hkui s s361 R R N A N G D p V C* N A c* G L Y Y K L H
1396 CGG AAG ATG381 N V R P L K K E G I Q T R N R K M
(Continued overleaf)
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1456 TCC AAC AAG TCC AAG AAG AAC AAG AAG GGT GCC GAG TGC TTC GAG GAG CTG TCC AAG TGC401 S N K s K K N K K G A E C F E E L S K C
1516 ATG CAG GAA AAG GCC TCC CCC TTC AGC GCG GCT GCC CTG GCC GGA CAC ATG GCA CCC GTG421 M Q E K A S P F S A A A L A G H M A P V
1576 GGC CAC CTG CCG CCC TTC AGC CAC TCG GGA CAC ATC TTG CCC ACG CCG ACG CCC ATC CAC441 G H L P P F S H S G H I L P T P T P I H
1536 CCC TCC TCC AGC CTC TCC TTC GGT CAC CCC CAC CCG TCC AGC ATG GTG ACC GCC ATG GGC461
1696481
P
TAG
S S S L S F G H P H P S S M V T A M G
1699 GGACTGCCCA CACCAACCGA CAGTCAGATG CCGCCGAGGA AGGCGCCCCC AGGATAGGAG GACCAGACCC
1769 TTAGCTGCCC GTCCTTCCCT GGAGACTGAC ACACCCCTGC CAGCGCAGCC GGAGCCCCAC GCTGCCTCAC
1839 CTGTGGGCGC TCCACTCCAT CGGCCGTCAC TGTGAAGATT CACCAGAGGC TGGGAGGCCG CTTCAGCCTG
1909 GCTGCCACCA GGTGGGGTTT CCTGCATGGA CACCTGTTTG GAGAGCAGAA AGGACAACTT TATGAAGATG
1979 AAAGGAGGGG GCAAGGGACA AAAGGAGGAA ACCATTTTTA GAAGAAGAAG GAGTAGGCAA ACATAATTTA
2049 TTTTGCTCTT GTTTCTAACA AGGCCTGGGA GACTCAGGAG GCATGGGCTG CCCTGAGCTC TCTGGTCTTC
2119 CTCAGAGCCA AGGGCCACTT GGCTGGCCCG CCTGCCAGGC TCTGGGGGCA GGTCTCCAGA GCCCTCAACC
2189 CACATGCTTT CCTCTAGCTC CCTCTCTGAA GCAGCTGGAC CCAGGTTGGG CTGAGCCAAG CCAGAGGGGC
2259 CCCAGCCGGG GAGGCTGAGC CAGTGCAGGC CCTGGCGGCC AGGCCCTGGA GTCCAGAGAC AATCACGGGC
2329 GGTCCTGCGC AGATTCCCAG GCCAGGGCTG GGTCACAGGA AGGAAACATT TTCTTGAGAG GGGAAACGTC
2399 TCCCAGATCG CTCCTCTGGC TCTGAGGCTG AAGCTGGTGT GACCCACGTC CCCTTAACGG GCCTGAGCCA
2469 TAGCCTGCCT CCTCTGCCAG TGGACCCCTG TACATACATC TTTTTTTCTG CTAACTTCTC AACCCCCTCC
2539 TCTCCAACTC CGAGAC
Figure 3.9. Nucleotide sequence and deduced amino acid sequence of porcine GATA-2 
transcription factor (1-2554 bp). Underlined sequences denote primers used for cycle 
sequencing. Blue shaded sequence denotes putative zinc-finger DNA binding domains, 
with asterisks marking the cysteine residues responsible for generating the zinc finger 
domain. Green shading denotes basic region (nuclear localisation signal).
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PorcineGATA2GATA3GATAIGATA4GATASGATAS
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PorcineGATA2GATA3GATAIGATA4GATASGATAS
F....NHLDS QGN...PYYA
P  MI-GFPSGPEG--A.........RF....L-APG
 HVP GAASSTA-..S QST..C-HRG AGS...-MFV ASS...-VYV
NPAHARARVS YSPAHARLTG GQMCRPHLLH 100-------- ------------------ S-------------
-SVR-.TVQR -PPTH...HG SQVCRPPLLHTATAAAAALA -....................ALLRAGPVL. ..PPGRR-RG LCVRRP....P--RVPSMLS -..... LSG ...CEP....PTTRVGSMLP GLPYH..LQG .SGSGPAN.H
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SPGLPWLDGG 
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...... AA. ..RP....GW AQTATAD-S- FGPGSP...H..... AGA. . .HP. . . .GW PQAS.AD-PP YGSG.....
Porcine PGAGGGGGGG SGSSVASLTP TAAHSGSHLF GFPPTPPKEV S.P.DPSTTG 200GATA2 ----- S---GATA3 -...... PA -S — LSG. . . ..G-ASP-- T------ D-GATAI .G-PYAGW.. ..-YGKTG-. .Y...-AST- C. -.... -RGATA4 .... TQQ-S PGW-Q-GADG .--Y..... ....T--P.- -.-.RF-.GATAS P........GATAS . . G - AA-- A A-PGG-GS.. A --VSAR. F PYSPS--MAN GAARE-G.
PorcineGATA2GATA3GATAIGATA4GATA5GATAS
PorcineGATA2GATA3GATAIGATA4GATASGATAS
AASPASSSAG GSAARGEDKD GVKYQVSLTE SMKMESGSPL RPGLAAMGTQ 250
LiST-G- . . —  . —  . -QDE-E CL P - P D  L —EDS-PQ.........AV--L- -.-GSTSFL- TLKTER..F-GTTGSL AA--AAAARE AAAY S -GGGAA-H--SGPGS- -.SAG-RD.. -SA--GA-.. .LPREQ Y-AAGSGG-- -VSGG-SSLA AMGGREPQYS -LSAAR
P.ATHHPIPT YPSYV.PAAA HDY......S SGLF.
-HS -GSMT-L-GA . .- SPD-LTL-PA 
\G- A.-REQY-RA..... FA-PL-RP.- - N .GTYHHHHH
,.H PGGFLGGPAS 3 00
SSS T- --P--....  PE-......- ---L.PSSL-VP. NSA-GGP... .-F......  -ST-AF-GSYSSP. --A-M.ADVG ASWAAAAAA- A-P-V.GTSYSAT. --A-VS-DV- QSW..... T A-P-H.HH SP. YSP-VGAPLT PAW..... P A-P-
..P... -SSL SPT....FS -T-SPLNS-A DSPVL- SLPGRAN-GA DGSVL- ..-LPGRRPT ETPVL- SLQSRAGAPL
PorcineGATA2GATA3GATAIGATA4GATA5GATAS
SFT.PKQRSK ARSCS.EGRE CVHCGATATP LWRRDGTGHY LCNACGLYHK 3 50
G-G.C-S-P- ST. -------S--YSS.P-L-GT LPLPPC-A-- ----------RHP.W..LDM FDDFS. ------MS--FVS DF LEEFPG ------LS--PVPRGPSADL LEDLS —  S— -----SIQ —
PorcineGATA2GATA3GATAIGATA4GATASGATAS
MNGQNRPLIK PKRRLSAARR AGTCCANCQT TTTTLWRRNA NGDPVCNACG 400
------ R — K--IVSK--I-----  -Q S - --V---VR -QK SS---LS -QK-VPSS —
---S----- ---- Q — T— — — —.
V—LS----- -------L--T--H- -N-' L-LS----H- --- E-E------E-B------
(Continued overleaf)
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PorcineGATA2GATA3GATAIGATA4GATASGATAS
LYYKLHNVNR PLTMKKEGIQ TRNRKMSNKS KKNK...KGA ECFEELSK.. 450-----     - - -  -------------  —  S - . , ,  . . 1__ ------------------ g-- --C-. . .-VH DSL-DFP-. .
----- Q-- -----R-E-- ------A-G-G --KRGSSLGG TGAA-GPAGG--M--- G-P- --A-R----  --K--PK-LN -SKT..PAAP SGS-S-PP..--M--- G-P- --A--- S-- --K--PKTIA -ARG..SSGS TRNASASP..--M--- G-P- --A------- --K--PK-IN -SKT...CSG NSNNSIPM..
Porcine .CMQEKASPF SAAALAG.HM A....PVGHL PP.FSHSGH. ....... ILGATA2 .---- S--- ------ - — * • * . “GATA3 ..... N-S- NP-- SR. -- S . . . . SLS-I S- .--- S- . ....... M-GATAI PMWAGG-GS GNCGEVASGL T ..LG-.PGT AHLYQGL-PV VLSGPVSHLMGATA4 .ASGASSNSS N-TTSSSEE- R.PIKTEPGL SSHYGHSSSV SQTFSVSAM.GATAS .SAVASTDSS A-TSK-KPSL ASPVC-GPSM A-..QAS-Q. ....EDDSLAGATAS .TPTSTS-NS DDCSKNTSPT TQPTASGAG. APVMTGA-E. ...... STN
Porcine PTPTP.I.HP SSS..LSFGH P....HP... SSMVTAMG..GATA2 ( 481)GATA3 ( 445) T--- .M . -- P- - . .--- . -H...—  ... ------- * .GATAI ( 414) -F-G-LLGS- TG-..... F -TGPMP-TTS TTV-APLSS.GATA4 ( 424) SGHG-SI.-- VL-.A-KLS. -QGYAS-VSQ -PQTSSKQDS WNSLVLADSHGATAS ( 389) -GHLEFKFE- . .E .. .DFAF -STAPS-..Q AGLRG-LRQ. ...... EAWGATAS ( 440) -ENSE.L.KY -GQDG-YIGV S ..LAS-... AEVTSSVR.. ..... PDSW
PorcineGATA2 ( 481) .....  (97 5%)GATA3 ( 445) .....  (62 .8%)GATAI ( 414) .....  (36 .8%)GATA4 ( 424) GDIITA (34 .3%)GATAS ( 389) CALALA (34 .9%)GATAS { 440) CALALA (34 .0%)
Figure 3.10. Sequence comparison of the deduced amino acid sequence of the acquired 
GATA clone with those of different human GATA isoforms (Accession N-s 
NM_002049, M68891, A39794,157561, NP_536721 and Q92908 for human GATA 1, 
2, 3, 4, 5 & 6 respectively). A denotes a homologous residue. The percentage 
amino-acid homology with GATA clone-7, as determined by ALIGN software, is 
shown at the end of each sequence.
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MEVAPEQPRW MAHPAVLNAQ HPDSHHPGLA HNYMEPAQLL PPDEVDVFFN 50 
   H D---------  HV------------
--- TD —--
--- TD----
-T-H--- G-
-- H—  LN —
..E------ ---------- ----------
HLDSQGNPYY ANPAHARARV SYSPAHARLT GGQMCRPHLL HSPGLPWLDG 100
GKAALSAAAA HHHNPWTVNP FSKTPLHPSA
-S------ 1
AGGPGGPLSV
--- 1----S
--- L---ES
YPGAGGGGGG 150
S----- ...
------- S- -G-A--- A- R-...-..S-
GSGSSVASLT PTAAHSGSHL FGFPPTPPKE VSPDPSTTGA ASPASSSAGG 200
C---------
S-TA--S-- -A. S----- ------------ ---- NS - S - ---•---- A
SAARGEDKDG VKYQVSLTES MKMESGSPLR PGLAAMGTQP ATHHPIPTYP 250
. . . -Q--- S
. . .~L--- S
I----- S-G
I-- M —  S-G --- GG---
SS-TS--A-- 
SS--P--- C S---------
SYVPAAAHDY SSGLFHPGGF LGGPASSFTP KQRSKARSCS E G R E g g H 300
G---------
----- S L ------------  S-
(Continued overleaf)
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.C g T T 'l ’TTLW  KKNANGDPVC NACGLYYKLH NVNKPLTM KK E G IQ l
:a t p l w r r d g TGHYLCNA jo LYHKMNGQNR PLIKPKRRLS AARRAGTCg 3 50
|RKM 400
SNKSKKNKKG AECFEELSKC MQEKASPFSA AALAGHMAPV GHLPPFSHSG 450
 s--- ----------------  s---  ------------ ------------
HILPTPTPIH PSSSLSFGHP HPSSMVTAMG 480
----- --------------- -------- (97.5%)
---------- ---------- ---------- (96.7%)
-------------  1-- -----------  (86.9%)
---------    -H-------- (83.1%)
Figure 3.11. Pileup of amino-acid sequences for GATA-2 transcription factors across a 
range of species (Accession N^s: human P23769, murine AK004675, chicken P23824, 
Xenopus P23770). A denotes a homologous residue. Blue shaded sequence denotes 
putative zinc-finger DNA binding domains. Green shading denotes basic region 
(nuclear localisation signal). The percentage homology with GATA clone-7, as 
determined by ALIGN software, is shown at the end of each sequence.
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The GATA clone-7 sequence was submitted to GenBank (Accession N° AY251012). 
Comparison with other, previously described family members by ALIGN software 
(Pearson et a l, 1997) showed highest homology with human GATA-2 (Accession N~ 
M68891), with an amino acid homology of 97.5%. A sequence comparison with other 
GATA isoforms is shown in Figure 3.10, showing GATA-2 to be the most likely 
isoform. A summary of the sequence homologies with GATA-2 molecules from other 
species is given in Figure 3.11. As might be expected, given the homology PGR-based 
strategy used in its isolation, GATA clone-7 showed high homology with previously 
characterised family members, particularly in the zinc-finger DNA-binding domains.
3.3.4 NFAT
NFAT cloning and sequencing presented entirely different problems to those 
encountered in obtaining the GATA-2 clone. Restriction digest analysis and initial 
sequencing of the six putative NFAT clones seemed to indicate little, if  any, difference 
in their sequences. A restriction map of NFAT clone-3 is shown in Figure 3.12. This 
map was common to all the NFAT clones analysed. As stated in Section 3.3.2, initial 
sequencing showed that all of the clones were missing an estimated 1 kb of sequence 
from the 5’ end, in comparison with known NFAT sequences. Based on BLAST 
homology searching, the section of transcript isolated started in the middle of a coding 
sequence, and was thus unlikely to represent an alternate splice variant. A repeat of the 
library screening process was no more successful. A PGR modification was attempted, 
in order to generate a useful clone from the incomplete material as detailed in Section 
3.3.4.3.
The truncated sequence, obtained from NFAT clone-3, is shown in Figure 3.13. Also 
shown is the deduced amino acid sequence from the available coding sequence. 
Gomparisons of this sequence with previously published data, through ALIGN software 
(Pearson et a l, 1997), showed a high homology (96.8%) with a recently published 
porcine NFAT-2 (Accession N~ AF069996) isolated from macrophages termed 
NFATmac (Miskin et a l, 1998). A sequence comparison with other NFAT isoforms is 
shown in Figure 3.14, showing that the NFAT clone is likely to be an NFAT-2 isoform 
(with a sequence homology of 82.6% with human NFAT-2).
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Bam HI
Smal 
/• Smal ~ Apal,K
pBK-CMV/ 
NFAT clone 3
7681 bp
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Figure 3.12. Restriction map of the truncated NFAT clone ligated into the pBK-CMV 
vector. Sites in the multiple cloning site (MCS) are shown in red. Vector features 
shown include: origins of replication and antibiotic selection genes for both prokaryote 
and eukaryote hosts, cytomegalovirus promoter and T3 and T7 primer sites used for 
initial sequencing.
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1 .CC GAC TTC CCA CCT GAG GAG TTT CCG CCC TTC CAG CAC ATC CGC AAG GGC GCC TTC TGC1 D F P P E E F P P F Q H I R K G A F C
60 GAC CAG TAC CTG TCG GTG CCG CAG CAC CCA TAC CCG TGG GCC AGG CCA CGG TCC CCG ACG20 D Q Y L S V P Q H P Y P W A R P R S P T
120 CCC TAT GCC AGC CCG TCT CTC CCT GCC CTG GAC TGG CAG CTG CCG TCA CAC TCA GGA CCC40 P Y A S P S L P A L D W Q L P S H S G p
180 TAG GAG CTG AGG ATC GAG GTG CAG CCC AAG TCC CAC CAC AGA GCT CAT TAC GAG ACA GAG60 Y E L R I E V Q P K S H H R A H Y E T E
240 GGG AGC CGT GGG GCT GTG AAG GCA TCG GCC GGA GGA CAC CCC AGC GTG CAG CTG CAC GGC80 G S R G A V K A S A G G H p S V Q L H G
300 TAC GTG GAG AGC GAG CCG CTC ACC CTG CAG TTG TTC ATC AGG ACG GCA GAC GAC CGG CTA100 Y V E S E P h T L Q L F I R T A D D R L
360 CTG AGG CCG CAC GCC TTC TAC CAA GTG CAC CGG ATC ACT GGG AAG ACC GTG TCC ACC ACC120 L R P H A F Y Q V H R I T G K T V S T T
420 AGC CAC GAG GCC GTC CTC TCC AAC ACC 7V1G GTC CTG GAA ATC CCG CTT CTG CCG GAA AAT140 S H E A V L S N T K V L E I P L L P E N
480 AAC ATG CGC GCA ATC ATT GAC TGT GCT GGG ATC CTG AAG CTC CGA AAC TCT GAC ATT GAG160 N M R A I I D C A G I L K L R N S D I E
540 CTT CGC AAA GGG GAG ACG GAC ATT GGG CGG AAG AAC ACC AGA GTG AGG CTG GTC TTC CGC180 L R K G E T D I G R K N T R V R L V F R
600 GTC CAC ATC CCG CAG CCC AAC GGC CGG ACA CTG TCG CTG CAG GTG GCC TCC AAC CCC ATC200 V H I P Q p N G R T L S L Q V A S N p I
660 GAG TGC TCC CAG CGC TCA GCC CAG GAG CTG CCC CTC GTG GAG AAG CAG AGC GCA GCC AGT220 E C S Q R S A Q E L p L V E K Q S A A S
720 TGC CCA GTC CTG GGC GGG AAG AGG ATG GTC CTG ACT GGC CAC AAC TTC CTG CAG GAC TCC240 C P V L G G K R M V L T G H N F L Q D S
780 AAG GTC GTT TTC GTG GAG AAA GCA CCA GAC GGC CAC CAC ATC TGG GAA ATG GAG GCG AAA260 K V V F V E K A P D G H H I W E M E A K
840 ACC GAC GGA GAC CTG TGC AAG CCG AAT TCC TTG GTG GTC GAG ATC CCG CCT TTC CGC AAC280 T D G D L C K P N S L V V E I P P F R N
900 CAG AGA ATC ACC AGC CCC GTC CAG GTC AAC TTC TAC GTG TGC AAC GGG AAG AGA AAG AGG300 Q R I T S P V Q V N F Y V C N G K R K R
960 AGC CAG TAC CAG CAT TTC ACC TAC CTG CCT GCC AAC GCT CCA GTC ATA AAA ACG GAG CCC320 S Q Y Q H F T Y L P A N A P V I K T E P
1020 AGT GAT GAC TAC GAG CCT GCC CTC ACC TGT GGA CCA GTG AGC CAG GGC CTG AAC CCG CTC340 S D D Y E P A L T C G P V S Q G L N P L
1080 ACG AAG CCT TGC TAT GGC CCG CCA CTC GCC CTG CCA CCC GAT CCC AGC TCC TGC CTT GTG360 T K P C Y G P P L A L P P D P S S C L V
1140 GCC GGC TTT CCA CCC TGT CCA CAG AGA AGC GCC GTG ATG TCT CCG CCA CCC AGC GCC AGC380 A G F P P C P Q R S A V M S P P P S A S
1200 CCG AAG CTC CAC GAC CTC TCC TGT GCC CCC TAC AGC AAA GGC ATG GCC GGC CCG GGC CAC400 P K L H D L S C A P Y S K G M A G P G H
1260 CTT GGA CTT CAG CGG CCA GCC GGA GGG GTC CTT GGA GGC CAG GAG GCA CCG AGA CCC GGG420 L G L Q R P A G G V L G G Q E A P R p G
(Continued overleaf)
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1320440 GGC CCA CAT CCC GGC GCT CCC CAG CCA CCA CCC G P H P G A P Q P P P CCC GCC CTG CTG CAG CCA CAG TAA P A L L Q P Q *
1377 ACGAAATAAT ACGAAACGAC CTCTCCAGCA CCAATATCCA CTATAGTTGG CAACGTGGGA CTCTCAGAAG
1447 CTCCGCAGCA TGGACGTGAT GGCAACAACT TCTGAGTAAA CACCCTGAAC TCACACGGGC ACCTGGTACC
1517 TCTCAGAACT GCCCACTGCA GGCTGACGTC ATGTGTACAG AGAAGTGACT CCGGGCAGGA AGGGATGCTC
1587 CACCTCCTGA GGGAAAGTGT CTCAAGAAGG AGAAGAAAGC GGGTGGCTGG GGTGAGCGTG GGACAGCCCG
1657 CGTGAGGCTC CCCTAAGCCA CCCCCCTGCC GAGGCAGCCT GGTCCCAGGC CTCACCCTTC CGGCACCCCT
1727 GAATTTCATG CTGGAAGTGC CTTAATTCCC CGACCACACC ATCAGGGTGT CGCAGAGTGG AGCAGTGAAT
1797 TTGCTACCAG GAAAGTATTT GTAGGAGCAG AAGCTAAAGA CGCTTGGCCA AGAGGCTTTA TTCTTTGTAC
1867 AAATTAAGGG AATCCTGGGG GGCAGAGCAT CTGGAGGAAG CCCAGTGCTC GTTTGCTCCT GTCTTCAACC
1937 TTTCCTGGGC GGGAGCATCA TGCTGATCCC GTTGCCTTAT TCAGTGCATT TCAGACTGCT CCCAAGTGTC
2007 ATCTCAGCTC TTTTATAACC TTCTCTCCCC GCCCCCGTGG TACGCAAACC ATAGGGCTGT TCATTGTAGC
2077 ATGTTTViGAT TTTGTTTTTA ATCTGGCTTC AAACACANGC ACAAGTAAGT TGAATAGCAC AAGACAGGTT
2147 ACTGGACAAA AAAAGAAATC TCTCCGCGTC AGGGTAGATT TTGCATTTGC ATGTGTGTAC ATATATAGGC
2217 ATATATTTAT GTATGAACAA TAACAGAGGT GGTGATATAC AGCCTTCGCC CAGCAAGGGC GTCCGCATTA
2287 GCAATAACCA GTGTCCATTT TGGAAAGAGC ACCCATGGCC CCAAACCTGG CTTCCTAGCC ATTCCCGTGG
2357 GGGAGCCCCG CCCCCTCCTC CCCCGCATCT GCGTTTCGTC GCCTCCTGCA GTTAACCAAG CACTTTAGAA
2427 GCCAGGAGAG GTGCGTTCAC AGTACCGTCT GTTACCAAAT GGCAAAATTG GAAAGAAACT GTAAATAGCA
2497 TTACAGAAGG AGTGTAATAT ATTTGTTCAG CTGTAAGATG GTTATTTCAC AGAAGCCTTA TAACCTCGCT
2567 TCATGTAAGA AAACGATTAC CAAAAACAGC ATTTTCATAT GCAGCGACTG TAGTGTGTTT CCAGACTAGT
2637 TACTGTTAAT ACGTAGGTTA GTGTAAGCTT TCTGCTGCAT TCCGTACACT TAACAGCTTA TTAGATGATT
2707 GCCAGCAGTG ACCCGTTGTC TCACGTAACC AAAAAGCATG GTGTGACGAA CACGGTTAAC CTAGTAACTG
2777 TGCCTTAGGA ACTCACGCCC CCTCATGGAG CACGGGGGAA TCGCACCCTC CGGCGAGGTG ACAAGCAGTT
2847 CCCCTCACTC GAGAGCTCTC CCACAGAAAG AATCACTTAA ATGTCCTTCT GTCCAATCAT GTCTTACTTT
2917 GTAAGTCACA GAGGCGAACA TCTGAAAGCC ATATTG7ACC ATTTGCACAT TACTGTGAAG AGCCGAGGAT
2987 CCATGGCTTC GTGTGCGTAG ACCTGCCCGC ATTTAGCTCT GTAGGACTTG CATGAGACAT TTTCTTGGTA
3057 GACTGTCATG GAAGGGACAC GTTTGCTCCT GTGTCAGCTA TCTCTGTAGT TAGAAGTAGG TCCTAATAAA
3127 GCAATATTTT TTTGCTGG
Figure 3.13. Nucleotide sequence and deduced amino acid sequence of porcine NFAT- 
2 transcription factor (1-3144 bp). Underlined sequences denote primers used for cycle 
sequencing.
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Porcine (1)  DFPPEEF PPFQHIRKGA FCDQYLSVPQ H.PYPWARPR 50NFAT2 { 332) PVGEDLGSPP PPA--A--DY SS----- G -------A--NFATl ( 313) SAAPSKAGLP RHIYPAV-FL G-CEQGBRRN SAPESILLVP PTWPKPLV-ANFAT3 ( 327) PASCNGKLPL GAEESVAPPG GSRKEVAGMD YLAVPSPLAW S.KARIG...NPAT4 { 336) ELCSDDQGSt SPARETSIDD GLGSQYPLKK DSCGDQFLSV PS-FT-SK-K
PorcineNFAT2NFATlNFAT3NFAT4
..SPTPYASP SLPALDWQLP SHSGPYELRI EVQPKSHHRA HYETEGSRGA 100 PL —~ TS“M— — T ~ — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
IPICSIPVTA P^E-P-S -Q— S  P ----------GHSPIFRTS A--P-----  -QYEQL   RA ----------PGHTPIFRTS —  - P A — F-QC —  R—  T ----------
PorcineNFAT2NFATlNFAT3NFAT4
VKASAGGHPS VQLHGYVESE PLTLQLFIRT ADDRLLRPHA FYQVHRITGK ISO
 PT--P V -------M~NK — G— I— G“ — E“I~K  -- - —  - ^  ^— AP---- V "K-Xj —  S . EK --T--M— G- — E-N  ---------- T---- V “K—L —  N.EK - IN— M — G ~  y- - - - - - - .--------
PorcineNFAT2NFATlNFAT3NFAT4
PorcineNFAT2NFATlNFAT3NFAT4
TVSTTSHEAV LSNTKVLSIP LLPENNMRAI IDCAGILKLR NSDIELRKGE 200
—  T---Y-KI VG--------~EPK T --------- —  -A ----M-A-A-Y V-G---- M T ---------N ----------  ----------— A-A - Q“II I AS----   S ~ S ------ — . — '--- —
TDIGRKNTRV RLVFRVHIPQ PNGRTLSLQV ASNPIECSQR SAQELPLVEK 250   V-- -S-------- ---------- -----------   - - - - g gg —  IV-— -T -  -------------------  — H  M —  R
---------- ------ V —  GGGRW^V-A — V------- - - - - -— QV~A — --— ---— — —  — —g — j —  I“V —  — —  — — — —  —RI —
Porcine QSAASCPVLG GKRMVLTGHN FLQDSKWFV EKAPDGHHIW EMEAKTDGDL 300NFAT2 --TD-Y--V- —  K--S--- ------ 1 — ------- V-NFATl -DTD--L-Y- -QQ-1-- Q- -TSE-- V-T --TT--QQI- --- TV-K-KNFAT3 Y-PSA-S-R- -EEL--- S- —  P--- V-1 -RG--KLQ- -E— TVNRLQNFAT4 Y-IN--S-N- -HE--V--S- --PB--II-L --GQ--RPQ- -V-G-IIREK
Porcine CKPNSLWEI PPFRNQRITS PVQVNFYVCN GKRKRSQYQH FTYLPANAPV 350NFAT2 --------------- - - - - - -------------------------------- — H- S---- ---------R ------ V-INFATl SQ — M-F-- -EY--JCH-RT -  - K ---- 1 - ----------------------p _ _ --HPV.. -ANFAT3 SNEVT-TLTV -EYS-K-VSR -----------Y---S- -R--- PT-S -RF--VICKENFAT4 CQGAHI-L-V --YH-PAV-A AV--H--L-- --- K—  S - R ---T-VLMKQ
Porcine IKTEPSDDYE PALTCGPVSQ GLNPLTKPCY GPPLALPPDP SSCLVAGFPP 400NFAT2 ---- T--- —  p ---------------------- --S--PR-Y- SQQ— M--- --------------------------------NFATl ---- T-E-D -T-I-S-THG --GSQPYYPQ H-MV-ES-SC LVATM-PCQQNFAT3 EPLPDSSLRG FPSASATPFG TDMDFSP-RP PY-SYPHED- ACETPYLSEGNFAT4 EHR-EI-LSS VPSLPV-HPA QTQRPSSDSG CSHDSVLSGQ RSLICSIPQT
Porcine CPQRSAVMSP PPSASPKLHD LSCAPYSKGM AGPGHLi, , GLi QRPAGGVLGG 450NFAT2 ---- TL-PA A-GV----- --P-A-T--V - S-- CHL " - PQ-- EAPAVNFATl FRTGLSSPDA RYQQQNPAAV -YQRSK-LSP SLL-YQQPA- MAAPLSLADANFAT3 FGYGMPPLY- QTGPP-SYRP GLRMFPETRG TTGCAQPPAV SFLPRPFPSDNFAT4 YASMVTSSHL -QLQCRDESV SKEQHMIPSP IVHQPFQVTP TPPVGSSYQP
Porcine QEAPRPGGPH PGAPQPPPPA LLQPQ.... 500NFAT2 -DV-- VAT- — -S"GQ--- —  PQ“....NFATl HRSVLVHAGS Q-QSSALLHP SPTN-QASPV IHYSPTNQQL RCGSHQEFQHNFAT3 PYGG-GSSFP L-L-FS--AP FRPPPLPASP PLEGPFPSQS DVHPLPAEGYNFAT4 MQTNWYNGP TCLPINAASS QEFDSVLFQQ DATLSGLVNL GCQPLSSIPF
(Continued overleaf)
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PorcineNFAT2NFATlNFAT3NFAT4
PorcineNFAT2NFATlNFAT3NFAT4
PorcineNFAT2
NFATlNPAT3NFAT4
PorcineNFAT2NFATlNFAT3NPAT4
.............................................................................................................................................................. 550
ÏMYCENFAPG TTRPGPPPVS QGQRLSPGSY PTVIQQQNAT SQRAAKNGPP NKVGPGYGPG EGAPEQEKSR GGYSSGPRDS VPIQGITLEE VSEIIGRDLS HSSNSGSTGH LLAHTPHSVH TLPHLQSMGY HCSNTGQRSL SSPVADQITG
  600
VSDQKEVLPA GVTIKQEQNL DQTYLDDELI DTHLSWIQNI L ........GFPAPPGEEP PA..........................................QPSSQLQPIT YGPSHSGSAT TASPAASHPL ASSPLSGPPS PQLQPMPYQS
........................................................  650
PSSGTASSPS PATRMHSGQH STQAQSTGQG GLSAPSSLIC HSLCDPASFP
..............................................  700  (82.6%)..............................................  (47.8%)..............................................  (46.4%)PDGATVSIKP EPEDREPNFA TIGLQDITLD DGKFISDMFL K (37.9%)
Figure 3.14. Sequence comparison of the acquired NFAT sequence with other human 
NFAT isofoi-ras (Accession N-s G02326, NP_006153, Q 14934 and NM_173164 for 
human NFAT 1, 2, 3 & 4 respectively). A denotes a homologous residue. Grey 
shaded sequence is 5’ of the existing NFAT clone-3. The percentage homology with 
NFAT clone-3, as determined by ALIGN software, is shown at the end of each 
sequence.
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Pig (1)   DFPPEEFPPF QHIR.KGAFC DQYLSVPQHP 50
NFATmac(337) SLALKVEPAA EDLGATPPTS ---------- --- .-----  ----------
Human (345) SVALKVEPyG EDLGSPPPPA --A--DYSS- --- .--G--  A -----
Mouse (347) SVALKVEPAG ÉDLGTTPPTS------ Y.T- --L-. E-------AS
Xenopus (326) RLAGKTELNT;EDLACLSPIV -M-AD-TSCS QH--VQDSST -~F----S-.
Pig
NFATmac
Human
Mouse
Xenopus
YPWARPR..S PTP.YASPSL PALDWQLPSH SGPYELRIEV QPKSHHRAHY 100
— Q  —  X- KPL — —  S*“M —  T^ -  --------- ------ ---—   --------
-Q--K-KSL- PTS.YMSPSL ---------- ---------- ----------
FT-NKHKS.G HTPVFRTSSL -P A  R Y-Q KV—  T-----
PigNFATmac
Human
Mouse
Xenopus
ETEGSRGAVK ASAGGHPSVQ LHGYVESEPL TLQLFIRTAD DRLLRPHAFY ISO---------       Q--------------
---------- -VT-S — I-K "I — T-.K-V NV-I--G E-YVK----
Pig
NFATmac
Human
Mouse
Xenopus
QVHRITGKTV STTSHEAVLS NTKVLEIPLL PENNMRAIID CAGILKLRNS 200
------II-
V-A-Q-I-IT -P-  MT-S--
Pig
NFATmac
Human
Mouse
Xenopus
DIELRKGETD IGRKNTRVRL VPRVHIPQPN GRTLSLQVAS NPIECSQRSA 250
-A TS - KV---- T— -I - -  ----■-
Pig
NFATmac
Human
Mouse
Xenopus
QELPLVEKQS AASCPVLGGK RMVLTGHNFL QDSKWFVEK APDG.HHIWE 300
------- TD“Y —  V K S-H  I —  - — —- — - —
-—- ------- TD“Y— I K^""S“H----------I ----. — V —
 Q Y- VN —  S^N —  L EL - I —  S —  M P----I-L —  GQ —  CT - .
Pig
NFATmac
Human
Mouse
Xenopus
MEAKTDGDLC KPNSLWEIP PFRNQRITSP VQVNFYVCNG KRPCRSQYQHF 350
-R-
A-G-I-LKK- QM-NI-
-R-
AYHNKSVAAE Q------- S-R-
(Continued overleaf)
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Pig
NFATmac
Human
Mouse
Xenopus
TYLPANAPVI KTEPSDD..Y EPALTCGPVS QG. .LNPLTK PCYGPPLALP 400
-----------  . . Y -----------  -----  ------------
-V-I- — ' —  T —  , , Y " —  P------------  —  ..-S —  PR - Y - SQQ— M -
---- V - I - -----T--..F L---- M- --..IS--PR -y-SQQ-TM-
N-T-...VLL -Q-NLE-QNL QE-.-AVS-A K-RGISDL.. HIIHTNLLFQ
Pig
NFATmac
Human
Mouse
Xenopus
PDPSSC..LV AGFPP...CP QRSAVMSPPP SASPKLHDLS CAPYSKGMAG 450
----- . . —  ----- ... —  TL- PAA- G VS ------ P-A-T— V-S
 G—  . . —  A- . . . -S — NTL —PT—  N -------- SPA-T— LTN
DQRSICKT-K SLSP-GVG-- NQLTFTSSLK HEA-HISNIQ EPCT-SSPCT
Pig
NFATmac
Human
Mouse
Xenopus
PG...HLGL. QRPAGGVLGG QEAPRPGGPH PGAPQPPPPA LLQPQ  500
--...--- .     LHPLN LSQSIVTRLT
--HC.---- P -P.--EAPAV -DV--VAT- -GS-GQ --PQ-.....
—  HSG---- . -P —  SEAPTM — V--MAIQ -NS-EQ— R- -—  .....
ADPETMENYP DTIYSSPQKQ SMPYQGFSSD ITILPSSSLT AMPHCGQPSS
Pig
NFATmac
Human
Mouse
Xenopus
EPQP.
HTHDCRLRDN SLSPTITHHR QNSTSSHPTD MSLGIKSELE DSDINFQTKD
Pig
NFATmac
Human
Mouse
Xenopus
.....................  (96.8%)
  (82.6%)
  (82.0%)
LQDITLDDVA EIIRRDMSH. (44.8%)
Figure 3.15. Pileup of amino-acid sequences for NFAT-2 transcription factors across a 
range of species. NFATmae is a porcine NFAT-2 isolated from macrophages 
(Accession N-s NFATmac AF069996, human NM_006162, murine NM_198429, 
Xenopus AB037471). A denotes a homologous residue. Grey shaded sequence is 5’ 
of the existing NFAT clone-3. The percentage homology with NFAT clone-3, as 
determined by ALIGN software, is shown at the end of each sequence.
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Comparisons with NFAT-2 from other species, as well as the porcine NFATmac, are 
shown in Figure 3.15.
As discussed in Section 1.4.2, NFAT-2 is synthesised in three different splice products 
(Chuvpilo et a l, 1999). These variants differ primarily in the length of the carboxyl- 
terminal end, though there also differences in the N terminal domain (reviewed in 
Serfling et a l, 2000). With the possession of the 3’ end, it was possible to determine 
that clone-3 showed elosest homology to NFAT-2b. However, without the 5’ end of the 
transcript, it was impossible to deteimine whether identity with this human orthologue 
was conserved at the N-temiinal end. The porcine NFAT-2 described by Miskin et a l 
(1998) is also closest to the 2b variant in terms of sequence homology and transcript 
length. However, homology between clone-3 and NFATmac was quite low at the 
extreme 3’ end of the deduced amino acid sequence (Figure 3.15). Homology was also 
low between the 3 ’ untranslated regions for the two transcripts, suggesting that while 
they may be the same isoform, they are different alternate splicing variants.
3.3.4.2 NFAT full-length PCR
The first attempt at isolating a full-length clone utilised the ZAP Express™ library as a 
template for PCR. The 3 ’ primer was based on the acquired, truncated sequence data, 
and the 5’ on the T3 polymerase site on the pBK-CMV vector. Several attempts were 
made to optimise conditions, such as annealing temperature and Mg^”^ concentration, 
but no fragments of the correct size were obtained. It seemed likely that no full-length 
species existed to be amplified, and that an alternative method of deriving the cDNA 
would have to be used.
3.3.4.3 Hybrid NFAT PCR-cloning
While attempts continued to clone a full-length NFAT, a cloning strategy was 
employed to convert the truncated clone into a useable protein. By adding extra 
sequence to the PCR primers, a Kozak consensus sequence and an fin fi:ame’ 
transcription start site would be added to the 5’ end of the NFAT clone. The protein 
generated from such a modified hybrid would lack the regulatory element and nuclear 
export signals. Provided the DNA-binding and /ra«5-activation domains remained 
functional, this NFAT would likely be constitutively active and give some insight into 
the role of NFAT in muscle. A eonstitutively active form of NFAT has been used
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successfully in other studies in T-cells and fibroblasts (Porter and Clipstone, 2002; Neal 
and Clipstone, 2003), though the NFAT used in these studies represented a less severe 
mutation (Neal and Clipstone, 2001).
The required PCR fragments were successfiilly obtained, but no colonies were observed 
following the ligation step and transformation into E. coli. The reason for the failure of 
this final step is not immediately clear, but is possible that gene product might be toxic 
to the E. coli host. While fiill length porcine NFAT-2 has been cloned in E, coli 
(Miskin et a l, 1998), the NFAT construct described here was a radical alteration of the 
native protein. In any case, it was clear that this ‘short-cut’ was not going to be an 
effective substitute for a full-length clone.
3.3.4.4 SMART RACE
Amplification using the 5’ RACE procedure did not produce a product, and in the end 
this technique also had to be abandoned. The reasons for the failure of this technique 
are unclear. The positive control RNA provided with the kit was reverse-transcribed 
and a full-length species amplified using the procedure outlined. It seems clear also that 
at least a fragment of the NFAT clone was also reverse-transcribed, since the internal, 
positive control, utilising both gene-specific primers, gave a fragment of the expected 
size. The failure of the full 5’ RACE may be due to a need for further optimisation of 
the reaction conditions, or it could be due to some problem sti’etch of sequence making 
it especially difficult for the reverse transcriptase employed in first stiand synthesis. 
This would possibly explain the difficulties in obtaining ZAP Express^^ clones with 
the full coding sequence.
As a final thought, it may have been beneficial to pursue a simplified RACE 
amplification step using the original methodology described by Frohman et a l (1988). 
The Clontech SMART RACE kit enriches for full-length cDNA species using a 
modified reverse transcriptase that incorporates a number of deoxycytosine residues at 
the 5’ end of first-strand syntheses that reach the end of the mRNA template. This poly- 
C tail serves as an adaptor, to which the SMART II oligonucleotide binds and primes 
for second stiand synthesis in the same reaction. The original RACE method uses a 
gene-specific primer for first-strand synthesis, and a poly A tail added by terminal
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deoxynucleotidyl-transferase. This poly-A tail serves as the template for second strand 
synthesis using a poly-deoxythymidine incorporating primer.
While the SMART RACE protocol is a faster method with fewer stages involved, one 
potential problem compared to the original method used by Frohman et al. (1988) is 
that the first strand synthesis must proceed through the entire length of the transcript, 
from the poly-A tail to the 5’ end. In the original RACE protocol, the 5’ reaction need 
only transcribe from the gene-specific primer to the 5’ end. While this results in a 
fragment that must be manipulated with other pieces to reconstitute a complete cDNA 
clone, the shorter read-through might be more likely to succeed where the other 
methods had failed. Had time permitted, this may have been easier to optimise than the 
SMART RACE kit.
3 .4  D is c u s s io n
A full-length GATA cDNA clone has been isolated, sequenced and characterised. This 
clone has been identified as the porcine orthologue of GATA-2, and submitted to 
GenBank (Accession N~ AY251012). The characterised sequence of this porcine 
orthologue further confirms the high degree of homology observed in GATA family 
members (Lowry and Atchley, 2000). At the time of writing, two other porcine GATA 
family members, GATA-4 and -6, have also been described (Gillio-Meina et a l, 2003), 
while a third, GATA-3, has been partially characterised (Nonneman and Rohrer, 2004). 
It seems highly likely that the family organisation, and therefore function, of GATA 
factors is conserved in the pig.
The pBK-CMV/GATA clone-7 construct is particularly well suited for conducting 
studies into the physiological role of porcine GATA-2. The mammalian replication 
origin and CMV promoter enable mammalian transfection of the construct, and over­
expression of GATA clone-7. Prior to this, however, the next step is to determine 
whether the obtained cDNA codes for a functional protein. The first part of this goal is 
to test whether GATA clone-7 is translated into protein. Since the clone lacks a strong 
Kozak consensus sequence, according to the context ANNatgG (Kozak, 1996), there 
remains the slight possibility that cDNA does not represent an actual mRNA transcript.
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Fortunately, the sequence data does not fall into any of the three ‘warning signs’ 
categories summarised by Kozak (2000), these being:
1. The presence of multiple, upstieam ATG codons.
2. An upstream ATG codon with an open reading frame overlapping that of the 
putative main start codon.
3. A veiy weak context that lacks both of the flanking elements of a sti'ong context, (a 
pyrimidine residue at position -3, or purine at position +4)
The absence of a sti'ong Kozak consensus is unsuiprising, given that GATA-2 is a 
transcription factor and therefore, in common with many regulatory genes, present at 
low copy number (reviewed by Kozak, 1996). However, evidence for the translation of 
a protein product of the suitable size, either by in-vitro transcription or from transfected 
mammalian cells, would provide a greater degree of confidence in later functional 
studies using the pBK-CMV/GATA clone-7 construct. This work is covered in Chapter 
Five.
Also detailed in Chapter Five is the development of isoform-specific primers and 
probes for real-time RT-PCR, in order to investigate the expression patterns of the 
mRNA transcript on which GATA clone-7 is based. The characterised sequence data 
contains untranslated regions that should be sufficiently isoform-specific for this task.
Only a partial NFAT sequence has been recovered, identified as NFAT-2. The 
transcript is most probably orthologous to the human NFAT-2b splice variant, as is 
another NFAT-2b orthologue previously isolated by Miskin et al. (1998), from porcine 
macrophages. It is possible that there is a different set of NFAT-2 variants in the pig 
from those characterised in humans. The C-terminal domain of NFAT-2 a is 
significantly shorter than that of the two porcine NFAT-2 forms, while the NFAT-2c C- 
terminal region is longer with an additional transactivation domain (Serfling et a l, 
2000). However, with only one porcine NFAT-2 variant characterised, and NFAT 
clone-3 only partially so, the number and respective sizes of the NFAT-2 alternative 
splice forms in the pig remains unknown. That NFATmac and NFAT clone-3 should be 
different transcripts is unsurprising, given the differences in source tissue. This is 
consistent with the obseiwation by Sherman et a l (1999), that mouse NFAT-2 splice
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variants are distiibiited in a tissue-specific manner. However, the 5’ region of NFAT 
clone-3 would need to be isolated in order to determine whether it constitutes a novel 
splice form NFAT-2.
While the NFAT cloning was unsuccessful in the stated aim of acquiring a full-length 
clone, the sequence data obtained does allow for studies into expression patterns of the 
gene. The possession of the 3’ UTR allows for the radiolabelling of isoform-speciflc 
fragments for Northern blot hybridisation, or for the generation similarly isoform- 
specific primers and probes sets for real-time PCR. This work, together with that for 
GATA clone-7, is described in Chapter Five.
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C h a p t e r  F o u r  - P o r c in e  E m b r y o n ic  M y H C  
P r o m o t e r  R e g io n  C l o n in g
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4.1 In t r o d u c t io n
So far, the isolation and characterisation of GATA and NFAT transcription factors has 
been the major focus of the work. However, the project also included a study of one of 
the potential targets of these factors, the porcine embryonic myosin heavy chain 
(emMyHC). Prior to the beginning of the study, most of the porcine myosin heavy 
chain (MyHC) genes had already been eharacterised to some degree (Chang et a i, 
1993; Chang et a i, 1995; Chang and Fernandes, 1997). The embryonic form was one 
of the two isoforms yet uncharacterised, the other being the perinatal promoter region, 
since identified by Da Costa et al. (2000). It was decided that the cloning of the 
emMyHC regulatory region could prove useful in subsequent functional studies, as well 
as completing the information on the MyHC gene family in the pig. This work was part 
of a collaboration with Dr Yuh-Man Sun, at the Roslin Institute, Edinburgh, who 
provided much of the starting material for cloning the regulatory region of the porcine 
embiyonie MyHC. Although the sarcomeric MyHC genes have been briefly covered in 
Section 1.2.1.2 it is worth covering their genomic organisation and sequence homology 
in greater detail, particularly those properties that were exploited in the emMyHC PCR 
cloning on which the subsequent genomic cloning was based. Also covered here is the 
background for the cloning strategies used in isolating genomic sequence, through the 
screening of a library of Bacterial Artificial Chromosomes (BACs) containing large 
(average size of 150 kilobase-pairs) inserts.
4.1.1 M y H C  G e n o m ic  O r g a n is a t io n
The eight MyHC genes important in skeletal muscle are clustered in a linear, head-to- 
tail an'angement in two chromosome regions (Figure 4.1). The cluster arrangement is 
well conserved, and is found in both humans and rodents where it was first studied 
(Weiss and Leinwand, 1996; Weiss et a l,  1999a), and also in the pig (Sun et a l,  2003). 
The first cluster contains the fast 2a, 2b, 2x and extra-ocular MyHCs, and the 
embryonic and perinatal developmental isoforms. This cluster is located on 
chromosome 17 in humans (Leinwand et a l,  1983), and chromosome 12 in the pig 
(Davoli et a l, 1998). The genes encoding the 2a, 2x and 2b isoforms are quite tightly 
clustered together, with much smaller intergenic distances than those between
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A.
perie m CO2x/d 2 b
4.5 kb 9.0 kb
B. — ► — ►
slow/p a
3.6 kb
Figure 4.1. Organisation of MyHC genes (adapted from Weiss et a l, 1999a). At the 
time of writing, this cluster organisation is conserved in all of the mammalian species 
studied. The intergenic distances listed are from characterised human sequence. A. 
Skeletal muscle cluster. B. Cardiac muscle cluster.
the embryonic to 2a or 2b to perinatal, respectively. The gap between perinatal and 
extra-ocular is believed to be of a similar magnitude, but is as yet uncharacterised in the 
pig. The second cluster contains the a-cardiac MyHC and the type I/slow MyHC, also 
referred to as the (3-cardiac isoform, and is located on chromosome 14 in humans (Saez 
et a l, 1987) and on pig chromosome 7 (Davoli et a l, 1998).
4.1.1.1 Homologous Regions and Cloning Strategies
The MyHC genes share a conserved primary structure and intron/exon organisation 
(Weiss and Leinwand, 1996), first described by Strehler et a l (1986). The majority of 
MyHC genes are around 30 kb in length, containing 40 or 41 exons with the 
translational start site located in exon 3. All of these MyHC genes are highly conserved, 
though there is a greater degree of sequence identity between the same isoforms in 
different species, than in different isoforms from the same species (Weiss and 
Leinwand, 1996; Weiss et a l, 1999b). The short stretches of isoform specific sequence 
present a useful target for cloning sti'ategies intended to isolate the same MyHC 
isoform from different species. The ATP binding site in particular is highly isoform- 
specific, and this has already been exploited in PCR-cloning strategies used to isolate a
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number of porcine MyHC genes using sequence known from other species (Chang and 
Fernandes, 1996).
4.1.1.2 Isolation of the emMyHC 5’ UTR
The method described by Chang and Fernandes (1996) was used by Dr Yuh-Man Sun 
to screen a X cDNA library (see section 3.1.3.2). This libraiy was constincted using the 
ZAP Express cDNA synthesis kit (Stratagene) (Short et ah, 1988), using total mRNA 
from a 50 day old porcine foetus. The sequence of the longest clone isolated from the 
PCR cloning is shown in Figure 4.2. The 135 bp of 5’ untranslated sequence was 
isolated, and was received from Dr Yuh-Man Sun as the basis for the further work to 
isolate the emMyHC regulatoiy region, described in this chapter.
1 AGTCACAGTG CCGCTTGTGC GGGTCCTTCC CATCTGAGGC TCAGAGGCTC GTGTGGCCCT GCCCGGCTTT 
71 C^GTCTGATT TCTCACGGCT GCTGCTGTCT GCTGTCCTCT GCGGGTGTGA CTCTCAGCCG ACACC
135 ATG AGC AGC GAC ACT GAA ATG GAA GTG TTC GGC ATA GCC GCT CCC TTC CTC CGC AAG TCG1 M S S D T E M B V F G I A A P F L R K S
195 GAA AAG GAG AGG ATC GAG GCG CAG AAC CAG CCC TTC GAT GCC AAA ACC TAC TGC TTC GTG21 E K E R I E A Q N Q P F D A K T Y C F V
255 GTC GAC TCG AAG GAA GAG TAG GCC AAG GGG AAA ATT AAG AGC ACC CAG GAT GGG AAG GTC41 V D S K E E Y A K G K I K S T Q D G K V
315 ACG GTG GAG ACC GAA GAC AAC AGG ACC CTG GTG GTG AAG CCG GAG GAT GTG TAT GCC ATG61 T V E T E D N R T L V V K P E D V Y A M
375 AAC CCC CCC AAG TTT GAC CGG ATC GAG GAC ATG GCC AGT CTG ACG CAC CTG AAC GAG CCG81 N p P K F D R I E D M A S L T H L N E P
435 GCC GTG CTG TAG AAC CTC AAG GAC CGG TAG ACC TCC TGG ATG ATC TAT ACC TAC TCG GGC101 A V L Y N L K D R Y T S W M I Y T Y S G
495 CTC TTC TGT GTC ACC GTC AAC CCC TAG AAG TGG CTG CCG GTG TAC AAC CCC GAG GTG GTG121 L F C V T V N P Y K W L P V Y N P E V V
555 GAG GGC TAG CGA GGC AAA AAG CGC CAG GAG GCC CCG CCC CAC ATC TTC TCC ATC TCC GAC141 E G Y R G K K R Q E A P P H I F S I S D
615 AAC GCC TAT CAG TTC ATG CTG ACA GAT CGT GAA AAC CAG TCC ATT CTG ATC ACC GGA GAA161 N A Y Q F M L T D R E N Q S I L I T G E
675 TCC GGG GCG GGA NAC ACG GTG AAC ACC AAG CGT 707181 S G A G X T V N T K R
Figure 4.2. Previously isolated porcine emMyHC cDNA (Acc. N-; AJ309014). The 
first 135 bp of the cDNA fragment (underlined) was isolated for use as an isoform- 
specific probe. The 'V ’ denotes the inti'on/exon boundaiy for intron 1.
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4.1 .2  B A C  L ib r a r y  S c r e e n in g
The cloning of regulatory sequences presents different problems to the isolation of gene 
coding sequence, such as the strategies described in Chapter Tliree. The cDNA libraries 
described there represent only transcribed, mRNA sequence. Where the sequence to be 
cloned falls outside of transcribed sequence, or is lost as introns during niRNA splicing, 
a genomic library is required. To present the total genomic DNA of a mammalian target 
organism in a manageable number of clones requires far larger inserts than are possible 
with normal plasmid vectors. A number of alternative systems have been developed for 
this purpose, such as Vphage packaged cosmid vectors (Collins and Holm, 1978). 
Though larger than normal vectors, cosmids are still constrained by the amount of DNA 
that can be packaged in a phage head, with around 35 to 45 kb being the upper limit. 
Larger inserts are possible with Yeast Artificial Chromosomes (YACs) (Burke et al.  ^
1987), up to 1 megabase-pairs (Mb) or more (Larin et a l, 1991). However, Y AC 
systems suffer a high incidence of chimeric clones, in which the insert does not 
represent a contiguous DNA sequence (Anderson, 1993).
Bacterial artificial chromosome (BAC) systems (Shizuya et a l , 1992) are based on the 
F-factor in E. coll Replication of the F ’ episome is tightly controlled with only one or 
two copies present in any one cell, greatly reducing the possibility of recombination 
events between inserts. In addition to its suitability for cloning large inserts, the F 
factor’s circular, supercoiled structure makes it more amenable to manipulation than 
linear YAC constructs that can easily shear. The bacterial host can be grown, 
transformed and screened tlirough colony lift far more conveniently than yeast cells. 
BAC libraries are therefore the method of choice for performing large insert screening, 
and were used in the embryonic MyHC promoter region described here.
4.1.3 A im s
The aim of the work described in this chapter was to isolate the porcine emMyHC 
regulatory domain, in order to further characterise the MyHC gene family in the pig. 
The work was based on the 135 bp fragment already isolated, using it as a radiolabelled 
probe to screen a BAC library. As a long-term aim, knowledge of the upstream 
regulatory elements of emMyHC would be vital for determining whether emMyHC 
was a target for the GATA and NFAT transcription factors investigated in the course of
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the study. The genomic sequence obtained was used to generate a number of emMyHC- 
promoter driven reporter constructs. These constructs were later used to characterise the 
effect of GATA-2 activity on emMyHC expression.
4.2 . M a t e r ia l s  a n d  M e t h o d s
4.2.1 B A C  L ib r a r y  S c r e e n in g
The Porcine Bacterial Artificial Chromosome (PigE BAC) library used was provided 
by the UK HGMP resource centre, constructed by Anderson et a l (2000). The library 
was filter screened and clones identified as described in the suppliers protocols, 
summarised briefly here. The library physically consists of around 102,000 clones in 
microtitre plates. These were grown up overnight in chloramphenicol selection, spotted 
in 4 X 4 arrays on Hybond N nylon membranes. The filters are subsequently processed 
as for colony lift, with SDS, dénaturation and neutralisation treatments followed by 
UV-crosslinking, supplied ready for pre-hybridisation.
4.2.1.1 BAC Clone Identification
The 135 bp emMyHC 5’ UTR fragment was labelled by the random hexamer method 
(see 2.2.4.1.1). As a test for isoform specificity, the labelled probe was used to probe a 
genomic southern blot. Genomic DNA was prepared from porcine liver tissue, and the 
blots prepared as described in Section 2.2.4.2.3. Once satisfied that there was a low risk 
of isolating different isoforms, the probe was hybridised with the BAC library filters. 
Hybridisation and autoradiography was as described in Section 2.2.4.2.2, using ‘home­
made’ rather than commercial buffer due to the requirement for increased specificity 
and lower background. Once identified, the clones themselves were ordered from the 
UK HGMP resource centre, supplied on agar slope cultures containing 
chloramphenicol. Clones were streaked out on LB agar plates, maintaining selection 
pressure with chloramphenicol. Single colonies were picked, as required, to create 
further glycerol stocks for storage or grown up in culture to isolate BAC preparations.
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4.2.1.2 BAC DNA Preparations
The main complication in obtaining BAC preparations from E. coli culture is the large 
size of the insert, requiring a modification of the standard plasmid preparation methods 
described in Section 2.2.1.2. A modified version of the Qiagen plasmid midi kit 
protocol was used, summarised as follows. Single BAC colonies were picked from the 
overnight agar cultures, and used to inoculate a 5 ml LB starter culture, supplemented 
with chloramphenicol. The following morning, 0.5 ml of the starter culture was used to 
inoculate 100 ml LB, grown at 37 °C for 14 hours with vigorous shaking (approx. 250 
rpm in an orbital shaker). The cells were divided into two 50 ml falcon tubes and 
pelleted at 4,500 x g for 20 min. Bacterial pellets were resuspended, lysed, and proteins 
precipitated by the addition of 10 ml buffers PI, P2 and P3, respectively (as described 
for large scale plasmid preps, section 2.2.1.2.2). Following the addition of buffer P3, 
the suspension was chilled on ice for 15 min, centrifuged at 20,000 x g for 30 min at 4 
°C. The supernatant was removed and filtered through a cell-strainer. During the spin, a 
Qiagen-tip 100 was equilibrated by applying 4 ml of Buffer QBT and allowing to drain. 
Supernatant from the centrifugation step was pooled and decanted into the Qiagen-tip, 
and washed twice with 10 ml Buffer QC. The DNA was eluted with 5 ml of Buffer QF, 
pre-warmed to 65 °C. DNA was precipitated by the addition of 3.5 ml isopropanol, 
centrifuging at 15,000 x g for 30 min, 4 °C. Supernatant was removed and the pellet 
washed with 70 % ethanol, spun as before for 10 min, the ethanol removed and the 
pellet air dried. The final pellet was resuspended in 10 mM Tris (pH 8.5).
4.2 .2  C l o n in g  e m M y H C  R e p o r t e r  C o n st r u c t s
The BAC clone was used as the basis of a number of cloning strategies, designed to 
create a number of reporter constructs from the emMyHC promoter region. These 
constructs were to be used in testing the effect of trans-^cXmg factors, such as the 
GATA and NFAT family members, on emMyHC expression. The basis of this strategy 
was the pEGFP-1 vector (Clontech), with the promoter fragments driving the 
expression of enhanced green fluorescent protein (EGFP). A number of approaches 
were used to acquire and clone fragments of regulatory sequence upstream of the 
emMyHC coding region.
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4.2.2.1 Genome Walking
The first approach used was genome walking, a method of obtaining unknown 
sequence from genomic DNA, based on short regions of known sequence. This work 
was carried out by Dr Yuh-Man Sun, using the GenomeWalker^^ kit (Clontech) 
according to the manufacturer’s protocols briefly summarised here. The BAC clone 
was subjected to blunt-end digestion, and the resulting fragments ligated at either end 
with the GenomeWalker^^ adapter fragments. Long range PCR was canied out, using 
sense primers based on adapter-specific sequence, and gene-specific, reverse primers 
based on known sequence, in this case the 135 bp of untranslated sequence. PCR 
products were cloned using the Blunt-ended PCR Cloning Kit (Amersham 
Biosciences), into the pMOS-blue vector.
4.2.2.2 PCR Cloning
PCR cloning was carried out to amplify part of the promoter region immediately 
upstream of the emMyHC gene. The sense primer was based on the 5’ sequence of a
0.25 kb, BamRl sub-clone of the GenomeWalker™ PCR fragment (see Section 4.3.2), 
containing the BamRl site. The anti-sense primer was based around sequence from 
exon 1, with an engineered Agel site to allow for later cloning into the pEGFP reporter 
vector. The primers are shown below, with the restriction sites underlined.
Sense Primer
5 '  TAG GAT CCT GTC ATT TCT ATA TAT 3 '  T m 5 8 .9 °C  
Anti-sense Primer
5 '  AAA CCG GTG GAG CCG GAG AAG GGG GAG TGT 3 ' Tm 74.8 ""C
PCR conditions were as follows; dénaturation for 3 min at 95 °C, followed by 35 cycles 
of a 45 second, 95 °C dénaturation step, 45 seconds annealing at 55 °C and a 45 second 
extension step at 72 °C. This was followed by a final 5 min extension step, before 
holding at 4 ‘^ C. PCR products were purified and cloned into the TopoTA vector 
(2 .2 . 1.6 .2).
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4.2.2.3 Southern Blot Screening
The BAC clone was subjected to restriction endonuclease digestion, the resulting 
fragments separated by gel electrophoresis (Section 2.2,1.4.1) and transferred to nitro­
cellulose filter by Southern blot (Section 2.2.4.2). The filter was screened using a PCR 
fragment obtained from the genome walking, the 1.6 kb fragment described in Section
4.3.2. This fragment was radiolabelled using the random hexamer method (Section
2.2.4.1.1), with probe hybridisation and autoradiography as described in Section
2.2.4.2.2. Restriction fragments positively identified by this screening process were run 
out again on agarose gel, excised and cloned into E. coli, using the methods described 
in Section 2.2.1,
4.2.2.4 Cloning into the pEGFP-1 Vector
PCR products and restriction fragments obtained from the promoter region cloning 
were ligated into appropriately digested and calf alkaline phosphatase treated pEGFP-1 
vector, using the protocols described in Section 2.2.1.5. Constructs were transformed 
into E. coli (Section 2.2.1.6) and prepared by large scale plasmid preparation (Section
2 .2 .1.2 .2).
4.2.3 LI-COR S e q u e n c in g
Sequence data for the emMyHC promoter region was obtained using the LI-COR large- 
gel, automated sequencing system (LI-COR). The sequencing reaction was based on 
the chain-teimination method (Sanger et a l, 1977), with the cycle-sequencing 
modifications described by Innis et a l (1988), using the Amersham Thermo Sequenase 
kit (Amersham Bioscience). Manufacturer’s protocols were followed, summarised as 
follows:
4.2.3.1 Cycle Sequencing
The plasmid templates for cycle sequencing were prepared by miniprep (section 
2.2.1.2.1). Custom oligonucleotides were supplied by MWG biotech, designed as 
described in section 2.2.3.1. For the Li-Cor work, the sequencing primers were based 
on T3 or T7 RNA polymerase promoter sites located on the cloning vectors.
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T3
5 '  ATT AAC CCT CAC TAA AG 3 '
T7
5 , TAA TAG GAG TGA GTA TAG GG 3 '
The cycle-sequencing reaction mixtures (four per DNA template) consisted of the 
appropriate Amersham reagent mixture (Applied Biosystems) and nucleotide (A,C,G or 
T), together with 200 to 500 ng of DNA template and 1 pmol sequencing primer, made 
up to 8 pi with Millipore-pure water. Cycle sequencing was carried out in a thermal 
cycler (Perkin Elmer), using the following program: a denaturing step at 95 °C for 5 
min, followed by 25 cycles of 30 s dénaturation at 95 ^C, 30 s annealing at 55 °C and 
30 s extension at 72 °C, with a final hold at 4 °C. The reactions were teiminated by the 
addition of 4 pi stop solution. Reaction products were stored at 4 °C until loading, 
which was carried out on the same day.
4.2.3.2 Large Gel Electrophoresis
The gel mixture was prepared (4% Gel Mix concentiate; National Diagnostic, 0.28 M 
Urea in 1.2 x TBE buffer), mixed well and chilled at 4 °C. The 66 cm glass plates were 
washed once with 100% ethanol, polished until dry, and once with isopropanol, again 
polishing until the surfaces of the plate were dry and completely free of dust, paying 
particular attention to the comb area and the base region read by the scanner. Bind 
silane (3-Methacryloxypropyltrimethoxysilane) was applied to the notched plate, using 
a mixture of 0.5% bind silane, 0.3% acetic acid in ethanol, spread across the comb area 
and gel base and allowing to dry. The glass plates were washed again with isopropanol, 
taking care to avoid the regions coated with bind silane. Gel plates were aligned 
together, with 0.2 mm spacers along each side, taking care to ensure coinect alignment. 
The side brackets clamped on, tight enough for a good seal but while avoiding cracking 
the plates. The gel plates were placed in the gel pouring stand, and the gel mixture 
retrieved from the fridge. Ammonium persulphate (APS) was added, 400 pi of a 10% 
stock, and a 4 ml aliquot taken for a base plug, the remainder returned to 4 °C. A 
further 40 pi 10% APS and 4 pi tetramethyl-1 -,2-diaminomethane (TEMED) was
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added to the 4 ml aliquot, which was then pipetted into the base of the gel and left to 
polymerise for 10 minutes. The remaining gel mix was prepared, adding 40 pi TEMED 
and syringed between the glass plates, taking care to avoid the presence of air bubbles. 
The well foimer was placed in the top of the gel and clamped in place with ‘bulldog’ 
clips, and the gel left semi-horizontal to polymerise for 1 hour.
The gel was read in a Li-Cor model 4000L automated sequencer. The well-former was 
removed, and the large well flushed. The assembled gel apparatus was cleaned a final 
time to remove any dried-on gel, and dried thoroughly to prevent electrical leakage. 
The gel apparatus was mounted in the scanner, the upper and lower gel tanks fitted and 
filled with 1 X TBE. A 48-well ‘shark-tooth’ comb was carefully inserted in the top of 
the gel to form the wells, and 1.5 pi of reaction mixPire loaded per well. The gel was 
run ovemight at 2000 V. Sequence data was collected automatically, after manually 
defining the lanes. Base ambiguities were checked by visual inspection of the gel 
image.
4.2.4 A B I S e q u e n c in g
Later in the project, sequencing using the ABI PRISM became available (Applied 
Biosystems). ABI sequencing was used for obtaining 5’ sequence data further 5’ fiom 
the promoter region PCR clone. A sequencing primer was designed, based on the 
sequence data obtained from the PCR clone.
5’ sequencing primer
5 '  CAC AAG TGA GGA CCA GCT CC 3 '
The methods used were as described in Section 2.2.3, for the Version 1.0 chemistry 
(Section 2.2.3.2.1).
4.2.5 S e q u e n c e  A n a ly s i s
Analysis of sequence data for both Li-Cor and ABI systems was carried out as 
described in Section 2.2.3.3. In addition, the deduced genomic sequence was analysed 
for the presence of possible transcription factor binding sites, using both Matlnspector 
version 2.2 (Genomatix Software) and Match™ version 1.0 software (Biobase)
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4.3  R e s u l t s
4.3.1 B A C  L ib r a r y  Sc r e e n in g
As discussed in Section 4.1.1, there is a high degi'ee of homology between different 
skeletal muscle MyHC genes. There remained the possibility that a probe derived from 
the 5’ untranslated region (UTR) of the emMyHC gene, which might be expected to be 
isoform specific in other, less homologous gene families, might hybridise to different 
MyHC isoforms. However, screening a genomic Southern blot using the labelled 135 
bp probe yielded only single bands for each of the enzymatic digests (Figure 4.3A), 
strongly suggesting that the probe was isoform specific. Screening the BAC filter using 
this 135 bp probe yielded one positive clone, subsequently obtained from the UK HMG 
centre.
4.3 .2  P r o m o t e r  R e g io n  C l o n in g
A total of three promoter constructs were obtained for the porcine emMyHC gene. A 
map showing their relationship to gene and the BatriBl sites that were used in their 
cloning is shown in Figure 4.4. Long-range PCR using the GenomeWalker™ kit 
yielded a 1.6 kb fragment, subsequently cloned into the pMOS-blue vector (Amersham- 
Pharmacia). The fragment was excised from the pMOS-blue vector using flanking 
i/mDIII and EcoBl sites present in the vector. This allowed the fragment to be re­
ligated into the corresponding sites on the pEGFP vector, in the sense orientation.
The 1.6 kb fragment was found to have an internal BamYH site, used to generate a sub­
clone with a smaller 0.25 kb insert. Initial sequence characterisation showed that this 
sub-clone contained the region immediately 5’ of the emMyHC gene. In order to clone 
this region into the pEGFP vector, the region was amplified by PCR, with the anti sense 
primer modified to engineer an Agel site into the 3’ end of the resulting PCR product. 
The pEGFP BamlAl and Agel sites were then used to insert the 0.25 kb PCR product in 
the correct orientation.
Screening the digested BAC DNA with the 1.6 kb fragment identified a positive BamlAl 
fragment, of approximately 5 kb in length (Figure 4.3B). This fragment was
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A. B.
M
Æ:coR1 M«DII1 Xba\ BamH\
Æ'coRI HinD\\\ 
Pst\ BamVW
>12.0 kb
9.0 kb
13.0 kb
5.0 kb
3.0 kb
2.5 kb
[.3 kb
Figure 4.3. Southern Blots from the BAC library screening. A. Genomic Southern blot 
screened with the 135 bp fragment cDNA probe from the emMyHC 5’ UTR, showing 
single isoform specificity (M, marker lane). B. Digest of BAC clone 36:L7 screened 
with the 1.6 kb GenomeWalker™ fragment. The 5 kb BamYil fragment was isolated for 
generating the third EGFP reporter construct.
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(-178)
Bam\\\ BamHlI A T G (+ 1)
(-5300) (-318),
emMyHC CDS
Exon 1
1.6 kb PCR fragment
0.25 kb sub-clone ■I
-5 kb /A /wlll fraiimcnt
Figure 4.4. BamHl restriction map of the three promoter region fragments used in the 
construction of reporter constructs.
immediately upstream of the 0.25 kb sub-clone containing the TATA box. To create a 
functional promoter construct, the 5 kb fragment was cloned into the BamHl site of the 
pEGFP/0.25 kb clone (Figure 4.5). The orientation of the insert was checked by 
sequencing, using the vector T7 promoter site. A summary of the three EGFP clones is 
shown in Figure 4.5.
4.3.3 S e q u e n c in g
The initial sequencing upstream of exon 1 was carried out on the 0.25 kb promoter sub­
clone. This sequence data was used to design a primer for subsequent sequencing 
further upstream using the BAC clone as a template. The furthest data 5’ of the 
emMyHC coding regions was obtained from the pEGFP/5.25 kb clone, once it became 
available. This data was acquired in successive reactions, beginning with primers 
derived from vector sequence and continuing with oligomers based on generated 
sequence data. Finally, intron 1 was sequenced from a sub-clone created by PCR 
cloning using primers derived from the flanking exons and using the BAC clone as a 
template. This clone was kindly provided by Dr Yuh-Man Sun. The compiled sequence 
is shown in Figure 4.6. Part of this sequence was submitted to GenBank with the 
Accession Number AJ309014.
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A. ///«Dili BamHl
31 CTCGAGCTCK AGCTT|c1GAAT TCfTGCAGTCG ACGGTACCGC GGGCCCG|GGA TCC|ACCGGT|C 90
£coRI Agel
B. HinDXW
B am \\\— Agel
L  EGFPInsert Insert
pEGFP/pEGFP/ 
1.6 kb
EGFP
pEGFP/ 
5.25 kb Insert
EGFP
Agel
BamHl
Figure 4.5. Cloning strategies used to generate the pEGFP-1/emMyHC reporter 
constructs. A. Multiple cloning site of the pEGFP-1 vector (Clontech), highlighting the 
restriction sites used in the cloning. B. Restriction maps of the three reporter constructs. 
Restriction sites used in each cloning step are shown in blue.
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Transcription Factor Position Strand
GATA-2 -4046 -
MEF-2 -3938 -
GATA-3 -3792 -
MyfS -3388 +
MyoD -338S +
GATA-3 -3271 +
GATA-1 -3073 -
MyfS -2840 +
MyfS -2769 -
MEF-2 -24S2 +
NFAT -2012 -
NFAT -1674 +
MEF-2 -1171 +
MEF-2 -7S6 -
MyfS -6S4 +
MyoD -6S1 +
Table 4.1. Putative transcription factor binding sites of interest found in the 5’ UTR 
sequence of the porcine eniMyHC.
The promoter sequence was compared with the emMyHC promoters from hamster and 
rat (Acc. N“S X56207 and X04267, respectively); this sequence comparison is shown in 
Figure 4.7. A high degree of homology was observed in the immediate 250 bp of the 
promoter regions. Through sequence comparisons, it became apparent that the 
translation start-site for the porcine emMyHC was located in exon 2, instead of 3, 
unlike all previously reported mammalian MyHC genes.
Comparisons with other species, and analysis with the Match^^ and Matlnspector 
software gave a deduced TATA box at 51 bp upstream of the transcription start site 
(position -51). A number of binding sites for MEF-2 and members of the MRF family 
were found, as summarised in Table 4.1. Of these two families, the consensus sites for 
MEF-2 are the more likely candidates for regulation of emMyHC activity. MEF-2 was 
first shown to interact with MyHC regulatoiy regions in studies on the a-MyHC 
promoter (Adolph et a l 1993; Molkentin and Markham, 1993). For the MRFs, 
however, the consensus has long been that there is no direct interaction between family 
members and MyHC regulatory elements (Weiss and Leinwand, 1996). More recent 
research, such as that by Wheeler et a l (1999) on the role of MRFs in control of MyHC 
2b, suggest that there is some direct interaction, so a role for the MRF-binding sittes 
found in emMyHC is this study cannot be entirely ruled out.
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Of particular interest to this study, however, was whether any GATA or NFAT binding 
sites were present in the emMyHC regulatory region. One putative consensus binding 
site was located for GATA-2, and two NFAT sites. Three other GATA binding sites for 
other family members were also found: one for GATA-1 and two for GATA-3. The 
GATA-2 site was located in the more distal sequence, approximately 4 kb upstream of 
the transcription start site (position -4046). This places the site in sequence unique to 
the larger pEGFP/5.25 kb reporter construct. The more distal of the NFAT sites 
(position -2012) is also unique to pEGFP/5.25. It is more difficult to acertain whether 
the second NFAT binding site (position -1674) is present on the pEGFP/1.6 kb 
construct without acquiring similar sequence data for this construct.
4.3.2.1 Problems with LI-COR
The LICOR system was only used for the earlier rounds of emMyHC regulatoiy region 
sequencing. The gel-based LI-COR sequencing method was abandoned in favour of 
ABI PRISM automated sequencing. There were a number of reasons for the change:
1. Four separate reactions were required per sequencing template, compared to just a 
single sequencing reaction required for the ABI system. Since just one failed 
reaction or gel-loading error out of these four could render an entire sequence 
worthless.
2. The pouring of the large-scale polyacrylamide gel presented numerous technical 
difficulties over the capillary system used by the ABI 310 and 3100 sequencers. 
The large, optical glass plates proved Ifagile, and easily cracked or broken. Minor 
imperfections, such as dust particles, pieces of old gel, etc could cause major errors 
in the laser-reading of the fiuorescently labelled sequencing products.
3. The set-up of the gel and running buffer was also a source of complications, with 
the smallest of imperfections in the seal around the upper buffer tank sufficient to 
cause electrical leakage and halt the run (most often only discovered the following 
morning).
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1 OOATCCGAGC CGCATCTGCA ACCTACACCA CAGCTCACGG CAACGTCGGA TCGTTAACCC
61 ACTGAGCAAG GCCAGGGATC GAACCCACAA CCTCATGGTT CCTAGTCGGA TTCGTTAACC
121 ACTGTGCCAC AACGAGAACT CCTGGCAGTT GACTTTTAGC AAATGCTTTT TCTGTATTTA
181 TTGAAATGAT CATGTGGTTT TTGTCTTTTG TTGACATGTG ATTTGTGTGT GTTGAACTGT
241 ACTTGTGATC CTAGGATGAA TCCAACTTGA TCATGGCGTA TGTGGTGTTG GATTTGATTT
301 GCTAATACTT TGTTAAGGAT TTTTGCATCT ATATTCATCA AAGATATTGG CCCACAGTTT
361 TCTTTTGGTG TGTCTTTGTC TGGTTTTGGG ATCAGGGTGA CGGTGGCTTC ATGGAATGAC
421 TTTGGGAGTG TTCCCTCTTC TTCAGTCTTT TGGAAGAGTT TGAGAAGGAC CAGTATAATT
481 CTTTCTTCCT CAGGGAAGCT GTCCTGGACT TTTGTTTGCA GGGAGTTTTT TGTTGTTGTA
541 TGTTTTATTA CAGACTCTAT TTCACTTCTG ATGATTGGTT GGTCTGTTCA TGTTATCTAT
601 TTCTTCTTAA TTGAGTTTTG GCAGGATGTA TATTTCTAGA AAGTTGTCCA TTTCTTCTAA
661 TCATCCGTCC TGTTGGCATG TAATTGTTCA CAGTATTCTC TTATGATTTT TTTATATTTC
721 TGCAGTGTTG GCTGTTATTT CTCCTCTTTC ATTCCTTATT TTGTTTATTT GGGTCCCCTT
781 TCTTGAAAAG CACAACTTTA AATGAAAATC CAGTGTTACC CTTCAATTTT AAGGTTAAGG
841 CTTAAATCTT CATCCACCAC CATGGCTCCA GTTGGCCACA GAGCTGTCTG TTCTCCATCC
901 CCTCCCTGTG GTGACCCCCT GGTGACCTTT GGCCTTTACC TTCCACAGCC TCATGCCCAT
961 GGCAGACTGA TCTGCTTGCC TCCTTCTCGA TGGCATTGTT CAGAGGCGTG CATTACTCTT
1021 CATTCCTGTC CCCAAATCCC CTGGCAGGGC CCTGGGCCAT GCCTGCCCTT TAGAGCCTTC
1081 TTTCCCTTGG AATGCCCGTC TTGTCCCTTC CCTCTCCGAG CATTCTTCCC CGCTTCAGTC
1141 ATGTCGCTCC ATGCTCCCAA CCACAAGGGC CCATCAATCT TCTGAATCAC AGGCCGACGA
1201 GGGACAGCAG CCACAGCCGC CCCACCCCAG GTAAGGGACT GACTCCGCTT TGCCAGCAGC
1261 TGTGTCTCCA GCCTTCTCTC GCTCGCATCT CTAGTCCTGT CCGCTGGCCT TCAGTGTGTG
1321 TGGAATCCTC TCTTCACCTG CTCACGTTCT GGCACCAGCT CGCTACAGAT TTCACGTACA
1381 GATTGAGGCT GGACGTTTTC AAGAAGTTTG CTCTGACATC ACGAACTTGT GGCTCCCGTC
1441 GTAATTCCGG AACCACCCAC TCCCCAGACT GCTCGCGTGT AGACAGCGTG GTGGTTCGCA
1501 GCGTGGCTCT GACATCAAAT TCAAGTGCCT CATAATCCTG GATGGTTAGT ACCACACCAT
1561 GTGCTTATCT AAGTGTATCT CCACAGCGTC CGTAGTAGAA ATTGGGGAAA GTGGATGTTT
1621 GTTACAGGAG AGTTGTGAGC ACGCTCTAAT TTCTACCTGG GGCTCTGAGC ACTGGTTCAG
1681 GACACCCCAC CCTTGGCCTC AGGCTGGGAA TGGTCTTGGC TCAGAATAAC CAGGCTCCCC
1741 ACTTGCAGTG ACACCTAATC CCCCTTGAGC GGGACGTGGA GAAGGCCCTT GATCCCAGAG
1801 GCATCTGCTG CGAGGCTGAC TTCATGCCCT GGCAGAGGGC AGGGCTGCAG AACTCAGGGT
1861 CCACATGCGG AATGGAGGCA GATGGCACAG GAGGAAGCTC AGGCTCCAGG AGGGGCCCAG
1921 CTGTGCTCTG GTCAGCGCCT CCCGAGCTGC TCGCATTCTT GAGACAAATC GTTTTCTTCC
1981 AGCATATCCG GGAGTAAAGG TGGCTCTCTG TCCAGGCCTG GGGGTCAGCT CTAGATGGGT
2041 GATGGCCGAG AGAACAGGGC TCCTCCTCTT CCTGGAAGGC TGGCTACTAA CACCCTGGGA
2101 AGTCGTTCTG CTCATCAGAG GAGTCCCACA CCAGCTGGCC CAAAAGCTGC CTGTTTAAGC
2161 ACCAAGAGGT TCTCTTCTTT GGATGTAAAT CTTTCTAAAA AATACATATA TATTTCTTTC
2221 TGCCTCCTCA GGTCAATAAA ACCAGTGTCC AATGTGATGT ACTCAATGCC ATCAAGAGGA
2281 CCAGTCGTAG TGGGCAGCAA CACACAGAAG CAAGCCTTCA GTCTCCAGCG AGCTACATGC
2341 AGCACCAGGC ACAGCGTGCC TGACATAATA TCCAGCCGAA TGCACGTAGC TGGTCTGCCA
2401 GGCAGCTCTA TCACCCCCAT TTTACAGATG AGAAAACAGA GGCTCAGAGA AGTTAGGTGC
2461 ACTGCCAGCC ATCACACGGT AGCGAGAGTG AGCGCCAGGT CCACAGCCGG GCCCGTCTGG
2521 CCCGACGCAC CACAGCCTTC AGGCTGCAGT TCCCACCGCC CCTCCCTCCT TATGGGTGTT
2581 TTCCGGGCGA CCTTGCTTCC GGATTCTTGA CCTCCGGTTT TACGGCTGTT TCCTATGTGG
2641 TGGTTATTGC CGCTGCTTCC ACCCTCAGGG TTCTCCTGGC GAGCGGAGCT CCCTGCCTAA
2701 CTCGGACCCT CGTTCCATGG CCCGGGCAGG CTTCTTCCCC TCGTGCCTTC CAGCCCCTCA
2761 TGTGCAGAAG CAGGCCGTCA GGCAGATGAC CCGAGACCTC CCAGCCGAGC CTCTGTGCTC
2821 GTGGAGGACG TGTGACGGAG AGAAGGAAGA CAGGCCGGCT GACGGGGGAA AAGCTGGGGT
2881 GGGAGGCCGT CAGCCTTGAG CTCGCCTTGG GCTCAGGGAT GCGACGTGGC TTCACGCTTG
2941 ACAAGAAGCT CAAAGAAATC CTGTGTOGAA AACGTCCTCT CGGTGTCCCG GAGGTGGGAT
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3001 GGATGTGGTT GTGCAGAGGT GGGTGAACCA GCGCCAACTA AAGGTCAAAA GCAAGCCGGC
3061 CTCAACCGCG GCCCCTGGTG TTTAAGAAGG GACCGCCAGC ACCCTTCCCC TGACCACCCA
3121 GCACACGTTA CAGCCTGAGA CGTAGCCAGG GCCCCTGCAC TGTCCCTCAG CCCCAGGGGG
3181 CTTGCTAACA CCTCTGCTTC CAGGTGACAT GCACCTGTCC TCACCAGGCC TCCCAGGATG
3241 GCTGGCCAAT GGCGCAGAGA GTCAGGCCGG CGCGTCCCTG GGCAGGGAGA CCACGCCCCT
3301 TCAGGACCGG AGGGTCCTTG AGGAGGGTCG AGCTCTCTTC TTGGACGAGG AGGATTTCTG
3361 GGGGAGGGGG TTTCAGTCCC AGCGGCGGGG GTGGGCGGTG GGGCGTGACA TGTAGCATGG
3421 CAGGTCCATG CTTCCTGACT TTCCTCCTGA TGGCCACTTG CCTACCTGCC TTGATCTAAA
3481 AATCACCAAA ATCTCAGACG TAATCGAGTC ACCATTTATC CAAGAAACTA TCGAGGGTAA
3541 AGCCGCAGCT TCCATTTCTT TTGATTCTTC TTCCAGGGTT CTGCCTTGGG CCCAGCATGC
3601 AGTGGGTGTT TAATTAATGC CCCTGCCCCT CAGGGACTGC AGCCCCACTC CCCCTGCCCC
3661 ACCCCCAGCC CTTAGAGTGG CCTCCTGGCC CGCGCTGCGT GTGGCTATGC TGGGAGGGGG
3721 CCGTTCTTAT TCTCCAGTGG GGACGGCTGA CACCAGAATG AACGACAACG GGTTACCCAC
3781 AGGCCACGCT CCCAACGGTC TGTCAGGGAA AAAAAGGGAA AAACAGACAT AAAGTGGAAT
3841 AAGAATGGGC AAACGCTTCA GCCATACCCC TCTGTGCTCC TAAGGCTTTA TTTTTCTAAC
3901 CCTGATTTAG AAACAGCCAT GCTCGTTAGA CGCCCCCTCA CCCCCCTTTC TCTGCAGGCC
3961 CTGCCATCCC CCCACCCCCG CCCCGGCCAG CAGCTGGTCT TTCCTAATTG GTGACATGTC
4021 TTAATAACTA CAGGTCCTTG AGCAGCTGTC ACTGTGGCTC CTGGCTGGTG GGCTACCTCC
4081 CTCTCAGTCA TTTACTCGTT GGTCCTACTG GCGCTTAAGA CAGAGGTTTA GTTAATGACG
4141 ATCCTAATAA TACAGCAGGA GGACTGCTGT TGTTCCCCCA CAAGTTGTAC AATCACACAT
4201 TCCTGCCACA ACCCTGTGTT GTAACAAAAG CCTTGCTCAA AACTCCAAGA GGATTTAAAC
4261 TTTTCCGTCC TTGGCTTCAT CCCTTTGCCC ACAGGCCGAG ATTCTAGGTC CCCGCTGTCC
4321 CAGAGACCAG GCTCATCTCC AAGCCGTGTG GCGCCTGTGG GATGGAGCGA GGGCCCCCGG
4381 CAAGGCTGTC CCATCACTGA GCCGCCGGTT CAGAGAAAGG CATCCCAAAC TTCCAGCTTT
4441 CTCCAGCTAO GATCCTGTCA TTTCTATATA TACCTCTCTC TTGGCAGCGG CAAAAAAAAG
4501 TGAGGAAGGA GCTGGTCCTC ACTTGTGGTG TCGGTCACTC TCTTTCCAAA TATAGAGAAG
4561 GAATGAGTGG CGGGGGTTAG CAGGGGCfrAT AAAA|g CCCGC GGGGAGCGCC CCTTGTAGCT
4621 GCTCTGTGGG CGGAGGAGAG TCACAGTGCC CCTTGTGCGG GTCCTTCCCA TCTGAGGCTC exon 1
4681 AGAGGCTCGT GTGGCCCTGC CCGGCTTTGG TAAGGACCAG ACGTGCGGCT GATTTTCAGC
4741 CCCTCCCCGC CTCCAGCATC CCGCTTCCTT CGCCTGTTCT CCCCCGTCCT CATCCTCCAG
4801 AGCCCTCTTG GGCAGGGTCC CTGCGGATGC TCTGTGGACC ACTGCCCGTC ACCCGGCCCA
4861 TGAACGCTGC CACCTCTCTG ACTTGTACAG AGGCCAGTGG GCCTGGCCGC CTCCCCACCT
4921 GCGCTGCGGG CCTGCGGTGT CTGTCCTCTA AGGCCACGCT GGCTGTGCAT CCGTCGGCTT
4981 GTCTGAGATT CACCCTGCCT GGCCACAGAA GACAGGGGCC TGGCCCTGGC TTGTAGGCAC
5041 AGGCTTTTCA AACAGAGCTT TTGTCCTGAC TGCTCACCTC TGAGGAGGAG GCACGGCAGA
5101 CAGAGGGTGG TGCCACCCGG GCAGGAGGGA GCCAGGTCTG GGGCGGCTGG GGGCTCTCCT
5161 GCCTTCAGGG CTCACCTGTG GGCCAGGTCC CATTTGCTCC TCCAGCTTGT CTCTGGGCCA
5221 AGGCTCCTTT AAAGTTATTC GTCCTTTCTC TTCATTAGAG AAAATTGATT AGGCCCATTC
5281 AGAACTGAAC CAGACACTCC CACGTCTCCT GACCTTTTGT GTATTTATTG CAGGTCTGAT exon 25341 TTCTCACGGC TGCTGCTGTC TGCTGTCCTC CTGCGGGTGT GACTCTCAGC CGACACCATG
Translation start
Figure 4.6. Genomic sequence 5’ of the porcine emMyHC coding region, including 
exons 1 and 2 (Acc. N- AJ309014). Sequences used for primer design, for amplification 
of the promoter region and for upstream sequencing are underlined. Exonic sequences 
are highlighted yellow, and the TATA box outlined. The GATA-2 and NFAT 
consensus binding sites are shown in green, BamWl sites in blue.
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Figure 4.7. Multiple alignments of the immediate emMyHC promoter regions of 
hamster, rat and pig, showing the high degree of homology (black shaded sequence) in 
the proximal 250 bp (Hamster and rat Acc. N~s X56207 and X04267, respectively).
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4 .4 . D is c u s s io n
The porcine emMyHC gene is the last of the major skeletal muscle isoforms to be 
characterised in the pig. As such, the isolation and sequencing of the 5’ regulatory 
region of this gene is among the final pieces in describing the porcine sarcomeric 
MyHC family. The findings described here were predictable, in that a high degree of 
sequence identity was observed between the porcine emMyHC regulatory domain, and 
previously isolated orthologues. However, the presence of the transcriptional start site 
on exon 2 is a novel finding not previously characterised in any other MyHC isoforms, 
which have start sites in exon 3 (Weiss and Leinwand, 1996). This feature has since 
been observed in the human orthologue, following the complete characterisation of 
human genomic data, and similarly in the chimpanzee (Ensemble genes; 
ENSGOOOOO109063 and ENSPTRG00000008773 respectively). At the time of writing, 
human, chimpanzee and porcine emMyHC genes are the only MyHC genes known to 
have a start of translation on exon 2, though the functional significance of the 
difference is unknown. It is likely that other emMyHC orthologues may be found to 
have a similar gene structure.
The emMyHC isoform is characteristic of a specific stage in development, both in 
embryonic myogenesis and in the early stages of muscle regeneration. Since GATA-2 
is known to be involved in muscle hypertrophy, it is possible that emMyHC might be a 
target for this transcription factor. This hypothesis is supported by the presence of a 
consensus GATA-2 binding site within the 5" regulatory region. One way to test this 
further would be to make use of the three emMyHC reporter constructs in conjunction 
with the GATA-2 clone described in Chapter Three. If GATA-2 does affect emMyHC 
expression via the consensus binding site uncovered in this study, it might be expected 
that overexpression of GATA clone-7 should have some effect on the activity of the 
pEGFP/5.25 kb construct. A preliminaiy investigation into the effect of the porcine 
GATA-2 on the emMyHC reporter constiucts is described in Chapter Five.
GATA-2 is just one of a number of potentially interesting regulatory sites listed in the 
5’ UTR of the porcine emMyHC (Table 4.1). The possibility of MEF-2 interaction with 
the emMyHC regulatory regions is especially relevant given the co-operative role of 
GATA-4 and MEF-2 in cardiogenesis (Morin et al., 2000). Though an investigation
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into the effect of MEF-2 on emMyHC is beyond the scope of this study, it might be 
speculated that GATA-2 and MEF-2 might similarly co-operate in regulating 
emMyHC. While a study into the role of NFAT-2 on emMyHC function could not be 
carried out without the full-length NFAT clone, the discoveiy of consensus binding 
sites leaves open the possibility that emMyHC may be regulated by calcineurin/NFAT 
signalling.
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C h a p t e r  F iv e  - GATA-2 a n d  NFAT-2 
F u n c t i o n a l  a n d  E x p r e s s io n  S t u d i e s
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5.1 In t r o d u c t io n
Chapters Three and Four have focussed on the cloning, respectively, of trans- and cis- 
elements involved in fibre-specific gene expression. This Chapter describes the studies 
that used these materials to investigate the potential roles for GATA-2 and NFAT-2 in 
porcine muscle. One such step, and the first study listed here, is to investigate its tissue- 
specific and developmental patterns of expression. As a means to accomplish this aim, 
the putative untranslated regions of GATA clone-7 offer isoform-specific targets for the 
design of primer and probe sets for quantitative real-time RT-PCR. Though lacking the 
complete coding region, the NFAT clone-3 still possesses 3’ untianslated sequence that 
can be used as the basis for a similar study into NFAT-2 expression patterns. Tlie 
possession of an apparent full-coding sequence for porcine GATA-2, cloned into a 
CMV promoter-driven expression-vector, allows for further studies into GATA-2 
function. Before the pBK-CMV/GATA clone-7 construct can be used, however, it is 
necessary to confirm that the cDNA insert represents an mRNA transcript, and will be 
transcribed and tmnslated in mammalian cells.
To a certain extent, the expression patterns of GATA-2 and NFAT-2 have previously 
been characterised in studies in other species. While both factors are the only isoforms 
of their respective families known to be expressed in mature skeletal muscle fibres 
(Abbott et a l, 1998; Musaro et a l, 1999), they are also expressed in a wide range of 
other tissues (Hoey et a l, 1995; Masuda et a l, 1995; Kumano et a l, 2001; Patient and 
McGhee, 2002). While briefly mentioned in Section 1.4, the expression patterns and 
tissue-specific functions of GATA-2 and NFAT-2 are considered here in greater depth. 
In addition, previously characterised functions of GATA-2 in muscle are also 
considered, to provide a context for the results that were obtained.
5.1.1 D is t r ib u t io n  o f  GATA-2
The transcription factor GATA-2 is expressed in a wide range of tissues, first 
characterised by Yamamoto et a l (1990) in studies in cells of the erythroid lineage in 
the chicken. It was found that GATA-2 was expressed at lower levels than GATA-1, 
but with a far more extensive tissue distribution. While GATA-1 was largely confined 
to cells of the eiythroid lineage, GATA-2 was expressed in developing brain, liver and 
cardiac muscle, in adult kidney and fibroblasts, and in all stages of the erythroid
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Tissue References
All Stages Erythroid lineage (Yamamoto et al ,  1990)
Development Placental trophoblasts 
Brain, Liver, Heart 
Urogenital system 
Pituitary gland 
Spinal cord
(Ng et al ,  1994; Ma et al ,  1997) 
(Yamamoto et al ,  1990)
(Zhou et al ,  1998b)
(Dasen et al ,  1999)
(Zhou et al ,  2000)
Adult Kidney, fibroblasts 
Epithelial cells 
Adipose tissue 
Skeletal muscle
(Yamamoto et fl/., 1990)
(Lee et al ,  1991 ; Dorfrnan et al ,  1992) 
(Tong et al ,  2000)
(Musaro et fl/., 1999)
Table 5.1 Tissue distiibution of GATA-2 during development and in the adult.
lineage. The importance of GATA-2 in haematopoiesis was confirmed by Tsai et al. 
(1994), who found that Gata-2 knockout mice die mid-gestation due to haematopoietic 
failure. While the majority of further studies focussed on the role of GATA-2 in 
erythropoiesis (reviewed in Orkin, 1995; Patient and McGhee, 2002), a wider picture of 
GATA-2 expression has been provided by a number of studies. The role of GATA-2 in 
the development of other tissues has been obscured by the early lethality of the Gata~2 
-/- phenotype, but studies have revealed a role for GATA-2 in urogenital development 
(Zhou et a l, 1998b), pituitary cell fate (Dasen et a l, 1999), placental trophoblasts (Ng 
et a l, 1994; Ma et a l, 1997) and neurogenesis (Zhou et a l, 2000). In adult tissues, 
GATA-2 expression was also found in epithelial cells (Lee et a l, 1991; Dorfman et a l, 
1992), adipose tissue (Tong et a l, 2000), and in skeletal muscle (Musaro et a l, 1999). 
The tissue distribution of GATA-2 is summarised in Table 5.1.
5.1.2 D is t r ib u t io n  o f  NFAT-2
NFAT-2, also commonly referred to known as NFATc or NFATcl, is the NFAT family 
member most closely associated with adult muscle fibres (Abbott et a l, 1998). As with 
other members of the NFAT family, NFAT-2 was first characterised in the immune 
system (reviewed in Rao et a l, 1997), specifically in T cells, thymus, spleen and 
peripheral blood lymphocytes (PEL) (Hoey et a l, 1995; Masuda et a l, 1995). NFAT-2 
expression has also been characterised in the endothelium of the developing heart, and 
is essential for heart valve formation (de la Pompa et a l,  1998; Ranger et a l, 1998). 
Nfat-2 -/- mice die in utero from congestive heart failure caused by defective valve
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Tissue References
All Stages T-Cells, thymus, spleen, PBL (Hoeyeïû/., 1995; Masuda e? a/., 1995)
Development Cardiac endothelium and 
developing heart valves
(de la Pompa et al ,  1998; Ranger et al ,  1998; 
Johnson et al ,  2003)
Adult Skeletal muscle (Ahhottef fï/,, 1998)
In vitro studies Differentiating osteoclasts 
Vascular smooth muscle 
Glomerular mesangial cells
(Ishida et al ,  2002; Takayanagi et al ,  2002) 
(Wada et al ,  2002)
(Sugimoto et al ,  2001)
Table 5.2 Tissue distribution of NTAT-2 during development and in the adult.
development. In addition to this developmental role, NFAT-2 expression has also been 
demonstrated in a number of cell types, in in vitro studies. These include differentiating 
osteoclasts (Ishida et a l, 2002; Takayanagi et a l, 2002), vascular smooth muscle cells 
(Wada et a l, 2002), and kidney glomerular mesangial cells (Sugimoto et a l, 2001). 
These in vitro studies do not specify a developmental stage, but the processes mediated 
by NFAT-2 leave open the possibility of a role either in development or the adult 
maintenance of the respective tissue. The distribution of NFAT-2 is summarised in 
Table 5.2.
As discussed in Section 1.4.2, the human NFAT-2 has three splice variants (Park et a l, 
1996; Chuvpilo et a l, 1999). Two of the splice products are known to be expressed in 
skeletal muscle (Hoey et a l, 1995, Masuda et a l, 1995), with the third characterised in 
T cells only (Chuvpilo et a l, 1999). Many studies in both muscle and non-muscle 
tissues do not specify which splice variant was observed, and so the exact distribution 
of these splice variants, together with their functional significance, remains unclear at 
present. The NFAT clone isolated during the work described in Chapter Three showed 
closest homology to the human NFAT-2b (Section 3.3.4).
5.1.3 G A T A -2 FUNCTION in  M u sc l e
GATA-2 was first characterised in skeletal muscle in the study on IGF-1 induced 
muscle hypertrophy by Musaro et a l (1999), in which GATA-2 was upregulated in 
response to IGF-1 expression in a transfected rat myoblast cell line. GATA-2 
upregulatioir was also induced by calcineurin expression, and in both cases was
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abolished by CsA administration. Even though a role for calcineurin/NFAT in muscle 
hypertrophy was later disputed (Glass, 2003a), the initial finding that GATA-2 is 
upregulated in hypertrophying muscle was further supported in whole-muscle studies in 
IGF-1 transgenic mice (Musaro et a l, 2001). In addition, GATA-2 was also identified 
in muscle regeneration in rats, following damage through bupivacaine injection 
(Sakuma et a l, 2003). This study showed co-precipitation of GATA-2 and NFAT-2, 
and that regeneration was affected by CsA, linking the activity of GATA-2 in the 
regenerative pathway with calcineurin signalling. GATA-2 has not been demonstrated 
to have a role in the expression of slow-fibre specific genes. However, GATA-4 has 
been shown to bind to the slow/p MyHC promoter and upregulate this gene (Wang et 
a l, 1998), and it remains possible that GATA-2 may have a similar role in skeletal 
muscle.
5.1 .4  A im s
There were thiee parts to the work described in this Chapter. The first was to study the 
tissue distribution of both GATA-2 and NFAT-2 by quantitative real-time RT-PCR, in 
order to analyse the expression patterns for the two transcription factors in the context 
of published data. The temporal distribution in developing muscle was also 
investigated, something not previously reported for GATA-2 and which could 
potentially indicate a novel role in myogenesis for this factor. The second goal was to 
produce and characterise the tmnslation products of the novel GATA-2 clone, as a 
prerequisite to use in further fimetional studies.
Finally, two studies were undertaken to test the possible relationship between GATA-2 
activity and MyHC expression. One approach, the more comprehensive of the two, was 
to characterise the expression of the different MyHC genes in porcine muscle fibres 
transfected with the pBK-CMV/GATA clone-7 construct, and to compare these 
patterns with untransfected myotubes. This required the establishment of porcine 
primaiy myoblast cultures and the development of differentiation protocols. The second 
approach, focussing more directly on the relationship between GATA-2 and emMyHC, 
was a preliminary investigation into the effect of the CMV promoter-driven GATA-2 
overexpression on the activity of the emMyHC/luciferase reporter constincts generated 
in the work described in Chapter Four.
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5.2  M a t e r i a l s  a n d  M e t h o d s
5.2.1 Q u a n t i t a t iv e  R e a l  T im e RT-PCR
For the most part, quantitative real-time RT-PCR was carried out exactly as described 
in the General Methods chapter, section 2.2.6. This section lists the specific primer and 
probe sets used, and the origins of the tissue samples assayed.
5.2.1.1 Design of Porcine GATA-2 and NFAT-2 probes
The TaqMan real-time PCR primer and probe sets were designed around the 3’ 
untranslated region of both GATA-2 and NFAT-2 clones using Primer Express® v.2.0 
software, as described in the manufacturer’s protocols (Applied Biosystems). RT-PCR 
primer and probe sets were as listed in Table 5.3. Also included in this table is the 
porcine (3-actin primer and probe set, designed previously by the same method, which 
was used to normalise GATA-2 and NFAT-2 results by the relative standard curve 
method (Section 2.2.6 .5).
Gene Sequence ( 5  ' to 3  ' )
GATA-2 Sense C T G G G A G G C T T C A G
Anti-sense C T T G C C C C C T C C T T T C A T C T
Sense probe T T T C C T G C A T G G A C A C C T G T T T G G A G A
NFAT-2 Sense T T T G T A A G T C A C A G A G G C G A A C A
Anti-sense C C A T G G A T C C T C G G C T C T T
Sense probe C T G A A A G C C A T A T T G A A C C A T T T G C A C  A T T  A C T
p-actin Sense C C A G C A C C A T G A A G A T C A A G A T C
Anti-sense A C A T C T G C T G G A A G G T G G A C A
Sense probe C C C C T C C C G A G C G C A A G T A C T C C
Table 5.3. GATA-2, NFAT-2 and P-actin primer and probe sets designed for TaqMan 
real-time PCR.
5.2.1.2 Preparation of Samples
Pigs were slaughtered by captive bolt, followed by severance of major neck blood 
vessels. Tissue samples for mRNA quantification were taken within 30 min of death 
and snap-frozen in liquid nitrogen. Direct extinction of mRNA from the tissue samples, 
quantitative real-time RT-PCR and data analysis was earned out as described in Section 
2 .2 .6 .
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To investigate GATA-2 and NFAT-2 expression across a range of tissue types, a range 
of tissue samples were taken from a six-week-old, Large White cross-bred animal. To 
analyse differences between longissimus dorsi (LD) and psoas muscles (fast- and slow- 
twitcli muscles respectively), pooled cDNA from a panel of six, adult (22 week-old) 
Duroc pigs was used. Finally, for the foetal stages of development, pooled cDNA was 
used from the LD muscles of three Large Wliite cross-bred animals each at 35, 49, 63, 
77 and 91 days gestation.
5.2.2 P r o t e in  A n a l y sis
Porcine GATA-2 transcription-translation was performed by Western blot analysis of 
GATA-2 transfected C2C12 cells and by an in vitro transcription/translation system. In 
both approaches, the primary objective was to test whether the pBK-CMV/GATA-2 
constiuct was transcriptionally functional and able to generate a viable protein in 
culture.
5.2.2.1 Preparation of Cell Extracts
5.2.2.1.1 Cell Culture and Transfections
C2C12 myoblasts were cultured as described in section 2.2.5.3. Cells were transfected 
with pBK-CMV/GATA clone-7 (Section 3.3.3.1) and a pCMV-IGF-1 expression 
construct. Stable transfections were earned out as described in Section 2.2.5.2, with the 
cells maintained in 1 mg/ml G418.
5.2.2.1.2 Cell Harvesting
Culture medium was removed and the cells washed twice in ice cold PBS. Further PBS 
was added, and the adherent cells scraped free. The resulting suspension was removed 
to a pre-cooled 50 ml Falcon tube, spun down gently to collect the cells, supernatant 
removed and the cell pellet resuspended in 1 ml of ice-cold PBS. This was transferred 
to a 1.5 ml microcentrifuge tube, spun at 10,000 x g for 5 min in a rotor chilled to 4 °C, 
The supernatant was removed and the cells snap-frozen in dry ice. Cell pellets were 
stored at -70 °C until use.
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5.2.2.1.3 Preparation of Nuclear Extract
Cells were resuspended in lysis buffer (10 mM Tris, pH 7.9, 10 mM NaCl and 2 mM 
MgCb, supplemented with 0.5 mM PMSF and 1 niM DTT immediately prior to use), at 
five times the volume of the cell pellet, and incubated on ice for 5 min. Cells were 
lysed with the addition of detergent (50 pl/ml 10% NP40), and the lysate kept on ice a 
further 10 min. The lysate was spun down at 3,000 rpm for 5 min, and the pellet 
resuspended in cold buffer (20 mM HEPES, 0.42 niM NaCl, 1.5 niM MgCb, 0.2 mM 
EDTA, 25% glycerol, supplemented immediately prior to use with 18.5 pi protease 
inhibitor mix (PIM), 0.5 mM PMSF, 1 mM DTT). The resuspended pellets were 
incubated with slow rotation at 4 °C for 30 min, then centrifuged again at 10,000 x g 
for 10 min at 4 ”C. The supernatant of nuclear extiact was transferred to a fresh tube, 
snap frozen and stored at -70 °C until use.
5.2.2.1.4 TCA Precipitation of Proteins
Precipitation of protein by the addition of trichloroacetic acid (TCA) was used in 
instances where the protein content of the samples was too dilute for loading onto SDS- 
PAGE gels. Samples were precipitated with the addition of 0.25 volumes of TCA 
solution (100% w/v trichloroacetic acid, 0.4% sodium deoxycholate), vortex mixed and 
placed on ice for 15 min. Following this incubation, the samples were spun at 10,000 x 
g for 15 min, and the supernatant carefully removed. To remove residual traces of 
TCA, 0.5 ml of acetone was added, vortex mixed and spun again at 10,000 x g for 5 
min. The supernatant was removed and samples vacuum-desiccated. Samples were 
resuspended in SDS-protein sample buffer, boiled for 5 min and loaded as described in 
the SDS-PAGE protocol outlined below.
S.2.2.2 SDS-PAGE
The separation of proteins according to their molecular weight, and subsequent 
visualisation was carried out using SDS-polyacrylamide gel electrophoresis as 
described by Laemmli (1970).
Gel plate, comb and spacers were cleaned and carefully assembled. The separating (or 
resolving) gel was prepared with 1.5 ml of 4 x Lower buffer (1.5 M Tris at pH 8 .8, 
0.4% SDS) and between 5 to 15% acrylamide, made up to 5 ml with water.
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Polymerisation of the gel was started with the addition of 11 pi tetramethyl-l-, 2- 
diaminomethane (TEMED) and 30 pi ammonium persulphate (APS), mixed hy vortex, 
and the gel applied between the glass plates with a Pasteur pipette. Isobutanol (2- 
methyl-1-propanol) was layered on top, and the gel left to polymerise for 1 hour at 
room temperature. The isobutanol was washed out with distilled water, and the loading 
comb placed between the glass plates. The stacking gel, consisting of 1.25 ml Upper 
buffer (0.5 M Tris, pH8 .8, 0.4% SDS), 0.7 ml 30% acrylamide and 3 ml water, was 
induced to polymerise as above, and applied to the gel. This was left for 30 min at room 
temperature, for the polymerisation to complete.
The polymerised gel was cleaned and placed in the running tank, with the lower 
reservoir filled with protein running buffer (10 mM Tris, 76.8 mM glycine, 0.1% SDS, 
pH 8.3). This was then sealed with 2% agarose. The gel comb was carefully removed, 
and the upper reservoir filled. Samples were prepared, if necessaiy precipitating with 
TCA as described above. Otherwise, an equal volume of sample buffer (250 mM Tris- 
HCl, pH 6.8, 2% SDS, 20% P-mercaptoethanol, 40% glycerol, 0.5% bromophenol 
blue) was added, the mixture boiled for 5 min and the samples loaded immediately. 
Gels were run at 100 volts for approximately 40 min until the dye front reached the 
interface, then at 160 volts until sufficient separation was obtained.
S.2.2.3 Western Blotting
Western transfer of proteins from SDS-polyacrylamide gels onto polyvinylidene 
fluoride membranes (Schleicher and Schuell UK) was carried out using a modification 
of the procedure of Towbin et al. (1979). The resulting Western blots were probed for 
the presence of GATA-2 using a mouse monoclonal IgG, anti-GATA-2 antibody, CG2- 
96 (Santa Cruz Biotechnology). Detection was by the enhanced chemiluminescence 
(ECL) method (Amersham). This method utilises a secondary antibody conjugated with 
horseradish peroxidase (HRP), which catalyses the oxidation of luminol by hydrogen 
peroxide in a light-emitting manner. Chemiluminescence is increased by chemical 
enhancers, to the point where it is detectable by autoradiography through blue-light 
sensitive film.
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5.2.2.3.1 Transfer onto PVDF membrane
The PVDF membrane was soaked in 100% methanol for 5 seconds, followed by water 
for 5 min, then in transfer buffer (25 mM Tris, 20% v/v methanol, 1.1% w/v glycine, 
pH 8.3) for 15 to 20 min. The SDS gel was soaked in transfer buffer for 15 to 20 min, 
and placed atop the membrane. Membrane and gel were sandwiched between two sets 
of three sheets of blotting paper, pre-soaked in transfer buffer.
5.2.2.3.2 Antibody Probing
Once blotted, the filter was washed for 10 min in TBS (25 mM Tris at pH 7.6, 150 mM 
NaCl), and blocked for 30 min in 500 ml milk buffer (MB) (1 x TBS, 0.5% Tween-20, 
4% powdered milk). The filter was probed with the primary antibody, mouse anti- 
GATA-2, for 2 hours at room temperature or overnight at 4 °C. The filter was then 
washed, three times for 2 min in MB, and probed with the secondary antibody, 
conjugated to horseradish peroxidase, for 1 hour at room temperature. The filter was 
washed a further five times in MB, three times for two minutes and twice for 15 min, 
before a final 5 min wash in TBS.
5.2.2.3.3 Development using ECL
The development of the Western blot was carried out as described in the Amersham 
ECL protocols. Equal volumes of the two detection reagents were mixed, sufficient for 
0.125 ml/cm^of filter, and pipetted onto the PVDF membrane. After 1 min, excess 
reagent was drained off and the filter Saran wrapped. The filters were exposed to ECL 
Hyperfilm™ (Amersham) in a darkroom, beginning with an exposure time of 1 min. 
Ideal exposure time, depending on the sample and backgiound levels, varied between 5 
s to 15 min.
5.2.2.4 In-Vitro Transcription Translation
The TnT® coupled reticulocyte lysate system (Promega) was used in the in vitro 
transcription translation of the novel GATA-2 clone, using T7 RNA polymerase. The 
procedure was carried out as described in the manufacturer’s protocol, briefly 
summarised as follows.
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The rabbit reticulocyte lysate was rapidly thawed and placed on ice. To prevent 
degradation of the lysate components, this reagent was not subjected to ffeeze/thaw 
more than twice. The reaction components, consisting of the TnT® lysate and reaction 
buffer, T7 RNA polymerase, amino acid mixture, RNasin ribonuclease inhibitor and 
DNA template, were assembled in a microcentrifuge. For the DNA template, 1 pg of 
GATA-2 plasmid DNA was used, purified by large scale plasmid preparation (section
2.2.1.2.2). The volume was made up to 50 pi with nuclease-ffee water, and mixed 
gently by pipetting. The reaction mixture was incubated for 90 min at 30 °C. 
Transcription translation products were visualised by SDS-PAGE largely as described 
in section 5.2.2.3.
5.2.3 P r im a r y  C e l l  C u l t u r e s
The harvesting of muscle tissue for satellite cells, and the subsequent culture and 
maintenance of the primaiy cell culture was as described in section 2.2.5. Primary cell 
cultures were prepared from LD and psoas tissue samples, from a six-week-old, Large 
White cross-bred animal.
5.2.3.1 Testing for Differentiation
A potential problem in the use of primary muscle cell preparations as a source of 
myoblasts is the presence of contaminating non-myogenic cells, such as fibroblasts 
(Baroffio et a l, 1995). Before using the primary satellite cells as a model for the effects 
of GATA-2 on fibre type, a sample culture was tested for the capacity to differentiate 
normally. One 75 cm^ flask of primaiy cells, fiom both the LD and psoas was grown to 
confluency, switched to differentiation medium and cultured for a further seven days 
(as described section 2.2.5.1.2). The cells were harvested for niRNA and cDNA 
prepared for quantitative real-time RT-PCR as described in Section 2.2.6. The cDNA 
was assayed for the presence of a-actin and for pre- and post-natal MyHC expression, 
using the primer and probe sets listed in Table 5.4.
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G e n e S e q u e n c e ( 5 '  t o  3 ' )
S k e l e t a l
a - a c t i n
S e n s e  C C A  G C A  C C A  T G A  A G A  T C A  A G A  T C  
A n t i - s e n s e  A C A  T C T  G C T  G G A  A G G  T G G  A C A  
S e n s e  p r o b e  C G C  C G C  C G G  A G C  G C A  A G T
P ~ a c t in S e n s e  C C A  G C A  C C A  T G A  A G A  T C A  A G A  T C  
A n t i - s e n s e  A C A  T C T  G C T  G G A  A G G  T G G  A C A  
S e n s e  p r o b e  C C C  C T C  C C G  A G C  G C A  A G T  A C T  C C
S l o w  M y H C S e n s e  G G C  C C C  T T C  C A G  C T T  G A  
A n t i - s e n s e  T G G  C T G  C G C  C T T  G G T  T T  
S e n s e  p r o b e  C C T  C T T  T C T  T C T  C C C  A G G  G A G  A T T  C G A
e m M y H C S e n s e  C C C  G G C  T T T  G G T  C T G  A T T  T
A n t i - s e n s e  G G T  G T C  G G C  T G A  G A G  T C A
S e n s e  p r o b e  T G C  T G C  T G T  C T G  C T G  T C C  T C T  G C G
p e r i M y H C S e n s e  C G A  G C C  C T C  C T G  C T T  T A T  C T C  
A n t i - s e n s e  T G C  C A G  A T G  A A A  A T G  C A G  G T T  
S e n s e  p r o b e  C C A  A G A  G C C  C A G  A G T  G T T  A G G  C A C  T T C  C
2 a M y H C S e n s e  T T A  A A A  A G C  T C C  A A G  A A C  T G T  T T C  A
A n t i - s e n s e  C C A  T T T  C C T  G G T  C G G  A A C  T C
S e n s e  p r o b e  T T C  C A G  G C T  G C A  T C T  T C T  C A C  T T G  C T A  A G
2 x M y H C S e n s e  A G C  T T C  A A G  T T C  T G C  C C C  A C T
A n t i - s e n s e  G G C  T G C  G G G  T T A  T T G  A T G  G
S e n s e  p r o b e  A G C  C C A  G T C  A A A  G A C  C C T  T T G  A G A  T G C  A
2 b M y H C S e n s e  C A C  T T T  A A G  T A G  T T G  T C T  G C C  T T G  A G
A n t i - s e n s e  G G C  A G C  A G G  G C A  C T A  G A T  G T
S e n s e  p r o b e  T G C  C A C  C G T  C T T  C A T  C T G  G T A  A C A  T A A  G A G  G
Table 5.4. Porcine primer and probe sets designed for TaqMan real-time PCR.
5.Z.3.2 Primary Cell Transfections
Transient GATA-2 transfections were set up in six-well plates, using a liposome 
transfection method with the lipofectamine reagent (Invitrogen) as described 2.2.5.2. 
One pair of wells was transfected with the pBK-CMV/GATA clone-7 construct, 
another with the insertless pBK-CMV vector. As an additional control, a further pair of 
untransfected wells was harvested prior to differentiation. The remaining wells were 
switched to differentiation medium, as described in 2.2.5.1.2, to induce the cells to 
differentiate. The cells were maintained for a further five days before harvesting for 
niRNA. The mRNA extraction, reverse transcription and qualitative RT-PCR were all 
carried out as described in Section 2.2.6. The same primer and probe sets were used as 
for the preliminary test (Table 5.4).
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S.2.3.3 Magnetic Antibody Cell Separation
One method investigated as a means of improving the yield of myoblasts in the primary 
cell extracts was the use of antibody-conjugated magnetic Dynabeads (Dynal Biotech). 
A positive selection method was used, following the manufacturer’s protocol derived 
from those described by Drake and Loke, (1991). In this method, the desired cells are 
labelled with the appropriate antibody. The cells are then rosetted with the magnetic 
Dynabeads, which are coated with a secondary antibody reactive against this primary 
antibody. On the application of a magnetic particle collector, the desired cells are 
separated from the mixture, and unwanted cells removed by a series of wash steps.
The 5.1 HI 1 antibody (mouse IgG) was used as the primaiy antibody for selecting 
myoblasts. This is a myoblast-specific antibody raised by Walsh and Ritter (1981), 
against neural cell adhesion molecule (NCAM). NCAM is a cell adhesion molecule 
first characterised in nervous tissue, but since found in a number of cell types including 
developing or regenerating skeletal muscle (reviewed in Baldwin et a l, 1996). While
5.1 H ll  was originally characterised as human myoblast specific, cross-species 
reactivity for porcine myoblasts was demonstrated by Blanton et a l (1999). The 
antibody was prepared from hybridoma cultures obtained from the Developmental 
Studies Hybridoma Bank at the University of Iowa, according to supplier’s protocols. 
The beads used were M-450 Dynabeads, coated with sheep anti-mouse IgG.
The cell culture to be sorted was trypsinised, resuspended in 1 ml growth medium and 
transferred into a 15 ml Falcon tube, and a sample counted in a haemocytometer in 
order to calculate the correct volume of beads to add for a ratio of five beads to each 
cell. The beads were thoroughly resuspended in their storage buffer, and the required 
volume transferred to a microcentrifuge tube for reconditioning in growth medium, The 
tube was placed in a Dynal MPC for 1 min until the beads had settled out of 
suspension. Storage buffer was then removed, the tube taken out of the MPC and the 
beads re suspended in 1 ml growth medium. The reconditioning step was repeated once 
more, and the beads stored on ice until used.
The cells were incubated with a 1:10 dilution of the 5.1 H ll  primaiy antibody for 30 
min at 4 °C, with continuous rotating and tilting throughout the incubation. The cells
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were washed twice with growth medium, spinning down at 400 x g for 5 min and 
resuspending in fresh growth medium each time. The washed, primary antibody-coated 
cells were then rosetted with the Dynabeads, 4 for 30 min with continuous rotating 
and tilting. To collect the cells rosetted to the Dynabeads, the tube was placed in a 
Dynal MPC for 2 min and the supernatant pipetted off. Cells were washed four times in 
growth medium, and transfen*ed to culture flasks. The selected cells were grown in 
PromoCell Skeletal Muscle Growth Medium at 37 °C to confluency, and then passaged 
into chambered slides for desmin staining.
5.2.4 C2C12 C u l t u r e s
C2C12 cells were cultured and maintained as described in section 2.2.5.3. Two stably 
transfected C2C12 lines were generated by lipofectamine transfection and maintained 
in appropriate selection media, as detailed in section 2.2.5.2. The first cell-line 
consisted of C2C12 cells transfected with the pBK-CMV/GATA-2 construct, referred 
to as C2C12/GATA-2. The second cell-line, generated for use as a control, was 
transfected with the pBK-CMV vector without the insert, referred to as C2C12/CMV.
5.2.4.1 Promoter Construct Transfections
A summary of the experimental set-up for the emMyHC/GFP promoter constructs is 
shown in Figure 5.1. Transient transfections were earned out using lipofectamine, as 
detailed in section 2.2.5.2, in six-well plates. The cells were induced to differentiate by 
switching to DMEM supplemented with 2% horse seium (section 2.2.5.3), and 
maintained for five days. After this period, the cells were examined under fluorescence 
microscopy for differences in fluorescence intensity between C2C12/GATA-2 and 
C2C12/CMV cells.
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C2C12 Cultures
1. 5.25 kb-GFP
2. 1.6 kb-GFP
3. 0.25 kb-GFP
4. -ve GFP control
5. Harvested for RT-PCR
Figure 5.1. Experimental set-up for transient emMyHC/GFP transfections in C2C12 
cells (shaded wells unused). A. C2C12/GATA-2 cells. B. C2C12/CMV cells. 1-3. 
Wells transfected with the pEGFP-l/emMyHC-promoter reporter constructs. 4. Wells 
transfected with insertless pEGFP-1 vector. 5. Undifferentiated wells harvested for 
quantitative real-time RT-PCR to assay for levels of GATA-2 expression.
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5.3  R e s u l t s
5.3.1 mRNA E x p r e s s io n
5.3.1.1 GATA-2
The mRNA expression data obtained by real-time RT-PCR is summarised in Figures
5.2 to 5.4. Tissue distribution of GATA-2 mRNA was found to be widespread (Figure
5.2), with low levels of expression in most of the tissues assayed. This pattern is similar 
to the earliest obseivations of GATA-2 distribution made by Yamamoto et a l (1990). 
However, the high abundance of GATA-2 in uterine tissue has not been previously 
reported.
GATA-2 mRNA was found in both LD and psoas skeletal muscles of the 22-week 
post-natal animal (Figure 5.3A), though at low levels compared to NFAT-2. Previous 
studies have reported that GATA-2 is normally absent from skeletal muscle, except as a 
marker for IGF-1 mediated hyperhophy (Paul and Rosenthal, 2002). This study did not 
address the presence of GATA-2 protein in the tissues assayed, and it is possible that 
translation may be repressed. The differences in GATA-2 expression between muscles 
of predominantly different fibre types were slight, and do not appear to provide 
evidence for a role of GATA-2 in promoting either the fast or slow fibre phenotype.
The levels of GATA-2 expression in LD muscle increased with gestational age, as 
shown in Figure 5.4A. From day 91 of gestation to 22-weeks of post-natal growth, 
GATA-2 expression increased almost twenty-fold, with relative expression levels of 
0.12 at 91 days versus 2.26 at 22 weeks post-natal (arbitrary units). This previously 
unreported, stage-specific increase of GATA-2 points to a role in development. The 
increase in levels of GATA-2 continued in post-natal growth, with expression levels 
appreciably higher in 22-week-old LD than in six-week-old.
181
25
20
u 15
XM
•B 10eg
g
r j = .
J □  GATA-2 B NFAT-2
n
[i
Brain Spleen Kidney Liver Uterus Heart 
Tissue Distribution
LD Psoas
Figure 5.2. Tissue distribution of GATA-2 and NFAT-2 expression in a six-week-old 
pig. GATA-2 tissue distribution was noticeably high in uterus, kidney, heart and 
skeletal muscle. NFAT-2 expression was more evenly distributed, with the highest 
levels in skeletal muscles and in liver.
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Figure 5.3. Relative expression of GATA-2 and NFAT-2 expression in fast (LD) and 
slow (psoas) muscles. A. GATA-2 B. NFAT-2.
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Figure 5.4. Expression of GATA-2 and NFAT-2 in different stages of pre- and post­
natal porcine development, in LD muscle. A. GATA-2 expression increased steadily 
throughout pre- and post-natal development. B. NFAT-2 remained at much the same 
level throughout development and in the young animal, but was greatly upregulated in 
the 22-week-old adult.
183
5.3.1.2 NFAT-2
The tissue-distribution of the porcine NFAT-2 mRNA, as determined by the real-time 
RT-PCR in a six-week-old pig, is shown in Figure 5.2. Of the tissues assayed, NFAT-2 
expression was highest in skeletal muscles and liver. Expression at lower levels was 
also observed in spleen, kidney and heart, with all of these tissues previously reported 
to express NFAT-2 (see Section 5.1.2), Similar levels of NFAT-2 expression were 
obseiwed in uterine smooth muscle, though this is also predictable to some degree given 
the previously reported expression of NFAT-2 in vascular smooth muscle (Wada et a l,
2002). The obseiwation of elevated NFAT-2 expression in liver was not expected. If 
this corresponds with elevated NFAT-2 protein in this tissue, then this may signify a 
previously unrepoited role for the NFAT-2 isoform in liver.
The comparison between NFAT-2 levels in 22-week-old LD and psoas is shown in 
Figure 5.3B. It was found that NFAT-2 expression was two-fold higher in the 
predominantly fast muscle, the LD, than in the predominantly slow-fibre psoas muscle. 
This result was unexpected given the widely reported role of NFAT-2 in mediating the 
slow-fibre phenotype (Chin et a l, 1998; Schulz and Yutzey, 2004). In both LD and 
psoas, NFAT-2 expression was higher than GATA-2. Figure 5.4B shows changes in 
NFAT-2 expression in LD during gestation and post-natal growth. The expression level 
in 22-week-old LD muscle was up to 40-fold that of gestational LD, with relative 
expression levels of 0.74 at 91 days, versus 31.95 at 22 weeks post-natal (arbitrary 
units). In contrast to the pattern obseived in GATA-2 expression in LD muscle, pre­
natal expression of NFAT-2 showed no discernible pattern, up to and including the six- 
week-old. It appears that the porcine NFAT-2 is restiicted to a role in frilly developed 
muscle, as previously reported (Abbott et a l, 1998; Schulz and Yutzey, 2004).
5.3 .2  P r o t e in  A n a l y sis
The results of the protein analysis are shown in Figure 5.5. The in vitro 
transcription/translation showed a band of the correct size of 52 kDa, as predicted from 
the primary nucleotide sequence for GATA clone-7 (Figure 5.5A). As further 
confirmation of a translated protein product for the construct, Western blotting showed 
a 52 kDa band, upregulated over untransfected controls, was obseiwed in the pBK- 
CMV/GATA clone-7 transfected C2C12 cells (Figure 5.5B). This same band was also
184
A. 1 .
GATA-2
Clone
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52 kDa
Figure 5.5. SDS-PAGE analysis of the porcine GATA-2 clone. A. In vitro 
transcription-translation run with luciferase as a marker. Lanes: 1) GATA-2 in vitro 
transcription translation. 2) Luciferase marker lane. 3) Control lane. B. Western blot of 
nuclear extract from C2C12 cells, probed with anti-mouse GATA-2. Lanes: 1) Non­
transfected. 2) Transfected with IGF-1 expression construct. 3) Transfected with 
GATA-2 expression construct. Both the IGF-1 and GATA-2 transfected cells show 
upregulation of a 52 kDa protein, corresponding to the predicted size of the novel 
GATA-2 clone.
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upregulated in the IGF-1 transfected cells, and most likely correlated to the increased 
expression of endogenous, murine GATA-2, induced by the over-expression of IGF-1. 
This is in accord with previous observations in both muscle cell culture and transgenic 
mice, in which GATA-2 was induced by IGF-1 (Musaro et a t, 1999; Musaro et a l, 
2001).
5.3.3 P r im a r y  C e l l  C u l t u r e
5.3.3.1 Initial Characterisation
The threshold cycle ( C t )  values obtained by quantitative RT-PCR for the initial 
differentiated primary cell cultures are shown in Table 5.5. Expression of a-actin and 
the em-, peri- and slow-isoforms of MyHC was detected, consistent with the early onset 
of differentiation as described by Sun et al. (2003). From this it was assumed that a 
significant proportion of the harvested cells were myoblasts and that the culture 
conditions were favourable for their growth and subsequent differentiation.
LD
Average Cj
Psoas
a-actin 22.30 24.27
emMyHC 23.65 24.71
slow MyHC 32.51 33.11
periMyHC 35.05 37.81
2a MyHC 37.42 38.40
Table 5.5. Average C% readings for the initial characterisation of myoblast cultures 
derived from primary tissue extractions.
5.3.3.2 Problems with Differentiation
Despite these earlier, promising results, subsequent GATA-2 transient transfection 
experiments using primary cell culture isolates failed to show expression patterns 
consistent with differentiation. Expression of a-actin, a marker of differentiating 
myocytes, was absent in all the cDNA preparations assayed. The absence of 
differentiation was found in both GATA-2 transfected cells, controls and in 
untransfected cells brought out of storage to test whether the transfection procedure was 
interfering with differentiation. From this, it was concluded that the method of
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obtaining differentiated cell culture was of low efficiency, and that the earlier success 
was not representative of the technique used. No mRNA was detectable for any of the 
MyHC isoforms, the only exception being emMyHC. The embryonic isofomi was 
observed at very low levels, at around the lower limit for detection ( C t  readings 
between 30 to 35). No consistent differences were observed in emMyHC levels 
between GATA-transfected and untransfected cells, though this may simply have been 
due to the low levels involved.
The underlying problem with the primary cell cultures was the presence of non­
myoblast cell populations, as determined by desmin antibody staining (Figure 5.6). It 
was considered that the most probable explanation for the failure of the primary 
cultures to differentiate and foim myoblasts in low serum conditions was the low 
percentage of myoblasts. The percentage of desmin-positive cells varied quite widely 
between different primary cell cultures. Initially, it appeared that the length of time in 
culture might be a contributing factor, given the success of the initial characterisation, 
described in Section 5.3.3.1. This raised the possibility that the myoblasts were simply 
outgrown by desmin-negative cell types, through the course of multiple cell passages. 
Further extractions from porcine tissue showed low populations of desmin-positive 
cells and lack of differentiation, even when induced to differentiate after a low number 
of passages. It was apparent that percentage of myoblasts in culture varied according to 
the particular isolate, as well as time spent in culture, and that the method used to 
isolate primary myoblasts was inadequate.
S.3.3.3 Cell Separation
Separation of the cells using the 5.1 HI 1 antibody conjugated to Dynabeads was tested 
as a means of enriching the primary cell cultures for myoblasts. However, comparisons 
between antibody-selected cells and non-sorted cells from the same primary cell line 
showed no increase in the proportion of desmin-positive cells. The affinity of the 5.1 
H ll antibody for porcine myoblasts has been demonstrated previously (Blanton et a l, 
1999), and so the failure of the selection process may have been due to the antibody 
fraction used. Given sufficient time, further optimisation of the technique may yield 
better results.
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Figure 5.6. Examples of desmin staining of primary cultures from porcine muscle, 
showing the variability of myoblast differentiation. Brown-stained cells are desmin 
positive. A. Differentiated myoblasts (cultured in 2% HS for 10 days) in the process of 
forming myotubes. B. Differentiated myoblasts (treated as above), with insufficient 
population of myoblasts.
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5.3 .4  C 2C 12 M y o b l a s t  C u l t u r e
The use of the C2C12 mouse myoblast cell line offered several advantages over the 
primaiy cell culture, chiefly the homogenous cell population and the relative ease of 
maintenance of the cell line. The chief disadvantage was species difference, and the 
possibility that the acquired porcine GATA-2 might not be functional in the mouse 
myoblasts needed to be considered. A pileup of murine and porcine GATA-2 is shown 
in Figure 5.7. As can be seen, the two proteins show considerable conservation in the 
functional zinc finger domains, sufficient that the porcine GATA would most likely be 
functional in the C2C12 myoblasts.
Pig MEVAPEQPRW MAHPAVLNAQ HPDSHHPGLA HNYMEPAQLL PPDEVDVFFN 50Mouse ------------------------------------          50
Pig HLDSQGNPYY ANPAHARARV SYSPAHARLT GGQMCRPHLL HSPGLPWLDG 100
Mouse ----------         100
Pig GKAALSAAAA HHHNPWTVNP FSKTPLHPSA AGGPGGPLSV YPGAGGGGGG 150
Mouse  -- - - - -S^ S“ ---------- — S------ -----A— I—  150
Pig GSGSSVASLT PTAAHSGSHL FGFPPTPPKE VSPDPSTTGA ASPASSSAGG 2 00
mouse ------------------------------------          2 00
Pig SAARGEDKDG VKYQVSLTES MKMESGSPLR PGLAAMGTQP ATHHPIPTYP 2 50
mouse “V --------  ------ S—  G   T »  -------- 250
Pig SYVPAAAHDY SSGLFHPGGF LGGPASSFTP KQRSKARSCS EGRBCVNCGA 300Mouse ----------G-S--------       300
Pig TATPLWRRDG TGHYLCNACG LYHKMNGQNR PLIKPKRRLS AARRAGTCCA 350Mouse ----------         350
Pig NCQTTTTTLW RRNANGDPVC NACGLYYKLH NVMRPLTMKK EGIQTRNRKM 400Mouse ----------         400
Pig SNKSKKNKKG AECFEELSKC MQEKASPFSA AALAGHMAPV GHLPPFSHSG 450Mouse “S S ----------- u. ^ ^ ^ gp.---  ^ - - - - -— --------- '—  450
Pig HILPTPTPIH PSSSLSFGHP HPSSMVTAMG 480Mouse ----------     480
Figure 5.7. Pileup comparison of the porcine GATA clone and murine GATA-2 
(Accession N~: AK004675) highlighting mismatches. A denotes a homologous
residue. Underlined residues denote GATA zinc finger motifs, i.e. the DNA binding 
and sequence recognition domains.
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The expression of the pBK-CMV/GATA clone-7 construct in the stably transfected cell 
-lines was verified by RT-PCR. The expression of porcine GATA-2 mRNA was not 
detected in the control C2C12/CMV cell-line (Figure 6.4).
= 3.0
W 2.0
« 1.0
C2C12/CM V C2C12/G ATA-2
C2C12 line
Figure 5.8. Verification of GATA-2 expression in the C2C12/GATA-2 cell line.
The results of the emMyHC/GFP transient transfections are shown in Figure 5.9. 
Unfortunately, time constraints prevented a more thorough analysis of differences in 
fluorescence between the C2C12/G ATA-2 and wild-type C2C12 populations. A more 
thorough study would require a numerical measurement of fluorescence intensity in 
each cell, and plotting the frequecy distribution of this intensity for over one hundred 
cells in each treatment well. This way, a meaningful measurement might be obtained of 
the different distribution patterns between the the C2C12 and C2C 12/GAT A 
populations than can be obtained simply by eye as in the preliminary study here. With 
this in mind, any conclusions drawn from the reporter study must be considered with 
caution, as preliminary data in need of further confirmation by a more detailed 
experiment.
As expected from previous work using these constructs (Dr Yuh-Man Sun, personal 
communication), the 0.25 kb-emMyHC/GFP reporter construct resulted in low levels of 
GFP expression compared to the constructs containing 1.6 kb and 5.25 kb of the
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A. Control B. GATA
Figure 5.9. Effect of GATA-2 on emMyHC reporter constructs. A. Control C2C12 
myoblast cell line, transfected with empty pBK-CMV vector. B. C2C 12/GATA cell 
line, transfected with the pBK-CMV/GATA construct. 1, 2 & 3. Transient co­
transfections with the pEGFP-1/5.25 kb-, 1.6 kb- and 0.25 kb-emMyHC reporter 
constructs respectively.
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promoter region, respectively. No difference in reporter activity was observed between 
GATA-transfected and untransfected cells either in the 0.25 or 1.6 kb reporter 
constructs. For the 5.25 kb construct, fluorescence intensity was lower in the 
C2C12/GATA-2 cells than in the control cell-line. This would indicate that GATA-2 
does repress emMyHC, with the GATA-binding site somewhere between 1.6 to 5.25 kb 
upstream of the TATA box.
5.4  D is c u s s io n
5.4.1 Ex p r e s sio n  P a t t e r n s
The tissue distribution patterns of the GATA-2 and NFAT-2 transcripts provide some 
insight into the function of these factors, although there are limits to the conclusions 
that can be drawn. Different levels of mRNA transcript do not necessarily equate to 
differences in the levels of protein. For instance, while NFAT-1 mRNA is quite 
abundant in brain and heart, NFAT-1 protein is absent from extracts of these tissues 
(Ruff and Leach, 1995; Wang et a l, 1995). The advantage of the quantitative real-time 
RT-PCR approach used in the expression studies is its sensitivity, and the capacity for a 
high throughput of different samples. However it is limited in that only mRNA levels 
have been quantified. Whether these reflect the levels of protein is yet to be verified.
This said, the expression data presented here provides a comprehensive study of the 
tissue distribution of GATA-2 and NFAT-2 in the pig, with a couple of unexpected 
findings that may point to previously uncharacterised flmctions for these transcription 
factors. For the most part, levels of the two transcription factors in the tissues of the six- 
week-old animal seemed to fit in with those previously described (see Sections 5.1.1 
and 5.1.2). There was evidence of a persistence of developmental patterns of 
expression, however, such as the presence of GATA-2 and NFAT-2 in the heart and the 
low levels of NFAT-2 expression in muscle, compared with the 22-week-old. This may 
be related to the young age of the animal fiom which the samples were derived. A 
similarly comprehensive study in the 22-week-old would be a useful comparison, 
though samples were not available in this study.
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The functional significance of the relatively high levels of GATA-2 in uterine smooth 
muscle and NFAT-2 in liver is unclear at the time of writing. That NFAT-2 is 
expressed in liver is the least surprising of the two observations, given the widespread 
expression of this factor and the ubiquitous nature of NFAT signalling (Hogan et a l,
2003). The expression of GATA-2 in the uterine smooth muscle, and at such relatively 
high levels, is not as easy to explain in the light of existing data on the role of GATA-2. 
From its first characterisation, GATA-2 expression has been reported as being quite 
widespread, but at low levels (Yamamoto et a l, 1990). In this study, GATA-2 
expression in uterine smooth muscle was quite high in comparison with other GATA-2 
expressing tissues. Also, GATA expression in smooth muscle tissue, such as the uterus, 
is generally thought to be restricted to the second ‘sub-family’ of GATA factors, 
GATA-4, -5 and -6 (reviewed in Patient and McGhee, 2002). The discovery of such 
relatively high levels of GATA-2 in the uterus may indicate that the distinction drawn 
between the two sub-families is not quite as clear-cut.
The upregulation of GATA-2 expression during development corresponds with a 
previously observed decrease in emMyHC expression (Sun et a l, 2003). A comparison 
is shown in Figure 5.5. While this in itself is only suggestive of a role for GATA-2 in 
the repression, it did provide further basis for the studies into the functional role of 
GATA-2, namely the effect of GATA clone-7 expression on the emMyHC-GFP 
reporter constructs.
5.4.2 GATA-2 FUNCTION
Despite the reservations expressed in Chapter Three regarding the absence of a strong 
Kozak consensus sequence, the GATA-2 clone was shown to be functional. The 
translation of a protein corresponding to the predicted size is the most important piece 
of evidence that the assessment of the main reading frame for GATA clone-7 given in 
Chapter Three is correct. The confirmation that the GATA clone-7 cDNA corresponds 
to an mRNA species lends support to the further studies to determine its biological 
function.
Though somewhat limited, the preliminary C2C12 study using the emMyHC reporter 
constructs provides some evidence in support of the conclusions drawn from the
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Figure 5.10. Comparison of developmental patterns of expression between the GATA- 
2 clone (see also Figure 5.4) and emMyHC (Sun et a i, 2003) during gestation and early 
growth.
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expression data discussed above, namely that GATA-2 represses emMyHC expression. 
However, a more in-depth study as laid out in Section 5.3.4 is required to confirm this 
finding. Since the repression of reporter activity seems to be restricted to the 
pEGFP/5.25 kb construct, this supports the conclusion made in Chapter 4 that the 
putative GATA-2 consensus site at postion -4 kb upstream binds GATA-2 and plays a 
role in emMyHC transcription. Again, this is a preliminary observation in need of 
further confirmation.
The initial studies using the primary cell culture remain something of a disappointment. 
The problems with cell culture appear to stem from a lack of a suitable source of 
porcine satellite cells. There are a number of ways that this could be addressed in future 
work. Firstly, it is apparent that the age of the animal is crucial. Satellite cell cultures 
have been shown to be highly sensitive to the age of the animal with one week after 
birth being ideal (Cardasis and Cooper, 1975). Owing to restrictions during the time 
period of the project on the movement of animals due to the foot and mouth crisis, pigs 
younger than the six-week-old animal used were not available. It soon became apparent 
that the stop-gap measure of culturing myoblasts from older animals was not a viable 
alternative. It is possible that the antibody separation and attempts to purify myoblast 
cultures may have failed because the population of myoblasts in the cell isolates was 
insufficient. That having been said, repetition of the separation technique with a 
different antibody extraction may have yielded better results, owing to the inherent 
variability in such preparations.
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6.1  In t r o d u c t io n
Changes in muscle phenotype, whether in development, regeneration or in response to 
changes in physiological demand, are brought about through the co-ordinated 
expression of fibre-specific genes. The signal transduction pathways believed to be 
responsible for mediating these patterns of gene expression have been the subject of 
many recent studies, as covered in Chapter One. Musaro et al. (1999) identified the 
transcription factors GATA-2 and NFAT-2 as having a role in the control of muscle 
phenotype, specifically in IGF-1 mediated muscle hypertrophy. Though these findings 
have been the subject of recent debate (reviewed in Schiaffino and Serrano, 2002; 
Glass, 2003), roles for both factors in various aspects of muscle biology have been 
further supported in later studies. GATA-2 and NFAT-2 have been identified as having 
a role in muscle regeneration (Sakuma et a l, 2003), while several studies have 
supported a role for NFAT-2 in the fast-slow change in phenotype (Liu et a l, 2001; 
Kubis et a l, 2002).
As major determinants of muscle fibre properties, such as shortening velocity and ATP 
utilisation, the MyHC isoforms are likely targets for transcription factors controlling 
fibre type. The aim of the study described in this Thesis was to investigate possible 
roles for GATA-2 and NFAT-2 in the control of MyHC isoform expression. As 
discussed in Chapter Three, a porcine GATA-2 orthologue was cloned and isoform- 
specific sequence data obtained for a porcine NFAT-2 orthologue. The latter was 
tmncated and incomplete, but most likely corresponding to the NFAT-2b isofonn. The 
investigation of one of the embiyonic MyHC (emMyHC), on of the last remaining 
uncharacterised isoforms in the pig, revealed a novel transcript structure, with the 
translation start site located on exon 2 .
Quantitative real-time RT-PCR studies confirmed earlier observations of widespread 
tissue distribution of both GATA-2 and NFAT-2. However GATA-2 was found to be 
highly expressed in uterine smooth muscle, a novel finding suggesting that the 
previously reported segregation of the GATA family into two functionally distinct 
groups (Patient and McGhee, 2002) may not be as distinct as was previously thought. 
Furthermore, developmental expression patterns of GATA-2 coincide with a drop in
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emMyHC expression (Sun et a l, 2003) suggesting a role in the regulation of this gene. 
Though only a preliminary study, the reporter studies using the cloned emMyHC 
regulatory region in conjunction with the GATA-2 expression constmct seemed to 
support the idea that GATA-2 inhibits emMyHC expression. The wider significance of 
these results is discussed in this Chapter, together with possible avenues for future 
research arising from the findings.
6.2 T h e  R o l e  o f  GATA-2
The evidence for a negative, regulatory role for GATA-2 in the control of emMyHC 
expression remains only an initial observation, and some questions remain unanswered. 
First of all, as discussed in Chapter Five, a more detailed study generating more data 
for statistical analysis is required. Assuming that the initial observations hold, however, 
one of the uncertainties is whether GATA-2 is binding directly to emMyHC upstream 
regulatory elements, or acting indirectly through the activation of another signalling 
intermediate. Evidence for a direct interaction is provided by the putative GATA-2 
binding site in the pEGFP/5.25 kb reporter construct. There is also a precedent in 
cardiac development for the control of MyHC gene expression by members of the 
GATA family. GATA-4 has been demonstrated to bind directly to the slow/p MyHC 
regulatory region (Wang et a l, 1998). Further confirmation of direct binding would 
need to be attained through other methods, perhaps the easiest method being the 
generation of reporter constructs that specificially lacked the -4kb GATA-2 binding 
site. Another possibility is the mobility shift, or band-shift, assay (Fried and Crothers, 
1981; Gamer and Revzin, 1981). This technique exploits the difference in mobility of 
the transcription factor or DNA fragments, compared to bound DNA/protein 
complexes, during gel electrophoresis.
Another question is the identity of other ti'anscription factors, if any, that might be co­
operating with GATA-2 in the putative regulatory role. The particular outcome of 
generic signal transduction or transcription factor activity is mediated by interactions 
between different pathways. In examples such as pathways downstream of IGF-1 
signalling (Singleton and Feldman, 2001), or calcineurin signalling (Crabtree, 1999), 
specificity is often conferred at the level of combinatorial activation of gene expression
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by transcription complexes. The association between GATA family members and 
NFAT is well studied (Molkentin et a l, 1998) and has been reported in GATA-2 and 
NFAT-2 in particular (Sakuma et a l, 2003). However, GATA has also been reported as 
a co-factor for other factors such as MEF-2 (Morin et a l, 2000). Consensus binding 
sites for both NFAT and MEF-2 have been uncovered in the emMyHC/5.2 kb 
construct. However, GATA factors can also self associate as functional homodimers 
(Crossley et a l, 1995), or as heterodimers with different GATA family members 
(Charron et a l, 1999). If it could be determined which of these transcriptional co­
factors are operating in conjunction with GATA in the regulation of emMyHC, this 
could detennine the upstream pathways that are involved and help further pick apart the 
molecular mechanisms for developmental emMyHC down-regulation.
6.2.1 F ib r e  t y p e  s w i t c h
The studies into the function of the porcine GATA-2 found no evidence in support of, 
or refuting, a role for GATA-2 in mediating the fast to slow switch in fibre-type. This 
was largely due to the mismatch between the in vitro differentiation model and the set 
of RT-PCR primer and probe sets for quantifying MyHC family expression. While the 
C2C12 cells proved a useful differentiation model, the MyHC primers and probes 
available to the project were porcine specific. Unfortunately there was insufficient time 
left to the project work to obtain murine primer and probe sets, and the use of a cell line 
as opposed to unaltered myoblast cells would have posed other problems may have 
given a false indication of the in vivo situation. Resolving the issue of non-myoblast 
contamination of the primary porcine muscle isolates and obtaining differentiated 
myotubes would rescue the primary cell culture as a useful model for RT-PCR studies. 
As demonstrated in the study by Da Costa et a l (2002), the use of quantitative real­
time RT-PCR to pinpoint changes in MyHC expression is a useful means to observe 
changes in fibre phenotype in the pig.
One avenue of research that might be explored is the relationship of GATA-2 with 
proliferator-activated receptor y-coactivator-la (PGC-la). As discussed in Section 
1.3.4.3, PG C -la has been described as a positive regulator of the slow-fibre phenotype 
(Lin et a l 2002). At the time of writing, there has been no report of an interaction 
between GATA-2 and PGC-la, either in muscle or any other tissue. There is an
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indirect connection, however, in that both PG C -la and GATA factors are associated 
with the regulation of peroxisome proliferator-activated receptors (PPARs) in other 
tissues, the PPARy isoform in particular. The PPARs are lipid-activated nuclear 
receptors that transcriptionally regulate genes involved in a variety of metabolic 
processes (reviewed in Berger and Moller, 2002). PG C -la is a co-activator of 
transcription with PPARy in adipose tissue (Puigserver et al. 1998), while the GATA 
factors act upstream of PPARy, regulating its transcription. GATA-2 and -3 down- 
regulate adipocyte PPARy expression (Tong et al. 2000), while in contrast GATA-6 
promotes PPARy expression in vascular smooth muscle (Abe et al. 2003), though it is 
not known if a similar interaction between GATA-2 and the PPARs exists in skeletal 
muscle. The relationships, if  any, between GATA-2 activity and either PG C -la or the 
PPARs might be a useful subject for further studies investigating a role for GATA-2 in 
the regulation of muscle fibre type and metabolism.
6.2.2 D e v e lo p m e n t  a n d  R e g e n e r a t i o n
To a certain extent, the process of muscle regeneration recapitulates the process of 
embryonic development (Parker et a l, 2003), with a number of featirres common to the 
two. For example, the c-met receptor mediates myoblast migration in both satellite-cell 
regeneration and embryogenesis (Tatsumi et a l, 1998; Buckingham et a l, 2003). With 
regard to MyHC expression, a similar pattern of activation of developmental isoforms 
is observed in the formation of myotubes during regeneration, cell culture in addition to 
prenatal myogenesis (Weydert et a l, 1987; Da Costa et a l, 2003; LaFramboise et a l, 
2003). If the effect of GATA-2 on emMyHC expression in development is genuine, as 
the expression data suggests, one question that might then be asked is whether GATA-2 
performs the same function in satellite cell differentiation.
As already discussed, there are previous reports of a role for GATA-2 in aspects of 
muscle biology mediated by satellite cell activation and differentiation, such as 
regeneration (Sakuma et a l 2003) and hypertrophy (Paul and Rosenthal, 2002). 
Sakuma et al. (2003) report a gradual increase in GATA-2 co-precipitation with NFAT- 
2 following muscle injury. It might be usefril to determine whether this is similarly 
associated with a decrease in emMyHC expression, as in the proposed interaction in 
development. Such experiments necessitate an in vivo model, though given the numbers
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of animals that a time course study might involve and the required lack of genetic 
variability, a rodent model might be a better choice over the pig for such studies. 
Similarly, observing the relative levels of GATA-2 and emMyHC following 
hypertrophic stimuli, such as IGF-1, could determine whether the relationship is 
common to differentiating satellite cells and developing muscle.
6.3  NFAT D i s t r i b u t i o n
The studies into the porcine NFAT-2 oithologue remain incomplete without the full 
transcript. The only two findings gleaned from this study on the porcine NFAT-2 
orthologue were the 3 ’ sequence information data and the expression data. Without any 
functional studies, the conclusions that can be drawn from the results of this study 
remain speculative. Firstly, the sequence data recovered indicates that the isoform in 
question is a distinct form from the other porcine NFAT-2 isofonn isolated from the 
pig, the NFATmac isolated from porcine macrophages (Miskin et a l, 1998). Both 
isoforms are closest in 3’ transcript structure to the human NFAT-2b isoform (Serfling 
et a l, 2004). The length of the 5’ UTR of either porcine isoform seems different 
enough from the NFAT-2a and -2c isofoims to suggest a significantly different family 
organisation in the pig, though this is impossible to verify without the 5’ sequence data 
for the transcript represented by NFAT clone-3.
The expression patterns of the NFAT-2 isoform are very different from that of the 
porcine GATA-2, suggesting a different role in function. While GATA-2 showed 
distinct upregulation late in development, NFAT-2 remained at a fairly constant level 
throughout development, at low levels compared with the adult. If there is a 
relationship between GATA-2 expression patterns and the possible regulatory role over 
emMyHC, then the differences would suggest that this particular NFAT-2 isoform is 
not acting as a co-factor for GATA-2 in the control of emMyHC. If the problems 
encountered in the NFAT cloning could be resolved, perhaps through through 
optimisation of different RACE techniques, the isolation of a full-length porcine 
NFAT-2 would go a long way to answering these questions.
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